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ABSTRACT OF DISSERTATION

THE ROLE OF CO-INFECTION IN THE SPREAD OF HIV
IN SUB-SAHARAN AFRICA
The cause of the high HIV prevalence in sub-Saharan Africa is incompletely understood,
with heterosexual penile-vaginal transmission proposed as the main mechanism.
Heterosexual HIV transmission has a very low probability; further, a single estimation of
heterosexual probability of HIV transmission fails to reproduce the variation associated
with important biological cofactors. In particular, studies of HIV incidence suggest that
co-infection with other infectious diseases influence the HIV transmission, and therefore
might substantially vary the pattern of the spread of the infection. To assess the effect of
co-infection on the spread of HIV, I developed and analyzed several mathematical and
statistical models based on published data. The results show that despite the low
probability of heterosexual transmission per sexual contact, the inclusion of individual
variation generated by transient but repeated increases in HIV viral load associated with
co-infections may provide a biological basis for the accelerated spread of HIV in subSaharan Africa, and raises the possibility that that the natural history of HIV in subSaharan Africa cannot be fully understood if individual variation in infectiousness is
neglected.
Co-infection might be a key explanatory variable for the rapid spread of HIV
infection in sub-Saharan Africa; in fact, co-infection may be a necessary factor, rather
than merely being a contributing factor, in the successful spread and survival of HIV in
populations where heterosexual vaginal-penile contact is the main mechanism of
transmission. Consequently, broad population based control strategies to decrease
infectivity and reduce the incidence of other sexual and parasitic infectious diseases
might be effective strategies in diminishing the spread of HIV in sub-Saharan Africa.
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Chapter 1 - Introduction

Overview
AIDS was first described in 1981 in homosexual men in North America (Gottlieb et al.,
1981) followed by the first report in patients from Central Africa in 1983 (Clumech et al.,
1983). Three years later, it was evident that HIV-1 had spread into populations of many
countries from sub-Saharan Africa and had become an enormous public health problem
(Quinn et al., 1986). Of the estimated 40 million HIV-seropositive patients in 2001, 70%
were from sub-Saharan Africa, residence of less than 10% of the human population
(UNAIDS/WHO). According to the global HIV/AIDS/STI working group
(UNAIDS/WHO), an HIV epidemic is generalized if the prevalence in pregnant women
consistently exceeds 1%. Using this definition, in 1999 the HIV epidemic was
generalized in most of the countries of sub-Saharan Africa. By contrast, in Asia, the
second most affected continent, only three countries had a generalized HIV epidemic
(UNAIDS).
The causes of the uncontrollable expansion of the HIV epidemic in most countries
from sub-Saharan Africa is incompletely understood (Curran et al., 1988; Hall et al.,
2008; Karon et al., 2001). Unlike the HIV epidemic in the US and Europe, which seems
concentrated in specific high risk groups such as injection drug users and men who have
sex with men (MSM) (Curran et al., 1988; Karon et al., 2001; Orroth et al., 2007), the
epidemic in Africa is more widely distributed across the general population. The core risk
group concept, the theory that a small group of people with large number of partners and
repeated infections can maintain a reservoir of the infection within a population, does not
fit in sub-Saharan Africa, where the infection has spread broadly beyond the putative risk
groups (Hamilton et al., 2008).
Additionally, the hypothesis that heterosexual penile-vaginal transmission is the
main mechanism of HIV transmission in sub-Saharan Africa (Gisselquist and Potterat,
2002; Orroth et al., 2007; Vernazza et al., 1999; Waver et al., 2005) seems inconsistent
with the low probability of heterosexual HIV transmission, estimated to be ~ 1/300 per
1

coital act in low-income countries (Boily et al., 2009; Gisselquist and Potterat, 2003). In
particular, the assumption that the high incidence of HIV epidemic among African adults
is almost exclusively due to sexual transmission actually requires much higher
probabilities of heterosexual transmission in Africa than in the developed world (Boily et
al., 2009). These contrasting differences observed among the HIV epidemics from
different settings of the world raise a fundamental question: why does HIV prevalence
vary so greatly in different locations? Answers to this question would help us to better
understand the natural history of HIV and implement appropriate interventions. The
identification of biological or behavioral factors that could explain the variation in
prevalence of HIV infection may help us to design the more efficient public-health
strategies to control the epidemic.
Epidemics caused by the transmission of infectious agents such as HIV are
characterized by heterogeneities in the pathogen and host populations, and interactions
between them profoundly affect the dynamic of the infection. There are several
epidemiologically important sources of variation: disease independent host parameters
such as sex, age and contact rates, and disease dependent host parameters such as
susceptibility, transmission rate and duration of the infectiousness. Resulting from the
possible influence of the population heterogeneity on the transmission efficiency of the
virus, individual variation emerges as an important element for understanding the natural
history of HIV. Regional factors may affect the spatial spread of the infection, while
individual heterogeneities such as behavior may influence the pattern of the spread of the
infection within populations. To understand the natural history of HIV, particularly in
sub-Saharan Africa, and thus generate the most cost-efficient method to control the HIV
epidemic, it becomes fundamental to identify the factors that generate the individual
variation on the HIV infectivity in space and time.

Background and motivation
The causes for the extremely high HIV prevalence in sub-Sahara Africa is one of the
biggest debates nowadays. Most attempts to explain the epidemic are based in behavioral
2

components of the population (i.e. number of sexual partners per year, partnership
concurrency and commercial sex), yet they have not explained satisfactorily the dynamic
of the HIV epidemic in sub-Saharan Africa. Unlike HIV in the US and Europe, which
seems concentrated among injection drug users and men who have sex with men (Curran
et al., 1988; Hall et al., 2008; Karon et al., 2001), the epidemic in Africa is evenly
distributed into the general population, with heterosexual penile-vaginal contact proposed
as the main mechanism of transmission (Gisselquis et al., 2002; Orroth et al., 2007;
Vernazza et al., 1999; Waver et al., 2005).
The transmission efficiency of the virus and behavioral parameters such as the
number of sexual partners per unit of time play a fundamental role in determining the
course of the HIV epidemic. For sexually transmitted infections (STI), the contact rates
are commonly used as a measure of the variation in infectiousness and susceptibility.
With a high rate of partner change, sexual behaviors are assumed to determine how
rapidly a STI can spread into the population. Thus host contact rates are used as a
measure of individual infectiousness leading to the concept of high-risk (core groups)
where most individuals experience low or no transmissions but a few are responsible for
most of the transmissions (Bansal et al., 2007). This assumption, however, only captures
the variability of the transmission generated by sexual behavior and therefore assumes
constant infectivity of HIV across human populations. Based on this premise many
studies have focused on the study of sexual behavior to understand the natural history of
HIV. These studies have indicated that despite substantial regional variation in the
prevalence of multiple partnerships, most people report having only one recent sexual
partner. Particularly, surveys and standard measures available for African countries
indicated that monogamy or serial monogamy is the dominant pattern (Ferguson et al.,
2004; Kapiga and Lugalla, 2002; Lagarde et al., 1996; Wellings et al., 2006).
Additionally, studies attempted to clarify the role of sexual behavior on the
pattern of the HIV epidemic from different locations have found that sexual behavior did
not appear to explain the observed differences in HIV prevalence (Ferry et al., 2001).
These results support the possibility that highly infectious individuals are not only
dependent on the contact rate but also may depend on other sources of host variation
generated by biological cofactors. Hence, a fixed value for the infectivity of HIV may
3

ignore important differences associated with biological cofactors such as circumcision
and the presence of co-infections with other STIs (Powers et al., 2008).
Studies have indicated that the infectivity of the virus is not constant but may vary
with space and time, and demonstrated that the risk of HIV transmission could be
strongly correlated with variations in blood viral burden (Corey et al., 2004; Pilcher et al.,
2004; Zetola and Klausner, 2007). Furthermore, a wide range of infectious diseases, from
STI to parasitic diseases, may affect the HIV viral load triggering an amplificatory effect
in the risk of HIV transmission in co-infected individuals (Corey et al., 2004; Freeman et
al., 2007; Kublin et al., 2005; Zetola and Klausner, 2007). Thus, biological cofactors such
as co-infections may then play an important role to understand the temporal and
individual variation on the infectivity of HIV.
The aim of this study was to explore the limitations of the consideration that the
existent heterogeneity on HIV infectivity could be explained merely by variations on
sexual behavior. Additionally this study wants to show some evidence that disregarding
the variation across individuals on the HIV infectivity generated by biological cofactors
would fail to describe the natural history of HIV, especially in sub-Saharan Africa.
Determining the degree of host heterogeneity in the transmission of the virus and the
sources of this variation is especially important: it may help us to understand the
contrasting differences on the pattern of the spread of the infection in different locations;
consequently it would allow us to identify the characteristics of super-infectious
individuals responsible for the majority of transmissions.
This study will be guided by the hypothesis that the inclusion of temporal and
individual variation on the infectivity of HIV generated by transient but repeated
increases in viral load affects the pattern of the spread of the infection at population level,
and could potentially explain the differences on the HIV epidemic between populations.
This research was conducted through mathematical and statistical analyses at three
specific levels of sources of variation explored in the different chapters: (1) Chapter 2
focused on population level variations generated by the structure of the sexual network
and the prevalence of co-infection with other STIs, (2) Chapter 3 and 4 assessed the
regional variations generated by the co-infection with environmental diseases such as
4

malaria, and (3) Chapter 5 and 6 explored the host variation generated by the immune
response in presence of co-infections, and methodological issues regarding control
interventions based on co-infections. The analyses of published data was focused on
describing the possible causes of the differences on HIV prevalence between locations,
and the implications of individual variations on the HIV infectivity on the spread of the
disease at population level.

Copyright © Diego Fernando Cuadros 2011
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Chapter 2 - Effect of variable transmission rate on the
dynamics of HIV in sub-Saharan Africa

Introduction
The cause of the high HIV-1 prevalence in sub-Saharan Africa is incompletely
understood (Curran et al., 1988; Hall et al., 2008; Karon et al., 2001). Unlike HIV in the
US and Europe, which seems concentrated among injection drug users and men who have
sex with men (Curran et al., 1988; Karon et al., 2001; Orroth et al., 2007), the epidemic in
Africa is more widely distributed across the general population, with heterosexual penilevaginal transmission proposed as the main mechanism (Gisselquist and Potterat, 2002;
Orroth et al., 2007; Vernazza et al., 1999; Waver et al., 2005).
Mathematical models are powerful tools in epidemiology: they can facilitate
understanding of the interplay between the variables that determine the course of
infection within an individual and the variables that control the pattern of infections
within communities of people. But, mathematical modeling studies that attempt to
reproduce the observed HIV epidemic curve in sub-Saharan Africa are often criticized for
using per-contact and per-partnership heterosexual transmission efficiencies that are
improbably high (Brewer et al., 2007; Deuchert, 2007). For example in the calculation of
per-partner rate of transmission, behavioral parameters such as number of sexual partners
per year and number of sexual contacts per partner may be overestimated by assuming
levels of promiscuity in African societies that are too high (Brewer et al., 2007).
Unlike more traditional epidemiological approaches that focus strictly either on
individuals or on populations, sexual networks are based on the dynamics of the sexual
links (connections between nodes = between individuals) and the topology of the linkage
in a group (Doherty et al., 2005; May and Lloyd, 2001). Sexual networks have multiple
advantages for characterizing individual heterogeneity of sexual behavior. This approach
to understanding the spread of a sexually transmitted infection (STI) has focused
attention on the properties of the frequency distribution of sexual partner number. In
sexual networks, partner number is the node degree, the number of sexual links that each
6

node (individual) has to others (Hamilton et al., 2008). Thus, network studies mainly
focus on the distribution of node degree, which can be characterized by the data
(Handcock and Holland, 2004).
Network models also focus on other components of the network structure that
cannot be described from the observation of individual nodes alone. The degree
distribution is only one example of an aggregate statistics obtained by the study of the
individual properties within the network. For the calculation of other statistics, such as
the level of clustering, it would be necessary to observe larger fragments of the network
(Proulx et al., 2005). Clustering measures focus on describing both the connections from
focal nodes and the connections made by its neighbors. In particular, high levels of
clustering may reduce the rate of spread of an infectious disease (Witten and Poulter,
2007).
The typically high skew of sexual degree distributions has suggested that sexual
networks may follow a power law (scale-free) distribution (Lilijeros et al., 2001; Ravasz
and Babarasi, 2003). Power law distributions are characterized by many nodes with only
one or few connections but also a few nodes with many more connections, generating a
high contact variance. The high variance generated in large populations that follow the
power law distributions implies that even very low transmission rates are consistent with
disease spread (Anderson and May, 1991; May and Lloyd, 2001).
Most of the studies that have attempted to describe sexual behavior in Africa have
found that the power law distribution does not adequately fit the data. Instead, fixed rate
models such as the negative binomial model, which is a generalization of the Poisson
model, appear to fit the degree distribution best (Hamilton et al., 2008; Handcock and
Holland, 2004). In the negative binomial model, the propensities of individuals to form
connections are estimated from a gamma distribution. This approach, with its lower
variance in connectedness among nodes, raises the possibility that the infectivity of HIV
may be an important determinant of the epidemic in sub-Saharan Africa (Anderson and
May, 1991; Doherty et al., 2005).
Yet this conclusion is inconsistent with the low probability of heterosexual HIV
transmission, estimated to be ~ 1/300 per coital act in low-income countries (Boily et al.,
2009; Gisselquist and Potterat, 2003). Moreover, studies that attempted to estimate the
7

probability of HIV transmission per sexual contact have found that the Bernoulli model
accurately estimates the per-partner probability of HIV transmission but does not seem to
correlate with the number of sex acts and thus fails to estimate the per sexual contact
probability of transmission (Padian et al., 1990). It has been suggested that the constant
transmission probability in the Bernoulli model may be the problem: variability of
infectiousness among individuals and over time, such as may arise from important
transmission cofactors, may be essential for a realistic representation of HIV transmission
(Kaplan, 1990; Padian et al., 1990; Powers et al., 2008).
Despite the low probability of heterosexual penile-vaginal transmission per sexual
contact, some studies have demonstrated that the risk of HIV transmission can be
strongly correlated with variation in blood viral burden (Attia et al., 2009; Cohen et al.,
2007; Pilcher et al., 2007). The most relevant finding from these studies is that
infectiousness can be directly correlated with the concentration of HIV-RNA in blood,
which indicates shedding of the virus into genital track secretions.
In a pioneering study attempting to correlate the viral load and the transmission of
the virus, Quinn and coworkers (Quinn et al., 2000) measured the HIV-RNA load in the
blood of more than 15 000 subjects. They found that the virus was hardly ever
transmitted by infected subjects with less than 1500 copies of HIV-RNA/ml, whereas
individuals with more than 50 000 copies infected their sexual partners at a rate of 23 per
100 person-years over 30 months.
A similar study conducted with discordant couples for HIV status in Uganda
showed the existence of a strong correlation between HIV plasma viral load and HIV
transmission rates (Wilson et al., 2008). The Uganda study indicated that a ten-fold
increment in viral load could increase the risk of HIV transmission per sexual contact
2.45-fold (95% CI 1.85-3.26). They pointed out that although blood and semen reside in
separate biological compartments, blood viral burden can be correlated with viral burden
in semen.
Growing evidence suggests the existence of additional biological factors that
cause variations in the viral load. The viral set point is actually not constant and may be
perturbed by reactivations of the immune system, such as those resulting from the
invasion of other pathogens (Bentwich et al., 1995). Changes in the host immune
8

response may account for variations in the viral load that could make the host more
infectious and increase the risk of transmission.
The average African host is usually exposed to numerous bacterial, viral and
parasitic infections. Of special importance is the very high prevalence of STIs,
particularly genital ulcerations caused by herpes simplex virus type 2 (HSV-2) (Bentwich
et al., 1995). The existence of a synergistic relationship between HIV and HSV-2 has
been strongly suggested by many observational and biological studies in which HSV-2
has been implicated as a biological cofactor for the acquisition and transmission of HIV
(Glynn et al., 2008; Weiss et al., 2001).
The rapid spread of HIV as a sexually transmitted disease is exceeded by that of
HSV-2 (O'Farrell, 1999). The prevalence of HSV-2, which may be as high as 75% among
women in parts of sub-Saharan Africa (WHO/UNAIDS/LSHTM), has reached a
prevalence of up to 90% in HIV-positive persons (Weiss et al., 2001).
While bacterial STIs such as gonorrhea and syphilis, which also amplify the risk
of HIV transmission (John-Arne et al., 2001), tend to be concentrated in high risk groups
(Brunham and Plummer, 1990), the biological characteristics of HSV-2 allow this virus
to be sustainable at high levels in the general population, as observed in sub-Saharan
Africa (Corey et al., 2004). Consequently, as the HIV epidemic reaches the general
population, the epidemiological overlap between HSV-2 and HIV is considerably larger
than any other STI.
The ulcers caused by HSV-2 contain substantial numbers of CD4+ lymphocytes,
the target cell for HIV, and therefore are likely to facilitate the acquisition of HIV in
HIV-negative individuals (Celum et al., 2004). Additionally, the high levels of HIV-RNA
in herpetic lesions from dually infected patients (Schacker et al., 1998) may be explained
by studies in vitro demonstrating that HSV-2 increases HIV transcription, which supports
the higher infectivity in co-infected individuals. Population-based studies have also
demonstrated that HIV-RNA levels can increase during active HSV-2 infection (Mole et
al., 1997), and suppression of HSV-2 with acyclovir was associated with a measurable
decrease on the HIV-RNA levels (Schacker et al., 2002).
The enhanced HIV infectivity caused by HSV-2 co-infection has also been
corroborated by population-based studies suggesting a relative risk of three-to five-fold
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of HIV transmission from co-infected individuals compared to HSV-2 seronegative
persons (Buve et al., 2001; Corey et al., 2004; Gray et al., 2001). These data, which
indicate epidemiologic synergy between the two infectious diseases at the population
level, suggest that HSV-2 may be playing a key role fueling the HIV epidemic in subSaharan Africa (Abu-Raddad et al., 2008).
The activation of the immune system, however, is not only produced by STIs such
as HSV-2, syphilis and gonorrhea. Parasitic infections such as helminth infections,
leishmaniasis and malaria might produce a strong response from the immune system and
consequently generate similar effects on the replication of the virus in HIV co-infected
individuals (Bentwich et al., 1995; Korenromp et al., 2005; Kublin et al., 2005; Pisell et
al., 2002; Reina et al., 2006). The geographical overlap observed between malaria and
HIV infections has suggested a possible interaction influencing HIV transmission in
some countries of sub-Saharan Africa. Malaria occurs throughout the tropical world,
where it remains one of the most prevalent infectious diseases, with an estimated 300
million cases per year (CDC).
The evidence of an interaction between malaria and HIV comes from various
sources. Several in vitro studies have found that malaria antigens significantly enhanced
HIV-1 replication (Kublin et al., 2005; Pisell et al., 2002; Reina et al., 2006; Xiao et al.,
1998). Additionally, population-based studies conducted with HIV-1 infected adults have
indicated that the HIV-1 RNA concentration almost doubled between baseline (96 215
copies per ml) and those co-infected with malaria (168 901 copies per ml). The authors
concluded that HIV-positive individuals co-infected with malaria had a significantly
increased viral load and possibly increased infection transmission (Kublin et al., 2005).
Based on the evidence previously mentioned, this study examines the limitations
of the view that the level of the HIV epidemic in sub-Saharan Africa could be explained
merely by a constant probability of transmission. We suspected that disregarding the
variation across individuals in HIV infectivity would fail to replicate the HIV epidemic
observed in a sexual network from sub-Saharan Africa. Instead, we predicted that
individual and temporal variations in HIV transmission generated by biological factors
such as co-infections with other infectious diseases could explain the severity of the HIV
epidemic.
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Methods
With the aim of testing the effect of temporal and individual variation on HIV
transmission generated by co-infection, we developed a dynamic sexual network model
(Witten and Poulter, 2007). Modeling studies of sexual networks have focused primary
on the node degree distribution (Bell et al., 2002; Doherty et al., 2005; Hamilton et al.,
2008; May and Lloyd, 2001). But the partnership acquisition process relevant to HIV
infections is too complex to be adequately captured by a static degree distribution. Other
nodal attributes such as gender, age and marital status are also of fundamental
importance, as are the dynamics of the linkages themselves. To include these
characteristics, we used Monte Carlo simulations to depict a dynamic sexual network
with given nodal and structural characteristics, where links between nodes are formed
and dissolved according to estimated parameters.
The model incorporates the dynamic of the behavioral components of the
population, as well as the dynamics of HIV and the co-infection effect on the HIV
transmission caused by other infectious diseases, including HSV-2, gonorrhea, syphilis
and malaria, along with the spread of HIV infections caused by commercial sex. We used
data from studies in Malawi when available as an example of a generalized HIV epidemic
(Helleringer et al., 2007a; Helleringer et al., 2007b; University of Pennsylvania, 2003).

Model structure
A stochastic, individual-based sexual network model was created to simulate disease
dynamics using the MATLAB® computing language version 7 (The MathWorks, 19942008). The model was divided in two main modules: a behavioral module and an
epidemiological module.
Sexual partnerships were assumed to be exclusively heterosexual, and two types
of partnerships, distinguished by duration, were considered. The population size
remained constant, with individuals maturing into the network to offset those who die or
mature out of the network. In accord with the highest resolution of relevant data, a
monthly time step was used. With this model, the effects of network structure on disease
transmission, relationship type, and co-infection with other infectious diseases were
evaluated.
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For the estimation of the main parameters of the sexual network, data were used
from a study of Malawi by the University of Pennsylvania Population Study Center and
called “The Malawi Social Network Project” (University of Pennsylvania, 2003), as well
as data from the Demographic and Health Survey (DHS) database from Malawi (National
Statistical Office). The study was conducted in three districts of Malawi, and the
sampling strategy is explained elsewhere (Helleringer et al., 2007a; Helleringer et al.,
2007b). The study focuses on the description of the sexual behavior in the Malawi
population, where the more important characteristics such as age distribution, number of
sexual partners per year, type of relationship, duration of the relationship and age mixing
patterns of marriage were derived. Table A.1 in Appendix A lists the key assumptions of
the behavioral module.
Equal numbers of individuals of each sex were created and assigned an age and
node degree (maximum number of partners per year). Consequently, individual age was
used to determine when individuals should be removed from the sexual network and was
the basis for other age-specific traits. The epidemiological module was subdivided into
two steps, the spread of the infections, and the progression and recovery of each
infection. We selected gonorrhea and syphilis as examples of bacterial STIs concentrated
in the high-risk (core) groups based on the amplification effect on HIV transmission, and
their relevance in terms of prevalence in the Malawi population (Lule et al., 1994;
Mensch et al., 2008). The dynamics of these infections are well known, and the effect of
each infection on the transmission of HIV has been determined.
We also included two infections with high prevalence in the general population:
herpes simplex virus type 2 (HSV-2) and malaria. The chronic nature of HSV-2 and its
relatively high transmission efficiency make it sustainable in the general population.
HSV-2 reactivations increase HIV transcription (Golden et al., 1992), which in turn
generates an increase in the HIV plasma viral load (Mole et al., 1997) and supports
higher HIV infectivity in dually infected individuals (Quinn et al., 2000). The evidence
suggests an epidemiologic synergy between both diseases, and HSV-2 has been
postulated as the most important STI driving the HIV prevalence in sub-Saharan Africa
(Abu-Raddad et al., 2008).
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We included malaria as an example of a parasitic infection, given its geographical
overlap with HIV and its high prevalence in Malawi. Malaria is endemic in all parts of
Malawi and many other countries in sub-Saharan Africa. According to The World Health
Organization, 6 million of episodes of malaria occurred in 2006, accounting for about
33% of all outpatient visits in Malawi. In one study malaria, infection was associated
with a 78% higher HIV RNA concentration than in malaria-free individuals also infected
with HIV (Kublin et al., 2005). Table A.2 in Appendix A lists the key assumptions of the
epidemiological module.
A key assumption for the epidemiological module is that the interaction caused by
co-infection has only one direction. In other words, we assumed that HIV infection has
no effect on the natural history of the other infectious diseases included in the model.
This assumption may be seen as an oversimplification, because studies have shown that
HIV infection affects the transmission and progression of other infectious diseases such
as HSV-2 and malaria. Yet, studies have mainly focused on the impact of co-infection on
HIV. As a result, uncertainty about the effect of co-infection on the other diseases is still
high.
The core of our model is the spread of HIV infection, through penile-vaginal
contact. Before the introduction of HIV infected individuals, the model simulates for
several months the dynamic of the other infectious diseases previously mentioned. When
an endemic steady state for all infectious diseases is reached (after about 500 monthly
time steps), the model introduces HIV infected individuals until the HIV prevalence
reaches 1%, which is the prevalence observed in Malawi in 1981 (Crampin et al., 2002).
For our simulation, the algorithm assessed whether the individual infected with
HIV has another infectious disease, and if co-infection was present, the HIV transmission
probability was increased depending on the amplification factor. Then, the new HIV
transmission probability including the amplificatory effect was calculated by
Tc = T * cofactor .
where T is the stage or sex-specific transmission probability per sexual contact (Table
A.2 parameter 1-6). The HIV transmission probability per partnership per month is then
calculated using the binomial (Bernoulli) model as
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Tp = 1 − (1 − Tc )cn ,

where Cn is the number of sexual contacts the individual has with the partner.
Cofactor values of the STI's included in the model were obtained from
population-based estimations expressed as odds ratios and relative risk per sexual contact.
For malaria, we assume that the enhancement on the transmission probability per sexual
contact depends on the logarithmic (base 10) incremental change in the viral load
according to Td ' = Td * 2.45LogInc . The 2.45 factor is the rate ratio increase in transmission

probability with each one-log increment in viral load (Quinn et al., 2000); see Kublin et
al. (2005) for malaria increment data. Cofactor values included in the model are listed in
Table A.2 in Appendix A (parameter 49-53).
When multiple co-infections are present, we assumed a saturation effect of the
enhancement on the transmission probability. Thus, when more than one co-infection is
present, the transmission probability is amplified only by the highest cofactor. For the
special case of HSV-2, the amplification factor is only effective if the HSV-2 infection is
reactivated (shedding) (Celum et al., 2004). Therefore, the algorithm not only verifies the
presence of HSV-2 co-infection but also its reactivation. On the other hand, HSV-2 not
only enhances the transmissibility of HIV but also affects the susceptibility to being
infected with HIV (Celum et al., 2004). For this reason, the algorithm verifies if the
susceptible receptor is infected with HSV-2 and its reactivation stage. In this case, the
transmission probability is also increased by the respective amplification factor (Table
A.2 parameter 53 in Appendix A). A detailed description of the methodology can be
found in the Appendix A.

Calculation of the epidemiologic synergy
HIV infections caused by co-infection with other infectious diseases may also generate
secondary HIV infections, regardless of the presence of co-infection (Abu-Raddad et al.,
2008). Therefore, the HIV prevalence measures both the HIV transmissions caused by the
direct biological effect of co-infection and the secondary or indirect infections caused by
co-infection. We estimated the effect of co-infection on the dynamic of the HIV epidemic
in the sexual network by comparing the prevalence for different scenarios: no coinfection, all co-infections (default scenario), no HSV-2 co-infection, and no malaria co14

infection. We also measured the direct effect of co-infection on the HIV incidence by
using population attributable fractions (PAF) (Heller et al., 2003; Heller et al., 2002;
Rockhill et al., 1998). We estimated the PAF of HIV incidence attributable to all coinfections, HIV-2, malaria, and gonorrhea and syphilis. The PAF is calculated by

⎛
IRnocofactor (t ) ⎞
PAF (t ) = ⎜1 −
Χ 100% ,
⎜ IRdefaultcofactor (t ) ⎟⎟
⎝
⎠
where IRnocofactor (t ) is the incidence rate of HIV in the different scenarios with the
cofactor effect removed at time t, and IRdefaultcofactor (t ) is the HIV incidence rate with the
default cofactor effect at time t (simulation 2) (Abu-Raddad et al., 2008; White et al.,
2008).
To identify the epidemiologic synergy at different periods of the HIV epidemic,
we calculated the PAF for different time points in a separate set of simulations by
removing the cofactor effect on HIV transmission over two years, starting at times (t) 0,
8, 15, and 20 after the introduction of HIV. This allows us to measure of the direct role of
co-infection in HIV incidence at each time point (t). Results from all different scenarios
are based on means over 200 simulations.

Uncertainty and sensitivity analyses of the key parameters
To conduct uncertainty and sensitivity analyses of the key parameters, we adopted the
Latin Hypercube Sampling/Partial Rank Correlation Coefficient (LHS/PRCC) technique
(Blower and Dowlatabadi, 1994; Marino et al., 2008). In LHS the estimation of
uncertainty for each key parameter is modeled by treating each input parameter as a
random variable with a uniform probability distribution function. Upper and lower
bounds on these distributions were assigned based upon the available data.
To study the uncertainty of the parameters for the two different modules, we
conducted three different uncertainty analyses. For the behavioral module, the
simulations did not include the amplification cofactor caused by co-infection. Hence, we
used the default probability of HIV transmission T= 0.003, and we performed a LHS of
the more important behavioral parameters. For the epidemiological module, the
15

simulations included the amplification co-factor caused by confection and we conducted
a LHS of the cofactor values. In the third uncertainty analysis, we performed a LHS of
both the behavioral parameters and the cofactor values. 200 simulations were run for each
uncertainty analysis. The variability in the outcome variable (HIV prevalence) was then
estimated by simple descriptive statistics. Sensitivity analyses were then performed by
calculating PRCCs for each input parameter. The details of these analyses can be found
in the Appendix A.

Results
Sexual network
The graphical representation of the degree distribution (i.e. number of sexual partners per
year) for both males and females shows that the gamma distribution provides a good fit to
the data (Figure A.1). For males, the mean number of sexual partners per year was µ =
2.12, with standard deviation SD = 1.23, and with a scale parameter θ = 1.1 and shape
parameter k = 1.9 for the gamma distribution. For females, the mean number of sexual
partners per year was µ = 1.84 with standard deviation SD = 1.04, and with scale
parameter θ = 0.4 and shape parameter k = 3.8 (Table A.1).
The resulting number of sexual partners per year obtained from the simulations
for both males and females seems to agree with the estimated annual degree distribution
from Malawi (Figure A.1), the age distribution of the entire population (Figure A.2), and
the age distribution of married individuals (Figure A.3). We found, however, that
individuals accumulated more long-term relationships (marriages) throughout their entire
sexual life than indicated by the data (Figure A.4). This inconsistency could result from a
low estimate of the average duration of marriage (~7 years) in the simulations.
Since long-term relationships increase the number of exposures, the risk of
transmission or acquisition of the virus also increases. Consequently, the observed
discrepancy between the lifetime number of long-term relationships observed in the
simulations and the data may generate an overestimation of the HIV prevalence.
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Using the number of connections per month (Appendix A, eq. 9) and the number
of connections generated by individuals who already have one connection, we found that
the frequency of concurrency estimated from the model was 0.3. In other words, 30% of
the individuals who had a sexual partner were in at least one concurrent relationship. This
value seems to be consistent with some estimates of concurrency from sub-Saharan
Africa (Lagarde et al., 2001). See also (Helleringer et al., 2009), where the concurrency
estimate was higher, but concurrent relationships were not clearly distinguished from
serial monogamy (Kretzschmar et al., 2010).

Simulation 1: no co-infection
The first simulation, which included the most recent estimate of the male-to-female
probability of HIV transmission T = 0.003 (Boily et al., 2009), suggests that with this
constant probability of HIV transmission the infection does not survive in the population:
no epidemic can be generated, and HIV prevalence decreases to extinction (Figure 2.1).
On the other hand, with T = 0.005 we observed that the infection can persist and reached
an endemic steady state at a prevalence equal to the initial prevalence (1%). Finally, with
a T = 0.0068 we could generate an epidemic curve similar to the HIV epidemic observed
in Malawi (Figure 2.1). This value is slightly above the 95% confidence interval
estimated for male-to-female probability of HIV transmission (Boily et al., 2009) (see
details in Appendix A).

Simulation 2: amplification cofactor
For this simulation, we used the baseline probability of HIV transmission for low income
countries T = 0.003 (Boily et al., 2009), but we also included the amplification cofactor
for HIV transmission generated by co-infection with HSV-2, gonorrhea, syphilis and
malaria. The results from this scenario showed that the amplification effect caused by coinfection was sufficient to generate an HIV epidemic curve similar to the curve observed
in Malawi (Figure 2.2 B, HIV prevalence estimated for 2005 ~17%).
From our model, we observed that the prevalence for gonorrhea (~2%), syphilis
(~4%), HSV-2 (~40%) and malaria prevalence in dry (30%) and rainy (40%) seasons
resemble the prevalence observed for these STIs in Malawi and other countries of subSaharan Africa (Buvé et al., 2001a; Crampin et al., 2002; Ghani et al., 1998; Holmes et
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al., 2004; Marion and Schecter, 1992; Pinkerton and Abramson, 1997; Salomon and
Murray, 2001; Zetola and Klausner, 2007) (Figure 2.2 A).
Even when parameter values of the model were obtained independently of the
Malawi data, our results resemble the HIV prevalence as well as the age distribution
prevalence observed in that country (Figure A.5 A, B). As reported in the data, the female
HIV prevalence was higher than the male prevalence; the resulting age distribution of
prevalence, however, differs somewhat from the distribution reported for Malawi. In our
results, the peak of the prevalence is located at ages 25-29 for both males and females,
while the data suggest that the peak is at ages 30-34. The model also overestimates the
HIV prevalence at early ages (Figure A.5 A, B).
We compared the simulated age distribution of HSV-2 prevalence with the
observed prevalence in Malawi. The age distribution for HSV-2 obtained from the
simulation is consistent with the data, but the resulting HSV-2 prevalence is somewhat
lower than the prevalence observed in Malawi (Figure A.5 C, D).
Our results also showed that more than 40% of the HIV infections were
associated with HSV-2 co-infection (Figure 2.3 A), and more than 70% of the total HIV
transmissions were associated with STI or malaria co-infection (Figure 2.3 C).
Significantly, these values indicate that transmission was commonly by co-infected
individuals, but the results do not estimate the incidence of HIV due to the direct effect of
co-infection.

Simulation 3: no HIV-HSV-2 co-infection
Because HSV-2 was the most important infectious disease in terms of co-infected
individuals who transmitted the HIV infection (Figure 2.3 A), we simulated the absence
of the amplificatory effect generated by HSV-2. For this simulation, the prevalence
decreased to ~6% in comparison with the prevalence observed in simulation 2 (Figure 2.4
A).

Simulation 4: no HIV-malaria co-infection
Without the malaria amplification effect, the HIV prevalence declined to ~10%,
indicating that malaria contributed ~7% to the overall HIV prevalence (Figure 2.4 B).
This result is higher than the result obtained by Abu-Raddad and coworkers (Abu-Raddad
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et al., 2006), who simulated the co-infection effect of malaria on HIV infection in
Kisumu, Kenya, using a system of differential equations. They found that excess of HIV
prevalence caused by malaria was 2.1%.

Population attributable fraction
The results indicated that the proportion of new HIV infections due to all co-infections
together was >50% and that this value remained constant over time (Figure 2.5 A). When
we obtained the PAF for each infection, however, we observed different patterns
throughout the simulation. At the beginning of the HIV epidemic, infections such as
gonorrhea and syphilis had the highest PAF (~26%). Over time, their influence on the
spread of HIV decreased to a final PAF of 13%, 20 years after the introduction of HIV
(Figure 2.5 B). In contrast, common infections in the general population such as malaria
and HSV-2 had a low initial PAF (~12%), followed by an increase. In agreement with
previous studies (Abu-Raddad et al., 2008; Freeman et al., 2007) we found that the PAF
due to HSV-2 increases during the first 10 years and then remained constant after 15
years from HIV introduction at the highest PAF (~30%).
Likewise, the proportion of new HIV infections caused by malaria increased
during the early years of the epidemic, and then remained constant after 15 years from
HIV introduction, with a PAF of ~ 25% (Figure 2.5 B); this value is in close agreement
with previous results for eastern sub-Saharan Africa based on regression analysis
(Cuadros et al., 2011b).

Discussion
Our results indicate that a data-supported fixed value for HIV infectivity fails to describe
the dynamics of the epidemic. Regardless of the low probability of heterosexual
transmission per sexual contact, the inclusion of individual variation in HIV infectivity
generated by transient but repeated increases in HIV viral loads associated with coinfections may substantially increase the transmission rate (Cohen et al., 2007).
Our model thus suggests that the HIV epidemic in sub-Saharan Africa may be
explained by heterosexual transmission, and supports the hypothesis that variation among
individuals and through time caused by biological cofactors such as co-infection may
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have triggered the vast HIV epidemic observed in sub-Sahara Africa. The high
prevalence of infectious diseases such as malaria and HSV-2 probably provided suitable
conditions for the spread of the infection in the general population.
The remarkably high HIV prevalence observed in sub-Saharan Africa may thus
reflect the particular environment at the early and mature stages of the epidemic that are
unique to this part of the world (Abu-Raddad et al., 2008). These results highlight the
possibility that co-infection is a necessary rather than merely a contributing factor in the
successful spread and survival of HIV in populations where heterosexual vaginal-penile
contact is the main mechanism of transmission.
According to our results, 50% of all new HIV infections throughout the epidemic
can be attributed to co-infection with the infectious diseases included in the model.
However, we observed opposite time trends in the contribution from two infections with
low prevalence in the general population (i.e. decreasing trends for gonorrhea and
syphilis), and from infections with high prevalence (i.e. increasing trends for HSV-2 and
malaria).
Some similar results have been obtained in previous studies (Abu-Raddad et al.,
2008; Freeman et al., 2007; White et al., 2008), but none has documented the pattern in
PAF that we observed for malaria throughout the epidemic. Our model is the first to
include not only the co-factor effect of other STIs on HIV transmission but also the cofactor effect of a parasitic disease such as malaria in the same simulation. The expected
high frequency of malaria-HIV co-infected individuals who transmitted the HIV infection
(Figure 2.3 A) raises the possibility that parasitic diseases like malaria with high
prevalence in Africa, may be playing a similar role to that STI like HSV-2 in terms of
new HIV infections. This similarity should be greatest in populations with a mature HIV
epidemic and where both infections overlap geographically. Despite the low co-factor
effect on HIV transmission generated by malaria (Table A.2, parameter 5), the high
prevalence of this infection may have increased its effect on the HIV incidence as the
HIV epidemic invaded the general population.
Our analysis suggest that the synergy among sexually transmitted infections and
parasitic infections allowed the HIV epidemic to reach the general population, which may
not have been possible without the cofactor effect on HIV transmission generated by co20

infection (Abu-Raddad et al., 2008). This in turn suggests that an HIV epidemic may be
mitigated or halted through measures that decrease viral infectivity. The control and
treatment of several common infectious diseases could decrease the incidence of HIV
over the long-term.
Although interventions aimed at reducing the incidence of STIs have a prominent
place in control strategies, some studies have failed to show an impact of STI treatments
on HIV incidence (Kamali et al., 2002; Wawer et al., 1999). Some authors have
suggested that population differences in sexual behavior, differences in STI prevalence
and the stage of the HIV epidemic may explain the poor impact of this control
intervention (White et al., 2004). These studies (Kamali et al., 2002; Wawer et al., 1999)
commonly focused on STIs with low prevalence in the general population, such as
syphilis, trichomoniasis, gonorrhea and chlamydia.
However, as our study and other studies (Baeten et al., 2008; Modjarrad et al.,
2008; Schacker et al., 2002) have indicated, infectious diseases present in the general
population such as HSV-2 and parasitic diseases have the highest impact on the HIV
incidence in mature HIV epidemics. A transmission study conducted to determine
whether HSV-2 suppression in HIV/HSV-2 co-infected individuals reduces the risk of
HIV transmission indicated that, despite a notorious reduction in the prevalence of genital
ulcer diseases generated by HSV-2, and a 0.25 log10 copies/ml reduction in plasma HIVRNA levels, HSV-2 suppression with acyclovir did not prevent HIV transmission (Celum
et al., 2010). In a subsequent work, however, Lingappa and coworkers demonstrated that
a 0.74 log10 copies/ml reduction in HIV plasma RNA concentration is necessary to reduce
the HIV transmission rate by half (Lingappa et al., 2010). HSV-2 suppression with
acyclovir may thus have been insufficient to yield a detectable reduction in HIV
transmission risk. They concluded that treatment of co-infections capable of reducing
plasma HIV levels by > 0.7 log10 copies/ml might be a valuable tool for suppressing of
HIV transmission.

Limitations of the model
The results of this study derive from a simulation model and depend on the validity of the
underlying assumptions and parameter magnitudes. Uncertainties about the magnitudes
21

of these parameters suggest that the conclusions presented here should be interpreted with
caution. HIV transmission probability and the effect of behavioral and biological
cofactors on HIV transmission require more thorough quantification (Abu-Raddad et al.,
2008; Freeman et al., 2007; White et al., 2008), and we hope that our results will help
motivate this work.
Additionally, cofactor values are commonly estimated from population-based
observations of co-infection status in individuals or couples (Korenromp et al., 2000). In
these cases, the association between the transmission of HIV and the presence of an STI
is generally expressed in terms of odd ratios, hazard ratios or relative risk per sexual
contact (Boily and Anderson, 1996). These estimates, however, can be particularly
difficult to interpret as a consequence of multiple potential biases.
To reduce confounding effects resulting from other behavioral and biological risk
factors, estimates of cofactor effects are statistically adjusted for the influence of these
risk factors. But these analyses may not completely control for the confounding effects
because STIs, HIV and other behavioral and biological risk factors may cluster not only
in study subjects but also in the unknown partners of the individuals included in the study
(Korenromp et al., 2000). Moreover, the confounding generated by the characteristics of
the sexual network such as concurrency, mixing patterns and numbers of sexual partners
is virtually impossible to control for completely (Korenromp et al., 2000).
On the other hand, the high variation in HIV prevalence produced by the model
observed in the uncertainty analysis compromises the accuracy of the model's predictions
(Table A.9). The sensitivity analysis indicated that the model is highly sensitive to the
behavioral parameters that influenced the per-partner probability of HIV transmission,
such as the average duration of casual relationships and the mean number of sexual
contacts, and to the biological parameters responsible for the cofactor effect of infections
present in the general population, such as malaria and HSV-2 (Table A.10). Thus, efforts
focused on more precise estimation of these parameters will improve the accuracy of
predictions from models exploring the causes of the HIV epidemic in sub-Saharan Africa.
Lastly, the model assumes that HIV is transmitted exclusively by penile-vaginal
heterosexual contact, and thus the model does not include anal intercourse as a
mechanism of HIV transmission. Since anal intercourse increases the probability of
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transmission (Boily et al., 2009), this type of sexual behavior has been proposed as an
important risk factor of HIV transmission. Although many authors claim that
heterosexual penile-vaginal contact is the main mechanism of transmission in subSaharan Africa, more of information about the frequency of anal intercourse, including
men who have sex with men, would allow an evaluation of this possibly important but
little-studied mechanism of transmission in the epidemic in sub-Saharan Africa (Smith et
al., 2009).
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Figure 2.1 HIV epidemic curves with constant probability of HIV transmission (no
co-infection)

At T = 0.003 no epidemic can be generated, and HIV prevalence decreases leading to
extinction (prevalence estimated for 2010 = 0%)). With a T = 0.005 the infection can
persist and reached and endemic steady state at a prevalence equal to the initial
prevalence (HIV prevalence estimated for 2010 = 1%). At T = 0.0068 the epidemic curve
generated is similar to the HIV epidemic observed in Malawi (HIV estimated prevalence
for 2010 = 10%).
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Figure 2.2 Time course of HIV with the inclusion of the amplification effect caused
by co-infection (simulation 2)

In (A), the dynamics of HSV-2, syphilis, gonorrhea and malaria were simulated and
allowed to approach steady state before the introduction of HIV into the population. Once
endemic steady states of these infections were reached, 1% of individuals were infected
with HIV, and HIV established in the population. (B) shows in more detail the time
course of HIV in Malawi simulated by the inclusion of the amplification effect generated
by co-infection (Simulation 2). The measured HIV prevalence from Malawi, for both
males and females in general population, was extracted from several studies (USAIDS,
2006).
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Figure 2.3 Fraction of new infections when the HIV infectious (transmitter)
individual had a co-infection (simulation 2)

The model tracks the mechanism of the transmission of the infection. For the simulated
period, if an HIV infection takes place, we recorded the presence in the infectious
individual of any of the four infectious diseases included in the model, or in the case of
HSV-2 due to the enhanced susceptibility caused by HSV-2 infection, we also recorded
the presence of this infection on the susceptible individual and identified the cause of the
amplification of the transmission caused by co-infection. (A) shows that HSV-2 was the
most prevalent infection in co-infected individuals who transmitted the HIV infection,
followed by malaria. This result is associated with the high prevalence of both infections
in the general population. Grouping all STIs, more than 50% of the HIV infections were
associated with an STI (B). More than 70% of the total HIV infections were caused by
co-infected individuals (C).
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Figure 2.4 Removing the amplification effect on HIV transmission

(A) shows the time course of HIV when HSV-2 does not have an amplification effect on
HIV (simulation 3) and the prevalence for 2005 decays to ~6% (C).In the scenario where
malaria does not have an amplification effect on HIV transmission (simulation 5), the
resulting prevalence decays to ~10% (B).

No HSV‐2

Default curve (simulation 2)

(A)

30

Prevalence (%)

25
20
15
10
5
0
1981

1986

1991

No malaria

1996

2001

2006

Default curve (simulation 2)

30

Prevalence (%)

25
20
15
10
5
0
1981

1986

1991

1996
Time (years)

27

2001

2006

(B)

Figure 2.5 Population Attributable Fraction (PAF) due to co-infection

We measured the direct effect of co-infection on the HIV incidence by using the
population attributable fractions. (A) The PAF due to co-infection in general, and (B) the
PAF due to HSV-2 (solid line), syphilis and gonorrhea (dotted line) and malaria (dashed
line).
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Chapter 3 - HIV-malaria co-infection: effects of malaria on the
prevalence of HIV in East sub-Saharan Africa

Introduction
The heterosexual transmission of HIV is characterized by a low transmission rate,
estimated to be ~ 1/300 per coital act in low income countries (Boily et al., 2009;
Gisselquist and Potterat, 2003). Despite this low probability of transmission per sexual
contact, some studies have demonstrated that the risk of HIV transmission can be
strongly correlated with variations in blood viral burden (Attia et al., 2009; Cohen et al.,
2007; Pilcher et al., 2007). The viral set point is not constant and may be perturbed by
reactivations of the immune system such as those resulting from the invasion of other
pathogens (Bentwich et al., 1995).
The average African host is usually exposed to numerous bacterial, viral and
parasitic infections. Of special importance is the very high prevalence of sexually
transmitted infections (STIs), particularly genital ulcerations caused by herpes simplex
virus type 2 (HSV-2) (Bentwich et al., 1995). The ulcers caused by HSV-2 contain
substantial numbers of CD4+ lymphocytes, the target cell for HIV, and therefore are
likely to facilitate the acquisition of HIV in HIV-negative individuals (Celum et al.,
2004). Additionally, the high levels of HIV-RNA in herpetic lesions from dually infected
patients (Schacker et al., 1998) may be explained by studies in vitro demonstrating that
HSV-2 increases HIV transcription, which supports the higher infectivity in co-infected
individuals.
The activation of the immune system, however, is not only produced by STIs
such as HSV-2, syphilis and gonorrhea. Parasitic infections such as malaria might
produce a strong response from the immune system and consequently generate similar
effects on the replication of the virus in HIV co-infected individuals (Bentwich et al.,
1995; Korenromp et al., 2005; Kublin et al., 2005; Pisell et al., 2002; Reina et al., 2006).
The geographical overlap observed between malaria and HIV infections has suggested a
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possible interaction influencing HIV transmission in some countries of sub-Saharan
Africa. Malaria occurs throughout the tropical world, where it remains one of the most
prevalent infectious diseases with an estimated 300 million cases per year (CDC).
Approximately 90% of these cases occur in sub-Saharan Africa (Snow et al., 2005). This
region has also experienced the greatest burden of HIV-1 infection, with an estimated 25
million infected individuals over the past two decades (WHO). The geographic overlap of
these diseases has sparked much interest in their potential interactions (Dolores et al.,
2007; Idemyor , 2007; Whitworth and Hewitt, 2005). Several in vitro studies have found
that malaria antigens significantly enhanced HIV-1 replication (Kublin et al., 2005; Pisell
et al., 2002; Reina et al., 2006; Xiao et al., 1998). A population-based study conducted
with HIV-1 infected adults in rural Malawi indicated that the HIV-1 RNA concentration
almost doubled between baseline (96 215 copies per ml) and those co-infected with
malaria (168 901 copies per ml). Researchers estimated that, on average, malaria
generates a 0.25 (95% CI 0.11-0.39) log increment on the mean HIV RNA concentration
(Kublin et al., 2005). Abu-Raddad and coworkers generated a mathematical model to
examine the impact of this increment on the HIV epidemic in Kisimu, Kenya (AbuRaddad et al., 2006). Using the functional relationship between HIV plasma viral load
and transmission probability per coital act, in which a logarithmic increase in viral load is
associated with a 2.45-fold increase in transmission probability (Quinn et al., 2000), they
demonstrated that the enhancement on the HIV infectivity of co-infected individuals may
account for a cumulative 8500 excess HIV infections in Kisumu district.
Despite the evidence about the relationship between malaria and HIV in vitro and
in silico, the causes and implications of this co-infection at the population level are still
unclear. One important limitation is the inaccurate documentation of geographical
overlap between the two infections in sub-Saharan Africa. Visual analysis of the spatial
distribution of each infection may be misleading in the absence of adequate statistical
adjustment. Moreover, assessing the impact of the co-infection is impeded by the scarcity
of data on co-infection prevalence and consequences in the transmission of HIV
infection.
In the present study, we measure the association between malaria and HIV
prevalence. To achieve this goal we combined current comprehensive databases for these
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two infections, namely the Demographic and Health Survey (DHS) for HIV and the atlas
malaria project for malaria, by using Geographical Information Systems (GIS) tools in a
representative area of East sub-Saharan Africa. Our hypothesis was that individuals in
locations with high prevalence of the vector that transmits malaria, namely the
Plasmodium falciparum parasite, which is the species responsible for most of the 95% of
the malaria cases in the region studied (USAID, 2008a; USAID, 2008b; USAID, 2009),
have increased likelihood of being infected with HIV.

Methods
Data
Data were extracted from DHS for 2003 in Kenya (KDHS) (Central Bureau of Statistics,
2003) and Malawi (MDHS) (National Statistical Office), and for 2003-04 in Tanzania
(THIS) (TACAIDS, 2005), to cover the population residing in households in these
countries. These countries exemplify the HIV epidemic in East sub-Saharan Africa
because they present similar HIV epidemic levels and risk factors for HIV infection as
the other East sub-Saharan countries (Buvé et al., 2002; Johnson and Way, 2006; Msisha
et al., 2008; Orroth et al., 2007), and the malaria prevalence in the region covered by
these three countries is heterogeneous for comparisons (Hay et al., 2009). A
representative probability sample of almost 10 000 households was selected from the
KDHS, 13 664 from the MDHS and 6900 from the THIS survey.
All DHS surveys were based on two-stage sampling of the households. The first
stage involved selecting sample points (clusters), 400 clusters in Kenya (129 in urban and
271 in rural areas), 522 clusters in Malawi (64 in urban and 458 in rural areas), and 345
clusters in Tanzania (87 in urban and 258 in rural areas). The global position system
(GPS) was used to establish and record the geographic coordinates of each of the DHS
clusters (TACAIDS, 2005).
Adult men (aged 15-59 years) and women (aged 15-49 years) in the selected
household were eligible for the survey, with a response rate of 86% and 96% for men
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and women in Kenya (Central Bureau of Statistics, 2003) and Malawi (National
Statisitcal Office Malawi, 2004), and 91% and 96% for men and women in Tanzania
(TACAIDS, 2005). In all households selected, anonymous HIV testing was performed
with the consent of all eligible men and women. We restricted the analysis to only
sexually active people and after combining all three DHS surveys and excluding missing
data, the final sample population for data analysis consisted of 8919 men and 10 816
women.
We used the dichotomous HIV serostatus for each individual as the response
outcome (TACAIDS, 2005). The HIV serostatus was identified by collecting drops of
blood from each individual for HIV testing with the Vironostika Uniform 2 Ag/AB kit.
All samples that tested positive and a random sample of 10% of samples that tested
negative on the first ELISA (enzyme-linked immunosorbent assay) test were tested with a
second ELISA, the Vironostika Uniform 2 plus O. A confirmatory INOLIA HIV Western
blot kit was done for all samples that were still discrepant (Central Bureau of Statistics,
2003; National Statisitcal Office Malawi, 2004; TACAIDS, 2005).

Socio-economic and demographic covariates
To adjust for socioeconomic and demographic factors, we conducted preliminary
univariate analyses with a total of 14 socioeconomic and demographic covariates
extracted from the DHS of each country. The covariates included age, place of residence
(urban or rural), highest educational level, main floor material of the house, main roof
material of the house, main wall material of the house, religion, current marital status,
ever been tested for AIDS, wealth index, number of sex partners, age at first intercourse,
responder have a bednet for sleeping, and responder sleeps under bednet. Covariates with
a P<0.2 in univariate analysis were included in the final model, which included age,
urban or rural residence, education, wealth index, marital status and religion. These
covariates have also been identified from previous studies conducted in Tanzania and
Kenya as the most relevant covariates for the risk of HIV infection in these countries
(Johnson et al., 2006; Msisha et al., 2008).
Education level was evaluated as a categorical variable with four levels: no
education, primary education, secondary education and higher education. Wealth index is
32

an ordinal variable that characterizes standard of living as determined by material
possessions. The DHS calculated the living standard of a household based on key assets
such as television and bicycles, materials used for housing construction, and types of
water access and sanitation facilities. The data were analyzed and weighted by principal
component analysis. The resulting asset scores were then used to define wealth quintiles:
poorest, poorer, middle, richer, richest. Marital status has been found in many studies as
an important risk factor for being HIV-infected (Auvert et al., 2001; Glynn et al., 2001;
Nunn et al., 1994). In the current study, marital status was represented by three
categories: never married, currently married and formerly married. Religion was also
included for its potential confounding effects and was composed of four categories:
Moslem, Catholics, Protestants or other Christians, and other religions.

Biological covariates
Previous studies have found that reporting any (STIs during the 12 months previous to
the interview was not correlated with being HIV-positive (Johnson et al., 2006; Msisha et
al., 2008). For that reason, and with the aim to control for potential confounding by STIs,
we included the reported presence of genital ulcerations during the last 12 months
previous to the interview. Male circumcision is a well known risk factor for being HIVpositive (Auvert et al., 2001; Gray et al., 2000; Rakwar et al., 1999). Males with a lack
of circumcision have nearly twice the risk of being HIV-positive than circumcised males.
For the risk analysis performed for males, we included male circumcision as a covariable.

Malaria covariate
We used the largest and most contemporary spatial database for Plasmodium falciparum
parasite rate (PfPR) (Hay et al., 2009; Hay et al., 2006). This database contains nearly
9000 distinct community surveys across 78 malaria endemic countries. To create a
continuous surface of malaria endemicity, previous research produced a model-based
geostatistical procedure in a Bayesian framework to incorporate factors such as the
spatial density and location of the data, and the number of people sampled in each survey
(Hay et al., 2009). Geostatistical algorithms generate a continuous map by imputing
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values at unsampled locations by using a weighted linear combination of the available
(neighboring) sample data. One of the most important characteristics of this database is
age-standardization for malaria prevalence (the PfPR reported by the atlas malaria project
is age-standardized to 2-10 years old), which provides a valid estimate of the
transmission intensity (Hay et al., 2009). Further details on the malaria data and
statistical procedures for mapping it have been described elsewhere (Hay et al., 2009).
To display and extract the PfPR from each DHS cluster we used the program
ArcGIS version 9.2 (ESRI, 2004). From each geo-referenced cluster we obtained the
PfPR, the value of which was assigned to each individual who belonged to that cluster.

Statistical analysis
We generated unadjusted models for each covariate using a simple logistic regression
model. To generate the final adjusted analysis, which included all covariates and
accounted for correlated data, generalized linear mixed models (GLMM) stratified by
gender (in order to include circumcision as a covariate for men) were then fitted with the
cluster as a normally distributed random effect. We included PfPR as a continuous
variable. In a second analysis, we categorized PfPR by its empirical quartiles. All
statistical analyses were conducted using R version 2.11.1 (R. Core Team, 2010).
Adjusted Probability Ratio (PR) parameters were used to compare regions with
varying degrees of PfPR, separately for men and women (Rockhill et al., 1998). To
calculate PRs, we dichotomized PfPR using its first quartile to define low malaria
prevalence. Areas with PfPR higher than the first quartile were defined to have high
malaria prevalence.

Results
Overall malaria and HIV prevalence
Results of the 2003-04 DHS from the region studied indicated that the HIV prevalence in
responders who have had sex was 6.66% for men and 9.46% for women. The prevalence
of HIV peaked for age group 35-39 for men and 30-34 for women (Table 3.1). The mean
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PfPR in the region was 0.27, with a standard deviation of 0.18. The quartiles of PfPR led
to four groups, namely PfPR less than or equal to 0.10, PfPR between 0.11 to 0.30 ,
PfPR between 0.31 to 0.42, and PfPR higher than 0.42 (Table 3.1). Areas where the PfPR
is 40% or more are identified as areas with high stable transmission, where theory
predicts that mixed control interventions need to be considered for the interruption of
malaria transmission (Hay et al., 2008). Hay and coworkers (Hay et al., 2009) estimated
that in Africa these areas cover 8.5 million Km2, which contains 345.28 million people at
risk.
Individuals (males and females) with higher education and with higher wealth
index were primarily distributed in (mainly urban) areas with low PfPR (PfPR <= 10%),
whereas individuals with lower education level and lower wealth index (poorest, poorer)
were mainly in rural areas with high PfPR (PfPR > 42%) (Table 3.2). In areas with low
malaria prevalence (PfPR < 0.10), the HIV prevalence was 5.11% for males and 8.27%
for females, whereas in areas with high malaria prevalence (PfPR > 0.42) the HIV
prevalence was 7.67% for males and 10.73% for females (Table 3.1).

Malaria
With PfPR modeled as a continuous variable, the unadjusted analysis indicated that PfPR
was a risk factor for HIV infection in both men (P < 0.001) and women (P = 0.013).
After adjusting for measured socio-economic and biological characteristics the PfPR
remained as a risk factor of being infected with HIV in both men and women ( P < 0.001
for both). After categorizing the PfPR we observed that malaria is positively and
monotonically related to HIV-infection (Table 3.3 and 3.4). The adjusted model indicated
that men and women who live in areas with high PfPR (>0.42) are nearly twice as likely
to be HIV-positive as those who live in areas with low PfPR (<0.10) (men: estimated OR
2.24, 95% CI 1.62-3.12; women: estimated OR 2.44, 95% CI 1.85-3.21).
To perform the probability ratio estimation we created a dichotomous variable for
malaria prevalence where low PfPR indicates low risk of being infected with malaria (for
individuals who live in areas with a PfPR≤ 0.10) and high PfPR indicates high risk of
being infected with malaria (for individuals who live in areas with PfPR >0.10). The
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calculated probability ratio attributable to malaria was 27% for males and 29% for
females.

Socio-economic characteristics
Men and women formerly married had the highest odds of having HIV compared with
individuals never married, (estimated OR 6.27, 95% CI 4.38-8.97) and (estimated OR
6.83, 95% CI 5.39-8.66), respectively in the unadjusted model. Controlling for all other
socio-economical and biological risk factors attenuated the estimated odds ratios to 3.15
(95% CI 2.03-4.90) for men (Table 3.3), and 4.20 (95% CI 3.09-5.71) for women (Table
3.4).
As expected (Johnson et al., 2006; Msisha et al., 2008), unadjusted models
indicated that men and women living in rural areas had lower odds of being HIV-infected
than those living in urban areas, with an estimated OR of 0.52 (95% CI 0.45-0.62) for
men and an estimated OR of 0.57 (95% CI 0.5-0.66) for women. In the adjusted analysis
the estimated effect remained similar with odds ratio 0.54 (95% CI 0.41-0.70) for men
and 0.59 (95% CI 0.46-0.77) for women. In the unadjusted model (Table 3.4), women
with a secondary educational level had increased odds of having HIV compared to
women with any level of education (estimated OR 1.45, 95% CI 1.15-1.83). Education
was not a risk factor for being infected with HIV in adjusted models for women
(likelihood ratio P = 0.12).
As observed in previous studies (Johnson et al., 2006; Msisha et al., 2008), the
wealth index for both men and women is positively correlated with HIV. In unadjusted
models, men and women in the highest wealth category were estimated to have 2.64
(95% CI 1.97-3.54) and 2.74 (95% CI 2.19-3.44) times the odds of being HIV infected
compared with those in the poorest category. The adjusted model attenuated the
estimated odd ratio for men to 2.32 (95% CI 1.58-3.42), but increased the estimated odd
ratio for women to 2.92 (95% CI 2.12-4.02).

Biological characteristics
In unadjusted models the estimated OR of having HIV was 2.59 (95% CI 1.76-3.8) for
males who had genital ulcerations during the last 12 months (Table 3.3). For women the
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odds were considerably higher than for males (estimated OR 3.21, 95% CI 2.94-4.05).
This difference was maintained in the adjusted model with 1.99 (95% CI 1.30-3.03) for
men and 2.79 (95% CI 2.07-3.76) for women. These results are consistent with previous
studies, which have found that the presence of an STI increases the risk of being HIVpositive (Blower and Ma, 2004; Freeman et al., 2006; Glynn et al., 2008b; Nunn et al.,
1994; Waver et al., 2005).
Lack of male circumcision has been proposed as one of the most important
biological risk factors of being HIV-positive in men (Auvert et al., 2001; Gray et al.,
2000; Jewkes et al., 2006; Orroth et al., 2007; Rakwar et al., 1999). In our analysis, the
adjusted models indicated that circumcised males had slightly more than half the risk of
those who were not circumcised to be HIV-positive (estimated OR 0.62, 95% CI 0.500.79).

Discussion
The factors related to high HIV-1 prevalence in sub-Saharan Africa are incompletely
recognized. The epidemic in this part of the world is widely distributed across the general
population, and heterosexual penile-vaginal mechanism of transmission has been
proposed to account for more of the 80% of the new cases (Orroth et al., 2007; Vernazza
et al., 1999; Waver et al., 2005). For many years, behavioral factors such as commercial
sex, concurrency and promiscuity have been proposed as driving the epidemic in subSaharan Africa (Lagarde et al., 2001; Morison et al., 2001). Recent behavioral studies
carried out in different populations from Africa, however, have found no significant
differences compared to populations in developed countries such as the United States or
Europe, and in some cases had no correlation with the risk of HIV infection (Brewer et
al., 2007; Lurie et al., 2009; Orroth et al., 2007; Reniers et al., 2010). In addition, a
previous cross-sectional population-based study, called the Four City study (Orroth et al.,
2007), examined the differences in the spread of HIV in four cities from the western and
eastern regions of sub-Saharan Africa and found that differences in sexual behavior could
not explain the differences between the HIV epidemics (Ferry et al., 2001; Lagarde et al.,
2001; Morison et al., 2001). The authors postulated that biological factors may be
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responsible for these differences (Buve et al., 2001). Biological cofactors such as male
circumcision and other STIs, especially Herpes Simplex Virus type 2 (HSV-2), thus have
been proposed as a plausible explanation for these observed differences (Orroth et al.,
2007).
The substantial evidence that sexually transmitted infections, HSV-2 in particular,
enhanced the transmission and acquisition of HIV infection contrasts with the scarce
information about the cofactor effect of malaria on HIV at the population level. Like
HSV-2, malaria contributes to transient viral load increases in co-infected individuals
(Kublin et al., 2005; Pisell et al., 2002; Xiao et al., 1998). Due to the methodological
difficulties in designing cross-sectional or prospective studies for measuring the
significance of malaria on the risk of HIV infection, however, the effect of malaria on the
spread of HIV in the population is virtually unknown.
This is the first study to report malaria as a risk factor for concurrent HIV
infection at the population level. After adjusting for important socio-economic and
biological covariates, we found that the PfPR of the area of residence is positively and
monotonically correlated with HIV prevalence (Table 3.3 and 3.4). According to our
results, men who live in areas with high PfPR ( > 0.42) have at least twice the risk of
being HIV-positive (estimated OR 2.24, 95% CI 1.62-3.12) in comparison to men who
live in areas with low PfPR (≤ 0.10). As we expected, the risk of malaria infection was
not related to gender; thus women who live in areas with high PfPR have nearly the same
OR (2.44, 95% CI 1.85-3.21).
The probability ratio attributable to PfPR indicated that malaria may account for
~27% of incidental HIV infections in areas with a PfPR higher than 0.1. This value is
similar to the value reported previously by Cuadros and coworkers (2011a), who by
computer simulations estimated that malaria might account for more than 20% of new
HIV infections in Malawi in 2003. The probability ratio due to malaria resembles the
population attributable fraction (PAF) associated with HSV-2, estimated by
epidemiological and mathematical models (Abu-Raddad et al., 2008; Blower and Ma,
2004; Freeman et al., 2007). This similarity may be due to the high prevalence of both
infections in the general population.
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Some studies have shown that curable STIs such as gonorrhea, syphilis or
chlamydia have had the biggest impact on HIV transmission at early stages of the HIV
epidemic (Freeman et al., 2007; White et al., 2008). These infections generally are
present in high-risk groups such as prostitutes or individuals with a high number of
sexual partners (Abu-Raddad et al., 2008; White et al., 2008). The effect of curable STIs
on HIV has decreased as the HIV epidemic has moved from the core group to the general
population. Prevalent infections, such as HSV-2, in the general population may then play
the most important role driving the HIV prevalence in populations with a mature HIV
epidemic (Abu-Raddad et al., 2008; Cuadros et al., 2011a; White et al., 2008). Although
malaria infection has a non-sexual mechanism of transmission, its high prevalence in the
general population and its ability to generate an immune activation associated with
increases in systemic HIV viral load suggests that malaria may have a similar role to
HSV-2 in mature HIV epidemics.
Although our work makes use of the most complete and contemporary databases
for both HIV and malaria, our results were based on geographical estimates for PfPR in
locations where demographic and health surveys were made. Despite the use of this
indirect measure of the possible synergistic interaction between malaria and HIV at the
population level, our results suggest that malaria is likely to be a frequent co-infection in
HIV infected individuals living in those areas with high malaria prevalence. Hence, we
emphasize that malaria might be playing an important role in the present HIV epidemic
of these areas. The scenario could be more complicated if we take into account infections
such as chronic helminth infections and water borne pathogens that, like malaria, are
associated with similar immune activation by inducing viral replication (Bentwich et al.,
1995; Lawn and Folks, 2001) and could also be affecting the HIV transmission risk and
the natural history of HIV in sub-Saharan Africa.
Our work emphasizes the need for field studies on the interaction among parasitic
infections and the risk of HIV infection and on the impact of control interventions. Thus,
it would be important to obtain data on individuals who are known to be dually infected
with malaria and HIV. Reducing malaria transmission becomes even more important to
address in the context of HIV. With the high numbers of cases of HIV and malaria, even
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small decreases in malaria prevalence could have an important impact on the relative risk
of HIV infection in areas with high malaria prevalence.
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Table 3.1 HIV prevalence by socio-economic and biological characteristics for
sexually active people surveyed in Kenya, Malawi and Tanzania
Characteristics

N(%HIV-positive)
Women
Men

Age

15-19
20-24
25-29
30-34
35-39
40-49
50-59
Religion
Moslem
Catholic
Protestant/other Christian
Other
Place of residence
Urban
Rural
Marital status
Never married
Currently married
Formerly married
Highest educational level
None
Primary school
Secondary
Higher
Wealth index
Poorest
Poorer
Middle
Richer
Richest
Circumcision
Uncircumcised
Circumcised

2285(2.67) 2018(1.24)
2276(9.31) 1578(3.99)
1939(10.93) 1483(7.75)
1543(14.32) 1237(9.54)
1172(12.8) 954(11.53)
1601(10.43) 1372(10.28)
277(7.94)
2610(9.00)
2998(9.71)
4060(9.70)
1148(9.97)

1996(5.96)
2530(7.19)
3222(6.55)
1171(7.00)

2629(13.47) 2064(10.22)
8187(8.17) 6855(5.59)
2434(4.27)
7137(8.80)
1245(23.37)

3457(2.37)
5046(9.06)
416(13.22)

2388(7.79)
6979(9.77)
1280(10.94)
169(8.88)

947(5.17)
6218(6.38)
1497(8.86)
275(6.18)

2067(5.27) 1507(4.11)
2111(7.01) 1811(4.36)
2101(8.66) 18.21(5.93)
2127(12.46) 1863(8.05)
2410(13.24) 1917(10.17)
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3423(8.41)
5496(5.57)

Genital ulceration
No genital ulceration last 12 months 10489(8.99)
Genital ulceration last 12 months
327(24.46)
Malaria
PfPR <= 0.1
2612(8.27)
PfPR [0.11-0.3]
2899(9.07)
PfPR [0.31-0.42]
2415(9.69)
PfPR > 0.42
2890(10.73)
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8708(6.45)
211(15.17)
2113(5.11)
2480(6.61)
2071(7.19)
2255(7.67)

Table 3.2 Socio-economic characteristics distribution by different PfPR levels (males
and females combined)
Total individuals (% per PfPR category)
Characteristics

PfPR <=0.1 PfPR

PfPR

PfPR > 0.42

[0.11-0.3] [0.31-0.42]
Age

15-19

1054(24)

1285(30)

941(22)

1023(24)

20-24

926(24)

1049(27)

895(23)

984(26)

25-29

785(23)

876(26)

809(24)

952(27)

30-34

665(24)

733(26)

634(23)

748(27)

35-39

521(25)

590(27)

480(23)

535(25)

40-49

678(23)

790(27)

665(22)

840(28)

50-59

96(35)

56(20)

62(22)

63(23)

Moslem

1130(25)

1253(27)

548(12)

1675(36)

Catholic

1162(22)

1510(27)

1626(29)

1230(22)

Protestant/other

2240(31)

2123(29)

1577(22)

1342(18)

193(8)

493(21)

735(32)

898(39)

Urban

2202(47)

1172(25)

803(17)

516(11)

Rural

2523(17)

4207(28)

3683(24)

4629(31)

Never married

1784(30)

1767(30)

1159(20)

1181(20)

Currently married

2558(21)

3167(26)

2971(24)

3487(29)

Formerly married

383(23)

445(27)

356(21)

477(29)

543(16)

901(27)

798(24)

1093(33)

Primary school

2865(22)

3659(27)

3103(24)

3570(27)

Secondary

1008(36)

744(27)

549(20)

458(17)

Religion

Christian
Other
Place of residence

Marital status

Highest educational level

None
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Higher

309(70)

75(17)

36(8)

24(5)

Poorest

521(15)

1193(33)

771(22)

1089(30)

Poorer

491(13)

1005(26)

979(25)

1447(36)

Middle

608(16)

1120(28)

1058(27)

1136(29)

Richer

1037(26)

983(25)

1033(26)

937(23)

Richest

2068(48)

1078(25)

645(15)

536(12)

Wealth index
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Table 3.3 Unadjusted and adjusted results: men's HIV serostatus according to
selected socio-economic and biological characteristics
OR(95% CI)
Unadjusted
Adjusted

Indicator
Malaria
PfPR <= 0.1
PfPR [0.11-0.3]
PfPR [0.31-0.42]
PfPR > 0.42
Age
15-19
20-24
25-29
30-34
35-39
40-49
50-59
Religion
Moslem
Catholic
Protestant/other Christian
Other
Place of residence
Urban
Rural
Marital status
Never married
Currently married
Formerly married
Highest educational level
None
Primary school
Secondary
Higher
Wealth index
Poorest
Poorer
Middle

1.00
1.31(1.02-1.69)
1.44(1.11-1.86)
1.54(1.20-1.98)

1.00
1.73(1.27-2.35)
1.74(1.25-2.41)
2.24(1.62-3.12)

1.00
1.00
3.13(2.08-5.29) 2.54(1.52-4.25)
6.69(4.32-10.38) 4.14(2.42-4.07)
8.40(5.42-13.01) 4.84(2.78-8.44)
10.38(6.68-16.15) 6.58(3.75-11.57)
9.13(5.93-14.05) 5.66(3.24-9.88)
6.87(3.82-12.37) 4.67(2.26-9.23)
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1.00
1.22(0.96-1.55)
1.11(0.88-1.39)
1.19(0.89-1.58)

1.00
1.05(0.78-1.40)
1.06(0.80-1.41)
0.93(0.64-1.33)

1.00
0.52(0.43-0.62)

1.00
0.54(0.41-0.70)

1.00
4.10(3.28-5.21)
6.27(4.38-8.97)

1.00
1.85(1.31-2.62)
3.15(2.03-4.90)

1.00
1.25(0.92-1.69)
1.78(1.26-2.49)
1.21(0.68-2.13)

1.00
1.15(0.83-1.61)
1.34(0.91-1.98)
0.68(0.36-1.29)

1.00
1.06(0.76-1.49)
1.47(1.07-2.02)

1.00
0.94(0.66-1.36)
1.34(0.96-1.91)

Richer
Richest
Circumcision
No circumcised
Circumcised
Genital ulceration
No genital ulceration last 12 months
Genital ulceration last 12 months
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2.04(1.51-2.77)
2.64(1.97-3.54)

1.94(1.38-2.71)
2.32(1.58-3.42)

1.00
0.64(0.54-0.75)

1.00
0.62(0.50-0.79)

1.00
2.59(1.76-3.8)

1.00
1.99(1.30-3.03)

Table 3.4 Unadjusted and adjusted results: women's HIV serostatus according to
selected socio-economic and biological characteristics
OR(95% CI)
Unadjusted
Adjusted

Indicator
Malaria
PfPR <= 0.1
PfPR [0.11-0.3]
PfPR [0.31-0.42]
PfPR > 0.42
Age
15-19
20-24
25-29
30-34
35-39
40-49
Religion
Moslem
Catholic
Protestant/other Christian
Other
Place of residence
Urban
Rural
Marital status
Never married
Currently married
Formerly married
Highest educational level
None
Primary school
Secondary
Higher
Wealth index
Poorest
Poorer
Middle
Richer

1.00
1.00
1.11(0.92-1.34) 1.61(1.23-2.12)
1.19(0.98-1.45) 1.68(1.27-2.23)
1.33(1.11-1.60) 2.44(1.85-3.21)
1.00
3.75(2.80-5.01)
4.47(3.34-5.99)
6.10(4.55-8.16)
5.35(3.94-7.27)
4.24(3.14-5.73)

1.00
3.31(2.36-4.65)
3.92(2.75-5.59)
5.29(3.69-7.58)
4.33(2.97-6.32)
3.30(2.27-4.80)

1.00
1.00
1.09(0.91-1.30) 1.22(0.97-1.52)
1.09(0.92-1.29) 1.28(1.03-1.59)
0.99(0.78-1.27) 0.95(0.70-1.29)
1.00
1.00
0.57(0.50-0.66) 0.59(0.46-0.77)
1.00
1.00
2.16(1.75-2.67) 1.22(0.92-1.60)
6.83(5.39-8.66) 4.20(3.09-5.71)
1.00
1.00
1.28(1.08-1.52) 1.16(0.95-1.41)
1.45(1.15-1.83) 1.05(0.78-1.42)
1.15(0.67-2.00) 0.71(0.38-1.35)
1.00
1.00
1.36(1.05-1.75) 1.43(1.07-1.89)
1.70(1.33-2.17) 1.83(1.39-2.43)
2.56(2.03-3.22) 2.69(2.04-3.56)
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Richest
Genital ulceration
No genital ulceration last 12 months
Genital ulceration last 12 months

48

2.74(2.19-3.44) 2.92(2.12-4.02)
1.00
1.00
3.21(2.52-4.26) 2.79(2.07-3.76)

Chapter 4 - No evidence of association between HIV and
malaria in populations with low HIV prevalence

Introduction
Malaria has been proposed as an important facilitator for the spread of HIV-1 in areas
where both infections geographically overlap (Abu-Raddad et al., 2006; Dolores Herrero
et al., 2007; Idemyor, 2007; Kublin and Steketee, 2006; Renia et al., 2006). This parasitic
infection is one of the most prevalent infectious diseases worldwide. Of the estimated 300
million cases per year, 90% occur in sub-Saharan Africa (Snow et al., 2005). Most of the
African continent is considered to have stable malaria transmission, with prevalence that
exceed the threshold (40%) above which theory predicts it is unlikely that malaria
transmission can be interrupted with insecticide-treated bed nets alone (Hay et al., 2009).
This region covers 8.5 million km2 of the continent, with 354.28 million people at risk.
Areas with malaria prevalence between 5% and 40%, the range in which theory predicts
that malaria transmission could be reduced with insecticide-treated bed nets, cover 5.6
million km2 of the continent, with 196.83 million people at risk.
Sub-Saharan Africa has also experienced a severe HIV-1 epidemic, with an
estimated 25 million infections over the past two decades (WHO Joint United Nations
Programme on HIV/AIDS (UNAIDS)/World Health Organization). The epidemic,
however, is not homogeneous, and its spread has been more intense in the southern and
eastern part of the continent, with the western region experiencing a slower growing and
less severe epidemic. The causes of this difference are not well understood (Buve et al.,
2001). In the western part of the continent, the epidemic seems to be more concentrated
in the high-risk (core) groups, such as female sexual workers and individuals with high
number of sexual partners, while the epidemic is more widely distributed across the
general population in countries located in the east and south part of the continent.
In previous work (Cuadros et al., 2011b), we showed that the prevalence of
malaria caused by the parasite Plasmodium falciparum is associated with HIV-1 infection
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in eastern sub-Saharan Africa. Our results indicated that individuals who lived in areas
with high P. falciparum parasite rate (PfPR > 0.42) were approximately twice as likely to
be infected with HIV than individuals who lived in areas with low P. falciparum parasite
rate (PfPR ≤ 0.10) [men: estimated odds ratio (OR) 2.24, 95% confidence interval (CI)
1.62–3.12; women: estimated OR 2.44, 95% CI 1.85–3.21]. In western sub-Saharan
Africa, the pattern of the HIV-1 epidemic is different and less severe, yet the prevalence
of malaria is high. To examine the association between malaria and the prevalence of
HIV-1 under these conditions, and to measure this association in a region with
intermediate HIV-1 prevalence in central Africa, we used the most current and
comprehensive database, namely the Demographic and Health Survey (DHS) for HIV-1.
We also utilized a new source of data for P. falciparum malaria endemicity, the malaria
atlas project.
To complement our knowledge of HIV-malaria co-infection, the objective of this
work was to assess the relationship between malaria and HIV-1 prevalence in the western
and central regions of sub-Saharan Africa. The primary aim was to examine the
difference in the likelihood of current infection with HIV between individuals who lived
in locations with high transmission intensity of the most common vector that transmits
malaria in the region, namely the P. falciparum parasite, and individuals who lived in
areas with low malaria transmission intensity.

Methods
HIV data
This study refers to HIV-1 exclusively. We considered the following countries from the
western part of sub-Saharan Africa: Burkina Faso, Ghana, Guinea, Liberia and Mali.
These countries have similar HIV prevalence (between 1% and 2%), and the collective
geographic region has heterogeneous prevalence of malaria for comparisons (Hay et al.,
2009). We also included Cameroon in a separate analysis to investigate for an association
between HIV and malaria in a country with an intermediate HIV prevalence (~5%) and
with similar malaria transmission intensity to the western region included in the study.
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To cover the population residing in households in these countries, we extracted
data from DHS for 2003 in Burkina Faso (EDSBF-III) (Institut National de la Statistique
et de la Démographie MdlÉedD) and Ghana (GDHS) (Ghana Statistical Service
NMIfMR), for 2004 in Cameroon (EDSC-III) (National Statistical Office aOM (2005)
Cameroon Demographic andHealth Survey 2004), for 2005 in Guinea (EDSG-III)
(National Statistical Office CG) , for 2006 in Mali (EDSM-IV) (Cellule de Planification
et de Statistique Ministère de la Santé DNdlSedlI), and for 2007 in Liberia (LDHS)
(Liberia Institute of Statistics and Geo-information Services LISGIS). Methods used in
these demographic and health surveys have been described in detail elsewhere (National
Statistical Office aOM (2005) Cameroon Demographic andHealth Survey 2004; National
Statistical Office CG). Briefly, the surveys used a two-stage cluster sampling technique.
The first stage involved selecting sample points (clusters); 400 clusters in Burkina Faso
(300 in urban and 100 in rural areas), 412 in Ghana (240 in urban and 172 in rural areas),
297 in Guinea (209 in urban and 88 in rural areas), 408 in Mali (265 in urban and 143 in
rural areas), 297 in Liberia (117 in urban and180 in rural areas), and 466 in Cameroon
(224 in urban and 242 in rural areas). The global position system (GPS) was used to
identify and record the geographic coordinates of each of the DHS clusters.
The second stage used by each DHS included in this study involved the
systematic sampling of households from the selected clusters. Adult men (aged 15-59
years) and women (aged 15-49 years) in the selected households were eligible for the
survey. In all DHS surveys included in this study, HIV testing was performed using blood
samples. The DHS reported that participation in HIV testing was voluntary, and before
collecting the samples, each selected participant was asked to provide informed consent
to the testing. Further details of the performed HIV test have been described elsewhere
(Ghana Statistical Service NMIfMR; National Statistical Office OM (2005) Cameroon
Demographic and Health Survey 2004). In summary, HIV testing was conducted in a
laboratory by following a standard testing algorithm that uses two HIV enzyme
immunosorbent assays based on different antigens. Discordant samples that were positive
on the first test were retested with the same enzyme immunosorbent assays. A
confirmatory HIV Western blot kit was used for all samples that were still discrepant.
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We used the HIV serostatus reported by the DHS for each individual as the
dichotomous response outcome and restricted the analysis to only sexually active people.
After combining all DHS surveys and excluding missing data, the final sample
population for data analysis consisted of 41 064 individuals: 18 385 men and 22 679
women for West sub-Saharan Africa, and 10 088 individuals: 4986 men and 5102 women
for Cameroon.

Malaria data
A commonly used index of malaria transmission intensity is the P. falciparum parasite
rate (PfPR), defined as the proportion of the population found to carry asexual bloodstage parasites. The enhancement of HIV replication generated by infection with malaria,
which supports higher HIV infectivity in co-infected individuals (Quinn et al., 2000), is
produced by the presence of any parasitaemia, and not only during clinical episodes
(Kublin et al., 2005). For that reason, this index of malaria transmission might be a
measure for use in the initial assessment of the association between malaria and HIV.
For this study, we used the largest and most contemporary spatial database for the
Pf PR for children aged 2 to 10 years old (Hay et al., 2006; Hay et al., 2009). This
database contains nearly 9000 distinct community surveys across 78 malaria-endemic
countries. Many of these surveys, however, reported crude PfPR without stratifying by
age. Thus, in previous research (Smith et al., 2007), an algorithm was developed to agestandardize PfPR data. The PfPR in children aged 2-10 years is correlated with the
entomological inoculation rate the number of infected bites per person per unit of time)
(Hay et al., 2008), and has provided a basis for the most common categorical measures of
malaria transmission (Smith et al., 2007). Therefore, the PfPR reported by the malaria
atlas project is age-standardized to 2-10 years old (Hay et al., 2009). Since the PfPR in
children aged 2-10 years is related to the entomological inoculation rate, which is an
estimate of the force of infection, we used this measure as an approximation of the
prevalence of malaria infections in the adult population studied. This assumption,
however, has some implications on the study results, which are discussed in the
limitations of the study.
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To create a continuous surface of malaria endemicity, previous research (Hay et
al., 2009) produced a model-based geostatistical map using a Bayesian framework to
incorporate factors such as the spatial density and location of the data, and the number of
people sampled in each survey. Geostatistical algorithms generate a continuous map by
interpolating values at unsampled locations using a weighted linear combination of the
available (neighboring) sample data. Further details on the malaria data and statistical
procedures for generating the map have been described elsewhere (Hay et al., 2009). To
display and extract the PfPR from each DHS cluster, we used the program ArcGIS
version 9.2 (ESRI, 2004). From each geo-referenced cluster, we obtained the PfPR and
assigned its value to each individual who belonged to that cluster.

Socio-economic and biological covariates
Socio-economic and biological covariates of potential importance were investigated for
inclusion into the final model. To select the covariates to be included in the final model,
we first conducted preliminary unadjusted bivariate analyses from a pool of 16 socioeconomic and biological variables: age, place of residence (urban or rural), highest
educational level, main floor material of the house, main roof material of the house, main
wall material of the house, religion, current marital status, previous AIDS testing, wealth
index, number of sexual partners in the last year, age at first intercourse, presence of bed
net for sleeping, use of a bed net for sleeping, male circumcision, and reported presence
of genital ulceration during the last month. Covariates of a priori importance with P<0.2
in the unadjusted analyses were included in the final multivariable model relating HIV
and malaria.
Several factors were included as categorical variables. Marital status was
comprised of three categories: never married, currently married and formerly married.
Wealth index is an ordinal variable that characterizes standard of living as determined by
material possessions. The DHS calculated the living standard of a household based on
relevant assets such as television and bicycles, materials used for housing construction,
and the availability of amenities such as electricity and source of drinking water. The
resulting asset scores, constructed using principal component analysis, were then used to
define wealth quintiles: poorest, poorer, middle, richer, richest (National Statistical Office
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aOM (2005) Cameroon Demographic and Health Survey 2004; National Statistical Office
CG). Religion was subdivided into four categories: Muslim, Catholic, traditional religion,
and other religions. Education level was included as a categorical variable with four
levels: no education, primary education, secondary education and higher education.

Statistical analysis
Data analysis used generalized linear mixed models (GLMM), specifically logistic
regression models with normally distributed random cluster effects to include covariates
and account for correlated data among individuals within the same cluster. We first
conducted unadjusted analyses for each covariate. We then generated an adjusted model,
where the PfPR was categorized into two transmission intensity levels, namely areas with
stable malaria transmission (PfPR > 0.46), which corresponds to areas with PfPR higher
than the first quartile, and areas with PfPR ≤ 0.46). We analyzed the data from the
western region and Cameroon separately. All statistical analyses were conducted using R
version 2.11.1 (R.Core Team, 2010).

Results
West sub-Saharan Africa
The HIV prevalence in responders included in the study for western sub-Saharan Africa
was 1.53%: 1.15% for men and 1.80% for women (Table 4.1). The mean PfPR in the
region was 0.52, with a standard deviation of 0.12. In areas with stable malaria
transmission (PfPR > 0.46) the HIV prevalence was 1.48%, whereas in areas with PfPR ≤
0.46 the HIV prevalence was 1.58% (Table 4.1).
The final model included age, gender, urban or rural residence, education,
religion, wealth index, marital status and the presence of genital ulcerations. Male
circumcision was not significantly associated with being HIV-positive in men
(unadjusted OR 0.63, 95% 0.31-1.26). A similar result has been reported by other studies
(De Walque et al., 2006; Mishra et al., 2007), and might be a consequence of the
extremely high prevalence of male circumcision in the area of study. We estimated that
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94% of the male individuals from the western region and 95% of the male individuals
from Cameroon were circumcised. For that reason, we combined the data for men and
women into a single analysis, and included gender to adjust for confounding in the final
models.
The results indicated no evidence that PfPR predicted HIV infection in western
sub-Saharan Africa, where we observed no statistical difference in the odds of being
HIV-positive between individuals who lived in areas with stable malaria transmission
(PfPR > 0.46) and individuals who lived in areas with PfPR ≤ 0.46 (estimated OR 1.14,
95% CI 0.86-1.50). Other categorizations of PfPR, such as grouping by quartiles, gave
the same qualitative conclusions. Men have almost half the likelihood of being HIV
seropositive compared to women (estimated OR 0.63, 95% CI 0.51-0.78), which could be
connected to the protective effect of male circumcision for HIV acquisition. As observed
in eastern sub-Saharan Africa (Cuadros et al., 2011b), age was found to be a strongly
associated with HIV infection. The HIV prevalence peaked at age group 30-34 years, and
these individuals had higher odds of being HIV seropositive compared with the age group
15-19 years (estimated OR 4.11, 95% CI 2.60-6.51).
As expected and in agreement with other studies (Johnson et al., 2006; Msisha et
al., 2008), the adjusted model indicated that individuals living in rural areas had lower
odds of being HIV-positive compared to those living in urban areas, with an estimated
OR of 0.58 (95% CI 0.43-0.78). Unadjusted analysis indicated that reported genital
ulcerations during the last 12 months increased the likelihood of current HIV infection
(estimated OR 1.65, 95% CI 1.21-2.26). The presence of genital ulcerations, however,
was not a significant factor after adjusting for the other variables. Following the same
pattern observed in the eastern part of the continent, being currently married was not a
significant factor compared with individuals that had never been married (estimated OR
1.17 95% CI 0.85-1.63), whereas individuals formerly married had higher odds of having
HIV compared with individuals never married (estimated OR 2.55, 95% CI 1.73-3.77).
Among the socio-economic covariates considered, the lone discrepancy between
the current study and results obtained from our previous study of eastern sub-Saharan
Africa (Cuadros et al., 2011b) was the relationship between wealth index and HIV. While
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in the eastern part of the continent the wealth index was found to be positively and
monotonically associated with HIV, where individuals in the richest category had the
highest odds of being HIV-positive compared with individuals in the poorest category
(Cuadros et al., 2011b; Johnson et al., 2006; Msisha et al., 2008), we observed no
significant association between wealth index and current HIV status in western subSaharan Africa (Table 4.2).

Cameroon
The general HIV prevalence in Cameroon was 5.4%: 4.0% for men and 6.7% for women
(Table 4.1). The mean PfPR in this country was 0.44, slightly lower than the PfPR
estimated for the western region. In areas with stable malaria transmission (PfPR > 0.46)
the HIV prevalence was 6.4%, whereas in areas with PfPR ≤ 0.46 the HIV prevalence
was 4.1% (Table 4.1).
The adjusted analysis indicated that PfPR predicted HIV infection in Cameroon
and suggested that individuals who lived in areas with stable malaria transmission had
increased odds of being HIV-positive compared to individuals who lived in areas with
PfPR ≤ 0.46 (estimated OR 1.56, 95% CI 1.23-2.00).The difference in magnitude of the
association between PfPR and current HIV status for Cameroon and west sub-Saharan
Africa was also identified in an analysis that included an interaction term between PfPR
and region (western sub-Saharan or Cameroon) in an adjusted model. The significant
interaction term (P = 0.04) indicated that the association between HIV and the PfPR was
different among these regions.
Unlike the countries from the western region included in the study, higher wealth
index was associated with higher odds of being HIV seropositive compared to individuals
in the poorest category (Table 4.3), resembling the relationship between wealth index and
HIV observed in East sub-Saharan Africa. Contrary to the results from the western and
the eastern parts of Africa, the adjusted model indicated that living in urban areas did not
increase the odds of being HIV-positive compared to rural areas (estimated OR 0.76,
95% CI 0.57-1.01).
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Discussion
In contrast to the observations from eastern sub-Saharan Africa, the results from this
study suggest the absence of evidence for an association between malaria transmission
intensity and current infection with HIV in western sub-Saharan Africa. The lower HIV
prevalence in the western region compared to the eastern region of the continent might be
a contributing factor for this difference. Unlike the eastern region, where the HIV
epidemic is present in the general population, the low HIV prevalence observed in
western countries might indicate that the HIV epidemic is concentrated in high-risk
groups.
Our collective work provides evidence that the epidemiology of co-infection is
not a simple additive relationship. The effect of co-infection on the spread of HIV might
be influenced by other external factors such as the stage of the epidemic, individual and
community behavior, and the HIV prevalence in the population, among others.
Mathematical models have suggested that the number of HIV infections attributable
directly to co-infection, estimated as the population attributable fraction, depends on the
stage of the HIV epidemic and the epidemiology of the parasite involved in the coinfection (Abu-Raddad et al., 2008; Cuadros et al., 2011a; Freeman et al., 2007; Orroth et
al., 2007). These models indicate that co-infections with sexually transmitted infections
prevalent in high-risk groups, such as syphilis, trichomoniasis, gonorrhea and chlamydia,
have the highest impact on the spread of HIV when the epidemic is concentrated in these
subgroups. On the other hand, infections that are highly prevalent in the general
population, such as herpes simplex virus type 2 and malaria, are more important
contributors to fueling the spread of HIV infection when the epidemic has invaded the
general population.
The results from this study and our previous work are thus consistent with the
results obtained from mathematical models and indicate that co-occurrence of HIV and
infections present in the general population, like malaria, might not play an important
role in the spread of HIV in populations where its prevalence is low. Malaria apparently
acts as a facilitator and fuels the spread of HIV when the epidemic is present in the
general population but it is not the cause of the invasion of HIV in the general population.
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This hypothesis is supported by the results obtained from data for Cameroon, where
regardless of the similar PfPR and prevalence of male circumcision compared to the
studied western region, the higher HIV prevalence in Cameroon was observed together
with a significant association between HIV and malaria.
In agreement with other studies (Auvert et al., 2001b; Buve et al., 2001b), we
found no difference in the socio-economic and demographic cofactors for HIV infection
between the eastern and western regions of sub-Saharan Africa. Circumcision, however,
was not significantly associated with HIV infection for men in our study. Circumcision is
almost universal in western sub-Saharan Africa (Auvert et al., 2001a), where 94% of the
male individuals included in our study were circumcised. In contrast, only 62% of the
male individuals included in the study for the eastern region were circumcised. This
difference has been proposed as a key factor for the difference between both epidemics
(Auvert et al., 2001a; Auvert et al., 2001b). Circumcision is a cultural practice, and
therefore it is plausible to hypothesize that the current prevalence of circumcision might
be similar to the prevalence at the early stage of the HIV epidemic in sub-Saharan Africa.
Consequently, the high rate of male circumcision observed in western sub-Saharan Africa
could have generated a protective effect that prevented the invasion of the epidemic to the
general population.
The results from Cameroon, however, did not support this hypothesis. Despite the
extent of male circumcision (95%), the higher HIV prevalence indicates the likely
presence of an HIV epidemic in the general population, which in turn might have
governed the interaction between HIV and malaria that is suggested by our results. Thus,
the factors (biological and behavioral) that trigger the movement of an HIV epidemic
from high-risk groups to the general population remain indeterminate. The identification
of these factors may give us a better understanding of the geographical differences
observed in the HIV epidemic and a better comprehension of the complex co-infection
relationship between HIV and other parasites.
The present work as well as our previous study (Cuadros et al., 2011b) indicate
that the presence of a parasite influencing the transmission of HIV, even when the
parasite is highly prevalent in the population, does not fully explain the interaction and
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the outcome of co-infection on the spread of HIV. Other factors such as the HIV
prevalence and the distribution of the infection in the population may dictate the role of
co-infection in fueling the epidemic.
Our work highlights the importance of identifying factors for the implementation
of effective control interventions focused on co-infection. The effect of co-infection
might not be the same in different populations, and control strategies will not necessarily
have the same impact in each population. Understanding the epidemiological effects of
co-infection and the relevant factors involved in this relationship is a prerequisite to
developing accurate and effective recommendations for population-level control
strategies.

Limitations of the study
Although our study makes use of the most complete and contemporary databases
for both HIV and malaria, it is important to emphasize that our results were based on
geographical estimates of PfPR in children aged 2 to 10 years old in locations where
DHS surveys were made, and thus we estimated the effect of malaria on the prevalence of
HIV based on indirect measures of malaria transmission intensity. Therefore, the results
obtained in this study depend on the quality of these secondary data and on the
methodology implemented in our and in previous analyses. Consequently, they should be
interpreted with caution.
Furthermore, it is important to highlight that our estimates are based on
prevalence data for HIV. Since HIV prevalence is highly influenced by other independent
factors, such as the stage and distribution of the epidemic in the population, this
epidemiological measure might not be the most appropriate for evaluating the interaction
between both infections. We used this measure based on the availability and quality of
the data derived from different DHS surveys. Other epidemiological estimates such as
HIV incidence, however, would be a more appropriate measure for direct estimation of
the association between incident HIV and malaria. Therefore, our collective work
represents a preliminary step to elucidate the role of malaria on the HIV epidemic in subSaharan Africa, and highlights the necessity of more appropriate data for understanding
the malaria-HIV relationship in order to implement effective control interventions.
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On the other hand, the PfPR values used in our study were obtained by
mathematical algorithms that standardized the malaria transmission intensity in children
aged 2-10 years (Hay et al., 2008). Whereas this estimation is a widely accepted
approximation of the malaria transmission intensity in a specific region (Smith et al.,
2007), it is important to note that most HIV infections occur in the adult population.
Repetitive malaria infections during childhood generate partial immunity to the infection
and thus decrease the prevalence of clinical malaria in adults, especially in areas where
malaria is endemic (Kamya et al., 2006). Although the PfPR in children aged 2-10 has
been widely accepted as a measure of the transmission intensity, this variable is only an
approximation to the malariological index. Furthermore, the relationship between this
variable and the transmission intensity in the adult population is still not well defined,
and most likely the PfPR in adults would be somewhat different. For that reason, it is
important to note that other malariological measures, such as the entomological
inoculation rate or the prevalence of malaria in the adult population, would be alternative
ways to investigate for the association between the co-infection studied here. These
alternative data, however, are scarce, whereas the database for malaria used here allowed
us to obtain the proxy data necessary for performing the analysis in this study. Moreover,
we expect that the geographic distribution of the intensity of malaria transmission
remains the same for all populations (children and adults), in which case the geographic
variability of the PfPR used here represents a useful approximation for the comparisons
made in this study.
Additionally, the relationship between malaria and HIV is bilateral, where HIV
infection might alter the natural history of malaria (and vice versa), especially in areas
with high HIV prevalence and unstable malaria transmission (Grimwade et al., 2004;
Korenromp et al., 2005; Whitworth et al., 2000). In our study, however, we focused on
the association between an ecological proxy of malaria infection and current HIV
infection rather than the potential effect of HIV on malaria. Since the region studied is
characterized by an endemic malaria epidemic (Hay et al., 2006) and low prevalence of
HIV, we expect that this assumption would not drastically affect the outcome of our
study.
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Table 4.1 HIV prevalence by socio-economic and biological characteristics in
western sub-Saharan Africa and Cameroon

Characteristics
Malaria
PfPR ≤ 0.46
PfPR > 0.46
Gender
Female
Male
Age
15-19
20-24
25-29
30-34
35-39
40-49
50-59
Place of residence
Urban
Rural
Marital status
Never married
Currently married
Formerly married
Religion
Muslim
Christian
Traditional religion
Other
Wealth index
Poorest
Poorer
Middle
Richer
Richest
Highest educational level
None

Western Africa
N (% HIV-positive)

Cameroon
N (% HIV-positive)

10 207 (1.58)
30 857 (1.48)

4871 (4.1)
5217 (6.4)

22 768 (1.80)
18 296(1.15)

5102 (6.7)
4986 (4.0)

8690 (0.52)
6844 (1.18)
6006 (2.00)
5247 (2.19)
5009 (2.15)
7614 (1.60)
1654 (1.75)

2443 (1.4)
1940 (5.0)
1582(8.2)
1245 (8.5)
966 (8.3)
1476 (5.6)
436 (2.0)

13 589 (2.25)
27 475 (1.16)

4887(6.6)
5201(4.3)

11 575 (0.83)
27 349 (1.60)
2140 (4.06)

3160 (2.7)
6013 (5.8)
915 (12.0)

19 884 (1.31)
12 755 (1.65)
388 (0.25)
8037 (1.87)

1628 (4.70)
4051 (5.60)
271 (1.85)
4138 (5.58)

8469 (1.02)
8235 (1.25)
8219 (1.27)
7937 (1.88)
8204 (2.17)

1569 (2.9)
1819 (3.2)
2264 (6.0)
2189 (7.0)
2247 (6.7)

21 502 (1.30)

1504 (3.6)
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Primary school
Secondary
Higher
Genital ulceration
No genital ulceration last 12 months
Genital ulceration last 12 months
Male circumcision
No circumcised
Circumcised
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8460 (1.45)
10 268 (1.94)
834 (1.99)

4007 (5.7)
4217 (5.9)
360 (4.4)

40 644 (1.42)
420 (2.22)

9843 (5.5)
245 (9.7)

17 364 (1.79)
1021 (1.31)

253 (1.59)
4733 (4.18)

Table 4.2 Unadjusted and adjusted results from western sub-Saharan Africa: HIV
serostatus according to selected socio-economic and biological characteristics
OR (95% CI)
Indicator

Unadjusted

Adjusted

Malaria

PfPR ≤ 0.46

1.00

1.00

PfPR > 0.46

0.95 (0.74-1.21)

1.14 (0.86-1.50)

1.00

1.00

0.64 (0.53-0.77)

0.63 (0.51-0.78)

15-19

1.00

1.00

20-24

2.39 (1.58-3.62)

2.12 (1.38-3.25)

25-29

4.18 (2.82-6.17)

3.66 (2.35-5.68)

30-34

4.68 (3.16-6.94)

4.11 (2.60-6.51)

35-39

4.62 (3.10-6.87)

4.18 (2.62-6.67)

40-49

3.46 (2.34-5.12)

3.14 (1.97-4.99)

50-59

3.91 (2.28-6.72)

5.30 (2.84-9.88)

Urban

1.00

1.00

Rural

0.48 (0.39-0.60)

0.58 (0.43-0.78)

1.00

1.00

Currently married

2.19 (1.70-2.82)

1.17 (0.85-1.63)

Formerly married

5.45 (3.90-7.62)

2.55 (1.73-3.77)

1.00

1.00

Christian

1.28 (1.01-1.62)

1.11 (0.86-1.46)

Traditional religion

0.24 (0.02-2.45)

0.28 (0.02-2.87)

Other

1.39 (1.07-1.80)

1.24 (0.94-1.63)

Gender

Female
Male
Age

Place of residence

Marital status

Never married

Religion

Muslim
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Wealth index

Poorest

1.00

1.00

Poorer

1.20 (0.85-1.69)

1.15 (0.82-1.62)

Middle

1.21 (0.86-1.70)

1.10 (0.78-1.56)

Richer

1.81 (1.31-2.51)

1.40 (0.97-2.01)

Richest

2.01 (1.45-2.77)

1.38 (0.92-2.08)

1.00

1.00

Primary school

1.03 (0.80-1.32)

1.21 (0.93-1.57)

Secondary

1.33 (1.07-1.66)

1.38 (1.06-1.79)

Higher

1.31 (0.74-2.29)

1.01 (0.56-1.82)

1.00

1.00

1.65 (1.21-2.26)

1.27 (0.93-1.76)

Highest educational level

None

Genital ulceration

No genital ulceration last 12 months
Genital ulceration last 12 months

65

Table 4.3 Unadjusted and adjusted results from Cameroon: HIV serostatus
according to selected socio-economic and biological characteristics
OR (95% CI)
Unadjusted
Adjusted

Indicator
Malaria
PfPR ≤ 0.46
PfPR > 0.46
Gender
Female
Male
Age
15-19
20-24
25-29
30-34
35-39
40-49
50-59
Place of residence
Urban
Rural
Marital status
Never married
Currently married
Formerly married
Religion
Muslim
Christian
Traditional religion
Other
Wealth index
Poorest
Poorer
Middle
Richer
Richest
Highest educational level
None

1.00
1.64 (1.29-2.07)

1.00
1.56 (1.23-2.00)

1.00
1.00
0.55 (0.46-0.67)
0.58 (0.47-0.71)
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1.00
4.05 (2.67-6.13)
6.65 (4.42-9.98)
7.07 (4.66-10.71)
6.45 (4.18-9.95)
4.58 (2.99-7.02)
1.36 (0.60-3.10)

1.00
3.59 (2.33-5.52)
5.86 (3.76-9.14)
6.07 (3.82-9.63)
5.65 (3.48-9.15)
3.98 (2.46-6.43)
1.72 (0.73-4.09)

1.00
0.63 (0.50-0.78)

1.00
0.76 (0.57-1.01)

1.00
2.41 (1.86-3.13)
5.39 (3.95-7.37)

1.00
1.17 (0.86-1.60)
2.66 (1.87-3.79)

1.00
1.17 (0.86-1.59)
0.45 (0.17-1.20)
1.14 (0.84-1.55)

1.00
0.94 (0.67-1.30)
0.51 (0.19-1.37)
0.92 (0.66-1.27)

1.00
0.99 (0.64-1.51)
1.94 (1.33-2.83)
2.26 (1.55-3.29)
2.09 (1.43-3.06)

1.00
0.88 (0.57-1.36)
1.66 (1.12-2.47)
1.90 (1.24-2.93)
1.70 (1.06-2.93)

1.00

1.00

Primary school
Secondary
Higher
Genital ulceration
No genital ulceration last 12 months
Genital ulceration last 12 months
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1.44 (1.03-2.02)
1.45 (1.03-2.04)
1.05 (0.57-1.96)

1.33 (0.91-1.94)
1.24 (0.82-1.86)
0.7 (0.37-1.43)

1.00
1.81 (1.14-2.88)

1.00
1.39 (0.87-2.22)

Chapter 5 - Heterogeneity in the HIV infectivity generated by
co-infection: insights from a mathematical model

Introduction
At present, the role of viral genetic factors in the HIV epidemic is poorly understood.
Many different HIV genetic subtypes circulate worldwide as well as their recombinant
forms (Saathoff et al., 2010). Moreover, there is a substantial variation in the length of
the asymptomatic (chronic) phase of HIV infection, ranging from few months to many
years. This variation has been correlated with the so-called set point viral load (spVL),
defined as the measure of the HIV RNA concentration in blood during the chronic stage
of the infection, representing the quasi-steady state equilibrium between virus production
and clearance (Perelson et al., 1996; Stafford et al., 2000).
The functional differences and the epidemic significance of these variations are
still unclear (Geretti, 2006). Some studies, however, have revealed potential differences
in the replicative capacity among different virus genotypes (Åsjö et al., 1986; Ayele et
al., 2010; Betts et al., 2001; Blaak et al., 1998; Hu et al., 2001; Kivelä et al., 2005). As a
result, it has been suggested that if viral factors can affect the efficiency of viral
replication and can be preserved from one infection to the next, this would imply a
significant role of viral genetic factors determining the spVL (Hollingsworth et al., 2010).
Recent studies conducted to assess this hypothesis have evidenced that virus
characteristics might indeed explain a significant proportion of the variation in the spVL
observed among individuals. They demonstrated a correlation of the spVL between
transmitting couples and suggested that the spVL might be a heritable factor. Even a
weak correlation between spVL of individuals in transmitting couples might correspond
to a large estimate for the role of viral genetic factors (Alizon et al., 2010; Fraser and
Hollingsworth, 2010; Hecht et al., 2010). This result has profound implications for
important virus-related processes in which the spVL is a key determinant, such as the
progression and transmission of the infection. The evidence suggests a strong correlation
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between HIV plasma viral load (VL) and HIV transmission rates (Quinn et al., 2000;
Wilson et al., 2008). It has been estimated that a ten-fold increment in VL almost doubles
the risk of HIV transmission per sexual contact (Quinn et al., 2000). Consequently, if
viral genetic factors influence the concentration of the virus during the chronic stage of
the infection, these viral characteristics might indeed play an important role on the
transmission of the infection.
The spVL, however, is not in an absolute equilibrium state; it is frequently
perturbed by immune activations generated by the invasion of other pathogens, resulting
in a significant amplification of the VL. Changes in the host immune response induced by
concomitant infections may account for increments in the VL that could make the host
more infectious and increase the risk of transmission of the virus during the chronic stage
of the infection (McLeans and Nowak, 1992; Modjarrad et al., 2008; Modjarrad and
Vermund, 2010). The amplification of the VL generated by co-infection may be an
important contributor to the successful transmission of the infection; especially in areas
were the immune system is constantly challenged by multiple infections, such as in subSaharan Africa (Barnabas et al., 2011; Bentwich et al., 1995; Lawn, 2004).
Furthermore, there is substantial heterogeneity in the effect of co-infection at the
individual and population levels. Within individuals, the co-infection induced increment
of the VL varies greatly (Kublin et al., 2005; Ostrowski et al., 1998; Rosok et al., 1996).
Likewise, the effect of co-infection at the population level depends on several behavioral
and epidemiological factors related to the stage and the distribution of the HIV epidemic
within the population. Co-infections with sexually transmitted infections (STI) such as
gonorrhea and chlamydia would have the highest impact on the transmission of the virus
in populations where the epidemic is concentrated in the high risk (core) groups.
Conversely, infections prevalent in the general population such as malaria and herpes
simplex virus type 2 (HSV-2) would be important contributors to the spread of the
infection when the epidemic has invaded the general population (Abu-Raddad et al.,
2008; Cuadros et al., 2011a).
Based on the biological evidence previously discussed, I suspect that viral factors
might contribute to the variation of the effect of co-infection at host and population level.
Here, taking a simple modeling approach, I examined how viral factors that dictate the
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spVL can alter the dynamics of the virus population in presence of co-infection and can
introduce heterogeneity among individuals. I expect that viruses with high replicative
capacity that sustain elevated spVL would also generate larger increments in the VL in
response to host immune activations induced by co-infection. In contrast, viruses with
poor capacity to infect target cells and replicate would generate lower spVL and
consequently lower VL increments in response of co-infection. Since the transmission
efficiency of the virus among individuals is associated with viral burden, highly
infectious individuals would have viral characteristics that maximize the increment of the
VL in presence of co-infection. This result might have important implications at both the
individual and the population levels.
To assess this hypothesis, I generated a mathematical model that describes the
dynamics of HIV and a concomitant pathogen within the host to evaluate the
heterogeneity of viral replicative capacity on the spVL and the increment on the VL in
response of co-infection. Additionally, I evaluated the effects of these variations at
population level.

Methods
I developed a deterministic differential equation compartment model based on two
independent models that describe the dynamics of HIV and another parasite, namely
malaria.

HIV model
The basic model of HIV dynamics implemented here has three variables: T the
population sizes of uninfected cells, T * infected cells, and V free virus particles
(Callaway and Perelson, 2002; Stafford et al., 2000). These quantities denote the total
abundance of the given population per milliliter (ml) of blood, and their dynamic is
described by the following system of differential equations:
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dT
= s − ( d t + kvV )T
dt
dT *
= kvVT − δ T *
dt
dV
= N δ T * − cV
dt
,

where s represents the production rate of activated immune (CD4+ T) cells, dt the natural
death rate of activated immune cells, kv the HIV infection rate of activated immune cells,
δ death rate of HIV infected cells, N the HIV production rate by an infected cell, and c
the HIV removal rate. The magnitudes of these parameters are summarized in Table 5.1.
From this system of differential equations it is possible to determine the concentration of
the virus population at equilibrium, which might be associated with the spVL in the
chronic stage of the infection, and is described by the following equation (Callaway and
Perelson, 2002):

V =

Ns d t
− .
δ c kv
This equation shows that virus concentration at equilibrium may depend on virus

factors that determine its replicative capacity: the infection rate of immune cells ( kv ) and
the production rate by infected cells (N). This result has been used by other authors to
estimate these parameters using least squares parameter estimation techniques (Perelson
and Nelson, 1999; Stafford et al., 2000). Since these parameters represent intrinsic
characteristics of the virus, and their variation generates different spVL, I focused on
evaluating the effect of such variations on the VL burden generated by the presence of a
concomitant pathogen.

Malaria model
Malaria was selected as the concomitant pathogen based on substantial biological and
epidemiological evidence suggesting an important malaria-HIV interaction, especially in
areas where the infections overlap geographically. Several studies have demonstrated the
71

increment of VL in individuals with acute malaria (Barnabas et al., 2011; Chen et al.,
2003; Hoffman et al., 1999; Kublin et al., 2005). Likewise, the risk of HIV infection is
higher in areas with high malaria prevalence (Cuadros et al., 2011b), and malaria has
been proposed as an important facilitator for the spread of HIV in sub-Saharan Africa
(Abu-Raddad et al., 2006; Cuadros et al., 2011a).
To introduce malaria into the system, I implemented a minimal model developed
earlier (Anderson et al., 1989) and used by several authors (Hellriegel, 1992; Mideo et
al., 2008; Mugisha et al., 2008; Thibodeaux, 2010) to study the population dynamics of
X uninfected red blood cells, Y infected red blood cells, M free merozoites, and Tm

malaria activated immune cells. The system is described by the following system of
differential equations:
dX
= Δ − μ x X − km MX
dt
dY
= km MX − ( μ1 + μ y )Y − μcYTm
dt
dM
= r μ1Y − km MX − ( μm + μ hTm ) M
dt
dTm
= ε + ⎡⎣ λ yY + λm M ⎤⎦ Tm − dtTm
dt
,

where Δ stands for the rate of red blood cell production, μ x the natural death rate of
uninfected red blood cells, km the infection rate of red blood cells by merozoites, μ1 the
differentiation rate of merozoites, μ y natural death rate of infected red blood cells, μc
clearance rate of infected red blood cells due to the immune system, μ m natural death
rate of free merozoites, μh death rate of merozoites by contact with immune cells, r
merozoite production per infected cell, ε rate of immune cell production, λ y proliferation
rate of immune cells in response to infected red blood cells, and λm proliferation rate of
immune cells in response to merozoites. The parameter values are summarized in Table
5.1.
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Within-host co-infection model
As previously discussed, co-infection activates host immunity, which in turn
enhances HIV replication (Modjarrad and Vermund, 2010). This phenomenon has been
suggested to be a direct consequence of T helper cell (CD4+ T) activation that
consequently raises the number of target cells susceptible to virus infection and
replication (Obrien et al., 1995). This increment in the pool of susceptible target cells has
been observed in reaction to different agents that induce an immune response such as
influenza vaccine (Staprans, 1995), tetanus immunization (Cheynier et al., 1994;
Ostrowski et al., 1998), and malaria (Hoffman et al., 1999; Xiao et al., 1998). This
biological argument was used to link both models in a single co-infection model. This
approach was also used by Jones and Perelson (2002) to model the effect of vaccination
on chronically HIV positive persons and the effect of opportunistic infections on patients
treated with antiretroviral therapy (Jones and Perelson, 2005). But this is the first model
to include the dynamics of more than one infection simultaneously to evaluate the effect
of a concomitant infection on the dynamics of HIV. It is important to notice, however,
that the immune stimulation that promotes HIV replication is multifactorial, and cell
proliferation is only one of these mechanisms. Malaria also stimulates HIV transcription
in other ways such as the activation of viral transcription via cytokines (Xiao et al.,
1998). Therefore, the model presented here is a simplification of the effect of co-infection
on the virus population and only describes one of the possible mechanisms in which
parasites might affect the immune pathway that could alter the replication of the virus.
For the complete model of co-infection, the two models were linked by describing
the mechanism in which malaria stimulates an immune response in terms of activation
and proliferation of malaria activated immune cells ( Tm ), which in turn will become
available to HIV infection. The model includes a maximum number of immune cells per
ml of blood ( Tmax ) (Perelson et al., 1993); thus, the immune cell population will grow in a
logistic fashion. After linking the two models, the dynamic of the HIV-malaria coinfection is described by the following system of differential equations:
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dX
= Λ − μ x X − km MX
dt
dY
= km MX − ( μ1 + μ y )Y − μcYTm
dt
dM
= r μ1Y − km MX − ( μ m + μ hTm ) M
dt
⎡ T +T +T* ⎤
dTm
= ε + ⎡⎣λ yY + λm M ⎤⎦ ⎢1 − m
⎥ Tm − (d t + kTmV )Tm
dt
Tmax
⎣
⎦
dT
= s − ( d t + kvV )T
dt
dT *
= kvVT + KTmVTm − δ T *
dt
dV
= N δ T * − cV
dt

.

I estimated the effect of the HIV infection rate ( kv ) and production rate (N) on the
increment of the VL induced by co-infection by conducting several numerical
simulations of the model evaluated over the bi-dimensional parameter space generated by
the range parameter values of 1.5 × 10-6 to 2 × 10-5/day for the HIV infection rate ( kv ), and
20 to 300 virions/cell for the HIV production rate (N). Due to the uncertainty associated
with HIV infection rate of immune cells produced by the presence of malaria ( kTm ), I
explored four different values for this parameter, which were proportional to the values
used for the HIV infection rate ( kv ): kTm = kv , kTm = kv /10 , kTm = kv / 20 , and
kTm = kv / 30 . The simulations started with the introduction of HIV alone; when the
dynamics of the virus reached a steady state equilibrium (the spVL), malaria was
introduced into the system (day t = 600). I recorded the VL immediately before the
introduction of malaria, which represented the value for the spVL, and the following 30
days after the introduction of malaria. The values recorded during these 30 days were
then averaged to estimate the increment on the VL generated by co-infection.
To compare spVL and the increment on the VL induced by co-infection, I
sampled the parameter space evaluated to generate different combinations of the two
parameters evaluated, kv and N. These combinations were then used to calculate the spVL
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and its corresponding increment on the VL induced by co-infection. Lastly, a geometric
per capita growth rate of the virus was estimated for each combination of parameters.

Effect of co-infection at the population level
Understanding how concomitant infections could influence between-host transmission
and epidemic dynamics represents a major challenge in epidemiology. The scenario is
even more complicated when possible viral genetic differences might introduce
heterogeneity into the outcome of co-infection. For that reason, using the within-host
model described previously, I attempted to evaluate the effect of virus heterogeneity on
transient co-infection-induced amplification of the VL at population level.
To estimate the effect of co-infection on the spread of HIV at population level, I
implemented a standard deterministic population model constructed by Abu-Raddad and
coworkers (Abu-Raddad et al., 2008; Abu-Raddad et al., 2006). The model is a
deterministic compartment model that stratifies the population into compartments
according to HIV sero-status and stage of HIV infection, and sexual-risk activity group.
Details of the model are described elsewhere (Abu-Raddad et al., 2008; Abu-Raddad et
al., 2006), and a short description of the model is included in the Appendix B.
For this model, the functional relationship between VL and the probability of
transmission per sexual contact was used as the within-host and between-host interface.
VL is one of the principal determinants of heterosexual HIV transmission (Fideli et al.,
2001; Gray et al., 2001; Operskalski et al., 1997; Pedraza et al., 1999). It has been
estimated that each one log10 increase in the VL doubles the per coital-act probability of
HIV transmission (Lingappa et al., 2010; Quinn et al., 2000). Consequently, transient coinfection-induced increments in VL could potentially enhance between-host transmission
(Abu-Raddad et al., 2006; Cattadori et al., 2007).
The model assumes that the effect of the VL on the infectiousness follows the
empirical relationship between VL and transmission probability per sexual contact as
observed initially by Quinn and colleagues (Quinn et al., 2000):
log( vlH / vlB )
p IHIV
p HIV , where p IHIV
( i ) → S ( j ) = 2.45
( i ) → S ( j ) stands for the probability of

transmission per sexual contact for an infected individual from the risk group (i) to a
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susceptible individual from the risk group ( j ) , p H IV is the baseline probability of
transmission per sexual contact in the chronic stage of the infection, vlH is the amplified
VL, and vlB is the baseline VL. The baseline probability of transmission per sexual
contact in chronic stage was assumed to be p H IV = 0.0008, with a VL of vl B = 15 000
virion copies/ml (Quinn et al., 2000). Thus, as an example of the calculations performed,
at VL = 33 478 virion copies/ml, the probability of transmission per sexual contact in the
log( 33478 /15000 )
chronic stage is p IHIV
* 0.000 8 = 0.00109 . Finally, to account for
( i ) → S ( j ) = 2.45

the potential effect of the VL on the HIV disease progression to AIDS, each log10 rise in
the VL increases the rate of HIV progression to the latest stage of the infection by
twofold (Modjarrad et al., 2008).
The spVL and its corresponding co-infection induced increment on the VL for
each combination of parameters evaluated previously were used to compare the spread of
HIV in two different populations: one population free of co-infection, in which the
probability of transmission per sexual contact was estimated at the spVL, and the
corresponding population affected by co-infection, in which the probability of
transmission was estimated by including the increment on the VL induced by the
concomitant infection with malaria. To calculate the probability of transmission in the
population affected by co-infection, it was assumed that each individual has, in average,
one episode of malaria infection per year. Thus, the mean VL per year was the average of
the spVL during 11 months and the increased VL for the month of the co-infection. The
model was also evaluated assuming two and four episodes per year.
The system was evaluated at the endemic equilibrium (see appendix B). After the
equilibrium solution was found through convergent successive approximations, the total
prevalence and incidence were calculated. Finally, to evaluate the effect of co-infection
under different viral replicative capacities, the direct effect of co-infection on the HIV
incidence was measured by using population attributable fractions (PAF) calculated as:
⎛ IRvlsp ⎞
PAF = ⎜1 −
⎟ ×100%
⎝ IRHvl ⎠
,
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where IRvlsp is the incidence rate of HIV with the spVL, and IRHvl is the HIV incidence
rate with the heightened VL in presence of co-infection for each combination of
parameters kv and N as defined previously.

Results
Within-host model
In general, the within host co-infection model indicated that small values for the two
parameters evaluated, the HIV production rate by infected cell (N) and the HIV infection
rate ( kv ), produced small increments on the VL when dual infection with HIV and
malaria is present. Conversely, the increment on the VL increased as both parameters
increased (Figure 5.1). Different values for kTm , however, generated different patterns.
When kTm = kv , the differences on the increment of the VL in response to co-infection
were determined by the variation on the HIV production rate per infected cell (N) (Figure
5.1 A). The highest VL amplification was produced at a very low HIV infection rate ( kv
= 1 × 10-6 ) and high HIV production rate per infected cell (N= 300). Contrary to
expectation, when kv increases, the increment in the VL generated by co-infection
decreases. This behavior is derived from the ability of the virus to infect new target cells
activated by malaria. At high kv , the virus rapidly infects the new target cells impeding
the proliferation of these immune cells. Consequently, this overexploitation of the new
target cells by the virus at early stages of co-infection prevents an effective immune
response to control malaria. This scenario seems to be unrealistic since individuals
infected with HIV are able to have an immune response and cell proliferation in presence
of concomitant infections (Wyler, 1976; Chougnet et al., 1992). In addition, the
increment on the VL in individuals dually infected with HIV and another pathogen is
associated with an increment on the CD4+ T cells (Chen et al, 2003; Hoffman et al.,
1999).
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On the other hand, when the kTm was a fraction of the kv , the increment of both
parameters, the HIV production rate per infected cell and the HIV infection rate, induced
larger increments in the VL in response of co-infection. This result suggests that large
HIV infection rates might affect the availability of the new target cells for infection by
the virus by diminishing the potential cell proliferation. When kTm = kv /10 the effect of
the overexploitation of target cells by the virus is still evident at high HIV infection rate
(starting from kv = 1 × 105) (Figure 5.1 B). This effect is diluted when kTm = kv / 20 (Figure
5.1 C), and apparently, the target cell concentration stabilizes with no substantial changes
at smaller fractions of kv (Figure 5.1 D). For that reason, and to include possible
differences on the HIV infection rate generated by the availability of the new target cells
for HIV infection, the remaining results were derived assuming kTm = kv / 20 .
Figure 5.2 illustrates the dynamics of the virus according to the variation of the
virus parameters used. The combination of parameters generating low spVL were almost
unable to produce an increment on the VL when malaria was introduced into the system
(Figure 5.2 A, B, and C). Conversely, larger spVL might be associated with more
efficient viral replicative capacity that generated much larger increments in the VL in
response to co-infection (Figure 5.2 D, E, and F). After the introduction of malaria, there
was a transient increment on virus concentration followed by a peak and successive
decay to the original spVL. These viral dynamics in response to immune stimulations
have been observed previously in vivo (Staprans et al., 1995; Xiao et al., 1998) and
replicated by other mathematical models (Jones and Perelson, 2002; Jones and Perelson,
2005).
On average, VL peaked after one week and returned to baseline levels four weeks
after the immune stimulation, consistent with other studies in which a large increase in
the VL was observed during acute malaria and after influenza vaccine (Kublin et al.,
2005; Staprans et al., 1995). The average increment in the VL generated by co-infection
estimated from the 30 days recorded during the co-infection episode ranged from 500 to
800 000 virion copies/ml, variation consistent with the ranges estimated from studies
designed to evaluate the effect of malaria on the VL of HIV-positive individuals in Africa
(Hoffman et al., 1999; Kublin et al., 2005).
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The simulations performed using the samples from the parameter space evaluated
when kTm = kv / 20 illustrate in more detail the positive correlation between the spVL and
the increment on the VL induced by co-infection. Viral genotypes with poor replicative
capacity that produce low spVL were not able to respond to increments in the activated
target cells induced by the presence of concomitant infections. Consequently, the coinfection related increment in the VL generated by these viruses was fairly small. At
lower spVL, the relationship between the increment on the virus concentration and the
spVL increased exponentially, suggesting that viral genotypes with potent replicative
capacity that were able to produce elevated spVL were also associated with large coinfection induced increments in the VL. The pattern followed a logistic function,
suggesting a saturation effect at very high spVL (Figure 5.3 A). Additionally, the high
per capita growth rate observed at large spVL might reflect the high replication capacity
of these viruses that were able to effectively respond to increments in the target cell
population (Figure 5.3 B).

Between-host model
The functional relationship between the viral load and the probability of transmission per
sexual contact was used to link the viral replicative capacity and the effect of co-infection
at the population level. As expected, and in accordance with the immunological model,
the PAF analysis indicated that co-infection would have a negligible impact in
populations where the circulating virus has low replicative capacity, reflected in low
spVL. Conversely, the impact of co-infection would increase as the spVL of the
population increased, reaching a maximum effect at spVL around 1 × 105 (Figure 5.4).
This result indicates that viruses with high replicative capacity that are able to maintain
elevated spVL would have a substantial impact on the spread of the infection in terms of
new HIV infections directly caused by co-infection. This result was consistent regardless
of the average number of co-infection episodes per year. In addition, the number of coinfection episodes has almost no impact on the PAF at low spVL; even four episodes
were not able to produce a PAF larger than 1% when the spVL is lower than 2 × 106.
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Discussion
In this work, I explored factors that could introduce heterogeneity in the effect of coinfection at individual and population levels. I postulated that if the HIV replication
capacity was an important determinant of the spVL, it would also determine the effect of
co-infection on the dynamics of the virus. Here, using a simple mathematical model to
describe the dynamics of HIV at host level, it was possible to determine that the variation
in the viral replication capacity described by two parameters, the HIV infection rate ( kv )
and the HIV production by infected cell (N), generated different spVL. Moreover, the
influence of the heterogeneity in these parameters on the increment of the VL in response
of co-infection, evaluated using a within-host mathematical model of HIV-malaria coinfection, indicated that the viral replication capacity would strongly influence the
induced increment of the VL when a concomitant infection is introduced in the system.
In addition, the model suggests the existence of differences in the HIV infectivity
rate for new target cells generated by co-infection. Infections such as malaria generate
localized immune response occurring in specific organs such as the spleen (Chougnet et
al., 1992).This infection also produces a decrease in peripheral T cells consequence of a
sequestration of these cells to specific lymphoid organs (Wyler, 1976). These
characteristics might generate a compartmentalization of the system in which not all new
target cells would be available to the virus. Consequently, the HIV infection rate for the
new target cells generated by co-infection might be a fraction of the HIV infection rate
for non-specific immune cells ( kv ), as suggested by the model. Poor virus replicative
capacity, associated with low spVL, generated modest increments on the VL in response
to co-infection. Regardless of the co-infection induced proliferation of target cells, the
low replicative capacity of these viruses prevented an effective viral response to the
newly available activated target cells. Conversely, viruses with more efficient replicative
capacity, reflected in high spVL, were able to produce much stronger increments on the
VL when the population of target cells were incremented. Regardless of the introduction
of new target cells to the system, the effect of co-infection could mainly depend on the
ability of the virus to efficiently exploit the temporal rise of the target cell population.
This in consequence would generate a considerable increment on the VL when the
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immune system of the host is stimulated by the presence of a concomitant pathogen. This
result might indicate that viral factors could play an important role not only in
determining the spVL but also in driving several virus-related processes such as the
increment of the VL induced by co-infections.
This result would have important implications for the identification of highly
infectious individuals. HIV-positive persons that sustain high spVL might therefore be
able to produce large increments in virus concentration in response to immune
stimulations and consequently become much more infectious individuals, compared to
those maintaining low spVL, even in presence of the same concomitant pathogen. This
argument was then evaluated at the population level by linking the results from the
within-host model with a population model using the functional relationship between
viral load and probability of HIV transmission per sexual contact. I generated several
virtual populations with different viral replicative capacities that sustained different mean
spVL, in which the direct effect of co-infection on the incidence of HIV was then
evaluated. The results from these simulations were consistent with the results from the
host level model and raise the possibility that co-infection might play a substantial role in
the spread of HIV in populations where the circulating virus maintains elevated spVL.
Conversely, co-infection would not be an important driver of the epidemic in populations
with low spVL.
This work underscores the possibility that viral factors might have an important
impact on the role of co-infection on the spread of HIV. Therefore, understanding their
variation would be a key element in the design of control interventions to prevent HIV
transmission. To pursue this goal, however, it would be necessary to evaluate the results
from the theoretical model proposed here with experimental data. These kinds of studies
should be conducted in HIV positive individuals in the chronic stage of the infection with
similar CD4+ T cell count, and whose spVL have being well established. Their immune
systems can be challenged with the application of previously used antigen immune
stimulants such as tetanus toxoid vaccine (Ostrowski et al., 1998) or influenza vaccine
(Obrien et al., 1995; Rosok et al., 1996). The VL should then be measured frequently
(preferably daily) over a considerable period of time (at least one month), to accurately
delineate the dynamics of the virus during co-infection.
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I emphasize that this work relies entirely on a hypothetical relationship between
viral genotypic factors and the spVL. As noted previously, regardless of the evidence
about the relationship between viral genetic factors and the spVL (Alizon et al., 2010;
Fraser and Hollingsworth, 2010; Hecht et al., 2010), the evidence about the role of virus
genotype on the natural history of HIV is controversial (Hemelaar et al., 2006; Thomson
et al., 2002), and the evidence about differences in VL among populations is limited
(Geretti, 2006; Morison et al., 2001b). Therefore, our study indicates the importance of
conducting such studies that focus on estimating the spVL to elucidate possible
differences at population level. Such studies would help us better understand the
extensive variation on the HIV epidemic.
As suggested by the model, biological differences could alter the effect of coinfection and underscore the importance of identifying these factors for the
implementation of effective control interventions focused on co-infection. The effect of
co-infection might not be the same among individuals and populations, and control
strategies will not necessarily have the same impact in each population. Understanding
the role of viral genetic factors on co-infection becomes an important element for
developing accurate and effective recommendations for population-level control
strategies.

Limitations of the model
This study is a theoretical exercise aimed to explore further implications of the variation
of viral genetic factors on the natural history of HIV. To achieve this goal, we developed
a within-host co-infection model based on two well known and extensively used
mathematical models describing the within-host dynamics of HIV and malaria. These two
models were linked by the activation of the immune cells induced by the concomitant
infection with malaria, increasing the target cell population for HIV infection.
This mechanism, however, is only one of the several mechanisms in which the
invasion of another pathogen stimulates the replication of HIV (Chen et al., 2003;
Copeland et al., 1996; Pisel et al., 2002; Staprans et al., 1995). The interaction between
HIV and concomitant pathogens appears to be multi-factorial at cellular and
immunological levels (Copeland et al., 1996). For example, the transcriptional signaling
82

used by lymphocyte cells to regulate cell functioning is also used by HIV to regulate
virus production. During co-infection, cytokines [small proteins secreted by specific cells
of the immune system used for local signals between cells during response to infection
(Nathanson et al., 2002)] might enhance their susceptibility to HIV infection and
stimulate production of viruses for weeks to months without significant cytopathic effects
(Kedzierska et al., 2003; Vicenzi et al., 1997).
Moreover, other infections might have additional mechanisms in which they
could affect the transmission of HIV. For example, the genital reactivations of HSV-2
generate local immune activations in genital ulcerations that might increment HIV
shedding in the genital tracks (McClelland et al., 2002). This STI infection not only
affects the risk of transmission but also increases the risk of acquisition in HIV-negative
individuals, characteristic that considerably affects the mode in which HSV-2 influences
the pattern of HIV transmission at the population level (Abu-Raddad et al., 2008;
Freeman et al., 2006). The differences in which other infections besides malaria interact
with HIV are not considered in this study, and they might alter the results observed at the
population level.

Copyright © Diego Fernando Cuadros 2011
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Table 5.1 Co-infection within-host model parameter values
Parameter

Value

Reference

2.5*108 cells/day/ml

(Saul, 1998;
Thibodeaux, 2010;
Tumwiine et al.,
2008)

0.0083/day

(Anderson et al.,
1989; Tumwiine et
al., 2008)

2.5*10-10/day

(Anderson et al.,
1989; Tumwiine et
al., 2008)

0.5/day

(Anderson et al.,
1989; Tumwiine et
al., 2008)

Natural death rate of infected blood
cells (µy)

0.025/day

(Anderson et al.,
1989; Tumwiine et
al., 2008)

Clearance rate of infected red blood
cells due to the immune
system (µc)

1*10-8/cell day

(Thibodeaux, 2010)

48/day

(Anderson et al.,
1989; Tumwiine et
al., 2008)

1*10-8/day

(Anderson et al.,
1989; Tumwiine et
al., 2008)

16

(Anderson et al.,
1989; Tumwiine et
al., 2008)

0.0001/cell day

(Hellriegel, 1992)

2*10-8/cell day

(Thibodeaux, 2010)

Rate of red blood cell production (Λ)

Natural death rate of uninfected red
blood cells (µx)
Infection rate of red blood cells by
merozoites (km)
Differentiation rate of merozoite (µ1)

Natural death rate of free merozoites
(µm)
Death rate of merozoites by contact
with immune cells (µh)
Merozoite production per infected
red blood cell (r)
Rate of immune cells production
(malaria specific) (ε)
Proliferation rate of immune cells in
response to infected red blood cells
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(λy)
3*10-8/ cell day

Proliferation rate of immune cells in
response to merozoites (λm)

(Thibodeaux, 2010)

1.5*106/day (Perelson et al., 1993)

Maximum number of activated
immune cells per ml of blood (Tmax)

[0.5 × 10-6 - 2 × 10-5]/day

Representative value

Production rate of immune cells (s)

1*104 cells/ml/day

(Callaway and
Perelson, 2002)

Natural death rate of immune cells
(dt)

0.01/day

(Mohri et al., 1998)

HIV infection rate for nonspecific
immune cell (kv)

Death rate of HIV infected cells (δ)
HIV production rate by an infected
cell (N)

0.7/day (Perelson et al., 1997)
[20 - 296] virions/cell

Representative value

23/day

(Ramratnam et al.,
1999)

HIV removal rate (c)
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Figure 5.1 Increment on the VL induced by co-infection using different values for
the parameters kv and N

The effect of the heterogeneity of the HIV infection rate ( kv ) and production rate (N) on
the increment of the VL generated by co-infection was evaluated using the bidimensional
parameter space generated by the range parameter values of 1 × 10-6 to 2 × 10-5/day for the
HIV infection rate ( kv ), and 20 to 300 virions/cell for the HIV production rate (N). I
explored different values for kTm , in (A) kTm = kv ; (B) kTm = kv /10 ; (C) kTm = kv / 20 ; and
(D) kTm = kv / 30 .

A

B

C

D
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Figure 5.2 Time course of the VL in presence of co-infection with different set of
parameters kv and N

Figures illustrate the HIV dynamics from day 550, to day 800. In (A) kv = 2 × 10-6 and
N = 50; (B) kv = 5 × 10-6 and N = 120; (C) kv = 6 × 10-6 and N = 170; (D) kv = 9 × 10-6

HIV virion copies/ml

and N = 220, (E) kv = 14 × 10-6 and N = 260; (F) kv = 18 × 10-5 and N = 280.

A

B
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D

E
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Time (days)
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Figure 5.3 Correlation between the spVL and the increment on the VL in response
to co-infection

Model estimations are indicated in blue dots and triangles; the black lines represent the
logistic fitted line. In (A) the results suggest that viruses with replicative capacity that
produce low spVL are not able to generate considerable increments on the VL.
Conversely, viruses with potent replicative capacity that are able to produce elevated
spVL would generate much larger increments on the VL. The pattern follows a logistic
fit, which suggests a saturation effect at very high spVL. In (B) the geometric per capita
rate of growth was estimated for each spVL evaluated. Large spVL are accompanied with
high per capita rate of growth, which might reflect the high replicative capacity of the
virus.
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Figure 5.4 Correlation between the spVL and the PAF

The between-host model indicated that co-infection would have a negligible impact in
populations where the circulating virus has low replicative capacity reflected in low
spVL. Conversely, the impact of co-infection would increase as the spVL of the
population increases, until it reaches a maximum effect at spVL around 1 × 105.
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Chapter 6 - HIV prevention randomized clinical trials:
quantitative and analytical insights on the failure to measure
efficacy

Introduction
HIV infection remains as one of the major public health problems especially in subSaharan Africa (UNAIDS/WHO, 2009). During the nearly 30 years of research on HIV,
the improved understanding of the determinants of HIV transmission has identified key
candidate interventions to prevent HIV infection. More than 40 randomized controlled
trials (RCT) were designed to measure the efficacy of interventions on HIV incidence
ranging from HIV vaccines to behavioral interventions and male circumcision (Padian et
al., 2010). Despite the solid foundation on observational epidemiological evidence,
almost 90% of the RCTs failed to measure a statistically significant efficacy against HIV
incidence (Padian et al., 2010). The reasons behind the failure of most RCTs to measure
efficacy, despite the robust scientific evidence supporting the intervention concept,
continue to be poorly understood.
The disappointing results of these trials after massive scientific field work and
cost exceeding often tens of millions of dollars per RCT has generated a flurry of
scientific research to elucidate plausible explanations for these failures (Cohen et al.,
2011; Hayes et al., 2010a; Hayes et al., 2010b; Padian et al., 2010). In this article, we
explore further factors that may explain the outcome of such trials by conducting the
RCTs in silico thereby simulating the actual RCTs and investigating the drivers of their
failures.
We focused on the Partners in Prevention HSV/HIV Transmission Study RCT,
which was designed to test the efficacy of acyclovir suppressive therapy for herpes
simplex virus type 2 (HSV-2) on reducing HIV transmission (Celum et al., 2010). This
study found that, despite a significant reduction in the mean plasma HIV concentration
and in the genital ulcerations in the acyclovir group, there was no significant effect of
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acyclovir on the incidence of HIV. For comparisons, we also generated a model that
simulates the effect of male circumcision on the risk of HIV infection. We chose this kind
of intervention based on the positive results obtained from three RCTs designed to test
the efficacy of male circumcision on the prevention of HIV infection (Hayes et al.,
2010b), and the accurate estimation of its effect based on substantial amount of
observational data (Weiss et al., 2000). We particularly focused on the RCT study
conducted in Rakai, Uganda (Gray et al., 2007). Using a mechanistic mathematical model
and RCT simulation, we assessed the drivers and implications of these findings.

Methodology
Simulation of RCTs is a growing area of interest in different fields including HIV
prevention (Desai et al., 1999). In pharmacology, simulation of RCTs is a wellestablished procedure to evaluate alternative trial designs, test hypotheses, and interpret
trial outcome (Holford et al., 2000; Karlsson and Sheiner, 1993; Sheiner and Steimer,
2000). The greatest benefit of RCT simulation is the ability to conduct a trial thousands
of times in silico, and under variable spectrum of assumptions, at very limited cost versus
the highly costly and demanding implementation of a single trial in the field. In this
article, we developed a Monte-Carlo approach based in the Partners in Prevention
HSV/HIV Transmission Study RCT (Celum et al., 2010), and the Rakai circumcision
RCT study (Gray et al., 2007). We generated a population of virtual individuals and
simulated the two different interventions proposed in these clinical trials. For this in silico
experiment, the unit of replication was an individual RCT trial.

Partners in prevention trial simulation
To simulate the Partners in Prevention trial, the model generates a population of
individuals and simulates the administration of acyclovir suppressive therapy as an
intervention in an RCT trial just as the clinical trial. The total number of individuals
simulated in each realization (which corresponded to an individual RCT trial) was 3400
(1700 in the control group and 1700 in the acyclovir intervention group). To match the
number of HIV sero-conversions within the control group in the Partners in Prevention
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trial, the probability of HIV transmission per sexual contact was fixed at pun −treat =
0.0012; nicely in unison with the values estimated from the state of the art empirical
measures for this parameter of 0.0012 in the cohort of the Rakai Study (Gray et al., 2001;
Wawer et al., 2005) and 0.0011 in the cohort of the Partners in Prevention Study (Celum
et al., 2010).
The core of our simulation is the calculation of the effect of acyclovir on the
reduction of HIV transmission per sexual contact. Acyclovir acts to reduce HIV plasma
viral load, and subsequently HIV transmission probability per coital act. We assumed that
the effect on reducing HIV infectiousness is according to the empirical relationship
between HIV plasma viral load and HIV transmission probability per coital act as
observed initially by Quinn and colleagues (Quinn et al., 2000), and affirmed recently in
log10 ( vl )

the Partners in Prevention trial (Lingappa et al., 2010): ptreat = pun−treat × 2.45

. Here

pun −treat is HIV transmission probability per coital act in absence of intervention (control
group), which was fixed at 0.0012, ptreat is HIV transmission per coital act in presence of
intervention (intervention group), and log10 ( vl ) is the logarithmic (base 10) reduction in
HIV plasma viral load with the intervention. The Partners in Prevention RCT reported an
HIV plasma viral load reduction of 0.25 log10 (95% CI 0.22-0.29) (Celum et al., 2010)
implying 20.1% reduction in the transmission probability per coital act with the
intervention ptreat = 0.0010 . If the HIV plasma viral load reduction was 0.75 log10 , as in
the higher dose acyclovir proof-of-concept studies, the reduction in the transmission
probability per coital act with the intervention is 48.9% leading to ptreat = 0.0006 .
The number of coital acts per susceptible individual per month was randomly
chosen from a gamma distribution parameterized by the data of the Partners in Prevention
trial (Lingappa et al., 2009) (Table 6.1). The coital acts are then divided into condom
protected acts with efficacy of 80%, based on a systematic review of condom efficacy
(Weller and Davis, 2001), and un-protected coital acts. The fraction of acts that are
condom protected is 93% based on the Partners in Prevention data. Using these data, the
number of un-protected exposures per month per susceptible individual to HIV infection
is then estimated by drawing from a binomial distribution, where the number of events
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indicates the number coital acts per month per susceptible individual, and a probability of
unprotected coital exposures of 93% (1.00 − 0.80 ) + 7% = 26% .
For this simulation, the total number of individuals simulated in each realization
(which corresponded to an individual RCT trial) was 3400 (1700 in the control group and
1700 in the acyclovir intervention group). The 2-year follow-up of the study was
simulated in 24 monthly time steps. Each time step (month), and for each unprotected
sexual contact, the simulation draw a random number from an uniform distribution to
decide if the sero-negative individual remains uninfected or if the individual becomes
HIV infected. If a transmission occurs, the time is recorded to perform a log-rank survival
analysis. Figure 6.1 illustrated the algoritm implemented for the Partners in prevention
RCT simulation.

Circumcision trial simulation
To simulate the Rakai RCT study conducted to assess the effect of male circumcision on
the prevention of HIV infection, we estimated the probability of HIV transmission per
month based on the number of cases per 100 persons per year. The Rakai study reported
1.33 new infections per 100 persons-year, which gave us a baseline probability of HIV
transmission per month, pm = 0.0008. We assumed that circumcision decreases the risk
of infection by 60% (Auvert et al., 2005; Bailey et al., 2007; Gray et al., 2007; Weiss et
al., 2000); therefore the probability of HIV transmission per month for individuals
allocated in the intervention group was pm −treat = 0.00032. We allocated 2522 individuals
in the control group and 2474 individuals in the intervention group. The model simulates
the HIV transmission every month over a period of 24 months.
To measure the efficacy of the interventions, we performed two statistical
analyses for each replication: log-rank survival analysis and relative risk (RR) estimation.
The power of a specific RCT design was then determined from the number of trials that
rejected the null hypothesis. All results were based on means of 1000 repetitions. Figure
6.2 ilustrate an example of a survival curve obtained from the tree scenarios
implemented.
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We designed three distinct scenarios for the RCT simulations. In the first
scenario, we assumed an effect size based on the log10 reduction in HIV plasma viral load
as reported in the actual Partners in Prevention trial (0.25 log10 ). In the second scenario,
we assumed a larger reduction in HIV plasma viral load of 0.75 log10 consistent with a
stronger dosage of acyclovir. In the third scenario, we simulated the male circumcision
RCT assuming a 60% efficacy for the intervention as measured in the three male
circumcision trials to date (Auvert et al., 2005; Bailey et al., 2007; Gray et al., 2007).
We generated a population of virtual individuals and simulated the two different
interventions proposed in these clinical trials. For this in silico experiment, the unit of
replication was an individual RCT trial. To measure the efficacy of the intervention
(acyclovir or male circumcision), we performed two statistical analyses for each
individual trial realization: log-rank survival analysis and relative risk (RR) estimation.
The power of the RCT to yield a statistically significant result was then determined as the
fraction of realizations that rejected the null hypothesis (Burton et al., 2006). All reported
results in this article were based on 1000 realizations of the model.
We designed three distinct scenarios for the RCT simulations. In the first
scenario, we assumed an effect size based on the log10 reduction in HIV plasma viral load
generated by a dosage of acyclovir of 400 mg twice a day, and reported in the actual
Partners in Prevention trial (0.25 log10). In the second scenario, we assumed a larger
reduction in HIV plasma viral load of 0.75 log10 consistent with a stronger dosage of
acyclovir. In the third scenario, we simulated the male circumcision RCT. We also
assessed the effect of the number of unprotected coital exposures on the RR estimation
and statistical power of the RCT.

Results
Table 6.2 summarises the results from all simulations.
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Scenario1: Partners in prevention trial with 0.25 log10 reduction in HIV plasma
viral load
T In this scenario, the mean number of HIV sero-conversions was 35 in the intervention
group and 44 in the control group (Figure 6.3 A) leading to a mean RR of 0.79 (95% CI:
0.51-1.25), where the CI represents the mean of the upper and lower bounds estimated
from the 1000 realizations of the model. The log-rank test indicated that 14% of the RCT
realizations showed statistically significant efficacy for the intervention, whereas the RR
analysis indicated that 16% of the realizations were statistically significant. The RR
distribution (Figure 6.3 B) displayed wide variation in RR outcome across the 1000
realizations, ranging from RR point estimates of 0.45 to 1.6 (Figure 6.3 B).

Scenario 2: Partners in Prevention trial with 0.75 log10 reduction in HIV
plasma viral load
In this scenario, mean number of HIV sero-conversions was 22 in the intervention group
and 44 in the control group (Figure 6.3 C) leading to a mean RR of 0.51 (95% CI: 0.310.85). The log-rank test indicated that 75% of the RCT realizations showed statistically
significant efficacy for the intervention, whereas the RR analysis indicated that 77% of
the realizations were statistically significant. The RR distribution (Figure 6.3 D)
displayed wide variation in RR outcome across the 1000 realizations, ranging from RR
point estimates of 0.2 to 1.1.

Scenario 3: Rakai male circumcision trial
In this scenario, the mean number of HIV sero-conversions was 19 in the intervention
group and 48 in the control group (Figure 6.3 E) leading to a mean RR of 0.41 (95% CI:
0.26-0.64). The log-rank test indicated that 94% of the RCT realizations showed
statistically significant efficacy for the intervention, whereas the RR analysis indicated
that 95% of the realizations were statistically significant. The RR distribution (Figure 6.3
F) displayed wide variation in RR outcome across the 1000 realizations, ranging from RR
point estimates of 0.15 to 0.9.
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Scenario 4: Optimal trial design
We estimated an optimal trial design to detect significant differences between the
intervention and control arm. We used the same parameters used in simulation 1 (Table
6.1), but the population and the time of the follow-up were increased five and four times,
respectively. Thus, the total number of individuals simulated was 20 000 (10 000 in the
control group and 10 000 in the acyclovir group) and 96 time steps (months). For this
scenario, both the log-rank test and the RR analysis indicated that 99% of the repetitions
showed statistical differences. The mean HIV incidence was 778 in the intervention arm
and 966 in the control arm (Figure 6.4), and the mean RR was 0.80 (95% CI 0.76-0.88).

Data Effect of the number of unprotected coital exposures on the RR estimation
We explored the effect of the number of unprotected coital exposures on the RR by
varying the number of unprotected exposures from five up to 200 for the total duration of
follow-up. We did so for both Scenario 1 and Scenario 3 as described above. The results
indicated that few unprotected sexual contacts per partnership generate a broad CI, which
then shrinks as the number of sexual contacts increases (Figure 6.5), evidencing the
dependence of the level of statistical significance on the number of unprotected sexual
contacts.

Discussion
It has been suggested that acyclovir is insufficiently effective to produce a reduction in
HIV plasma viral load necessary to generate an effect on HIV transmission (Hayes et al.,
2010b). As a result, acyclovir therapy has been discredited as an alternative control
intervention for HIV prevention (Cohen et al., 2011; Hayes et al., 2010b). The reduction
on the plasma concentration of HIV, however, suggests that acyclovir (in a dosage of 400
mg twice a day) may be able to produce in average a 20% reduction on the risk of HIV
transmission. This information, complemented with the computer simulation of the trial,
indicated that the RCT designed by the Partners in Prevention team could not be expected
to detect a significant reduction of the incidence of HIV in response to acyclovir.
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We observed that only 14% of the realizations of the simulation obtained
statistically significant results, and evidenced the low power of the study to detect any
significant efficacy of acyclovir. Moreover, despite a reduction on the relative risk of
HIV transmission in the intervention group by 0.79 (95% CI: 0.51-1.25), the wide CI
indicated a high variation in the outcome of the simulation, which was consistent with the
findings of the study (hazard ratio with acyclovir 0.92; 95% CI: 0.60-1.41) (Celum et al.,
2010).
Based on the effect of acyclovir dosage used and other parameters estimated from
the trial, our model indicated that a sample size of ~20 000 couples with a follow-up time
of ~8 years would be necessary to provide enough power to detect a statistically
significant effect (Figure 6.4). However, the modest clinical significance of 20%
reduction on the HIV incidence might avert the implementation of such expensive and
logistically intensive clinical trial. Conversely, our results suggest that higher dosage of
acyclovir (or other antiviral drugs that generates a larger reduction on the mean
concentration of plasma HIV viral load) might generate the clinical efficacy desired
(Schacker et al., 2002), and indeed, increase the likelihood of success of the clinical trial.
Additionally, the Partners in Prevention team calculated the power of the study
based on an incidence of 4.0 per 100 persons-years in the control group, whereas the
incidence observed was 1.8 per persons-year. Like the expected effect size of the
intervention, the event rates assumed also play an important role in the calculation of the
statistical power (Schulz and Grimes, 2005). Our results suggest that the small number of
exposures to the infection (unprotected sexual contacts), which was associated with high
frequency of condom use, might be an important reason for the low observed incidence
and consequently, the failure on the detection of significant effect.
For the Partners in Prevention trial, a minimum number of sexual contacts would
be necessary to observe a statistical effect of the intervention. Despite the reduction on
the RR of HIV transmission generated by acyclovir, it would not be possible to detect a
significant effect on the reduction of the HIV transmission with fewer than 100
unprotected sexual contacts (Figure 6.5 A). Assuming a high rate of condom use (80% of
protected sexual contacts), which (in agreement with ethical issues) is the norm in this
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kind of studies (Hayes et al., 1997), gives an average of 19 unprotected sexual contacts
per partnership during the entire study. According to our analysis, this number of
exposures to the infection is far too low to detect a significant effect of the intervention,
and cannot provide the basis for an evaluation of the effectiveness of acyclovir.
Conversely, the more effective the intervention the smaller the number of
unprotected sexual contacts required to detect a significant difference. Due to the strong
effect of male circumcision in reducing the hazard of HIV infection (60% reduction),
even with a small number of unprotected sexual contacts, it would be possible to observe
a significant effect of the intervention (Figure 6.5 B). This may explain why all RCT
studies designed to test the effect of circumcision have shown significant results, and it is
consistent with the high power estimated from the simulation of the Rakai study, where
94% of the realizations showed statistically significant results. The estimated mean RR of
0.41 (95% CI 0.26-0.64) nicely agrees with the estimation from the Rakai study (KaplanMeier risk ratio 0.40; 95% CI 0.23-0.70) (Gray et al., 2007), and suggests a high accuracy
of the mechanistic approach implemented here.
Our work highlights the risk of designing clinical trials to evaluate interventions
to prevent HIV infections solely based on results from sample size calculations and
statistical power estimations. Standard formulas used to calculate the sample size of an
RCT are unlikely to capture the entire complexity generated by several factors that might
play an important role in the transmission of HIV. Key parameters such as frequency of
condom use, number of exposures to the infection, duration of the follow-up, measured
efficacy of the intervention based on biological data, adherence to the intervention,
among others, could be evaluated by the use of computer simulations to observe their
influence in the range of outcomes, and to design the most appropriate clinical trial.
The implementation of these virtual trials (i.e. computer simulations) that
synthesize the mechanistic process of the intervention (and the system in which it is
implemented) would help us to evaluate the design and performance of future HIV
prevention trials. It will help to succed in implementing costly and logisitcally intensive
clinical trials, and more importantly, it will avert confusing evidence on the effectivenes
of potential interventions.
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Table 6.1 Key parameters used in the RCT simulations
Parameter

Value

Time of the follow-up
Average number of sexual contacts per
month
Percentage of unprotected sexual contacts
per month

Reference

24 months

(Celum et al., 2010)

4 (95% CI 2 - 8)

(Lingappa et al., 2009)

26%

(Myer et al., 2002)

Number of individuals
(Celum et al., 2010)

Scenario 1
Control group

1700

Intervention group

1700
(Celum et al., 2010)

Scenario 2
Control group

1700

Intervention group

1700
(Gray et al., 2007)

Scenario 3
Control group

2522

Intervention group

2474

Probability of HIV transmission in the
control group
Scenario 1

0.0012 per sex act

(Celum et al., 2010)

Scenario 2

0.0012 per sex act

(Celum et al., 2010)

Scenario 3

0.0008 per month

(Gray et al., 2007)

Scenario 1

20.1%

(Celum et al., 2010;
Quinn et al., 2000)

Scenario 2

48.9%

(Celum et al., 2010;
Quinn et al., 2000)

Scenario 3

60%

(Gray et al., 2007;
Weiss et al., 2008)

Reduction on the probability of HIV
transmission in the intervention group

100

Table 6.2 Summary of the RCT simulations from the different scenarios
Result

Value

Mean HIV incidence rate per 100 persons/year
Scenario 1
Control group

1.29

Intervention group

1.03

Scenario 2
Control group

1.29

Intervention group

0.65

Scenario 3
Control group

0.95

Intervention group

0.38

Percentage of simulations with significant results
Scenario 1
Log-rank test

14%

RR analysis

16%

Scenario 2
Log-rank test

75%

RR analysis

77%

Scenario 3
Log-rank test

94%

RR analysis

95%

Relative risk estimation

RR (95% CI)

Scenario 1

0.79 (0.51-1.25)

Scenario 2

0.51 (0.31-0.85)

Scenario 3

0.41 (0.26-0.64)
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Figure 6.1 Flow diagram of the algorithm implemented to simulate the Partners in
Prevention HSV/HIV transmission study RCT

Control group

Intervention group
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Figure 6.2 Example of the survival curves estimated from a single realization

In (A) 20% reduction on the probability of HIV transmission per sexual contact (scenario
1); (B) 50% reduction (scenario 2); and (C) male circumcision (scenario 3).

A

B

C
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Figure 6.3 Number of HIV infections and RR distribution for the different scenarios

In (A) 20% reduction on the probability of HIV transmission per sexual contact (scenario
1), distribution of the number of HIV infections for intervention group (red bars), and
control group (blue bars); (B) its corresponding RR distribution, in this simulation for a
number of realizations, the RR exceeded one implying that despite the actual reduction in
the probability of HIV transmission per coital act, it is possible just because of stochastic
statistical nature, to observe higher HIV incidence in the intervention group compared to
the control group; (C) 50% reduction (scenario 2), and (D) its corresponding RR
distribution; (E) male circumcision (scenario 3), and (F) its corresponding RR
distribution.
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Figure 6.4 HIV incidence distribution for the optimal RCT designed to evaluate
acyclovir

In (A) distribution of the HIV incidence for intervention arm (red bars), and control arm
(blue bars); (B) its corresponding RR distribution.
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Figure 6.5 Effect of the number of unprotected sexual contacts on the RR estimation

The red line represents the RR trends and the blue lines its corresponding CI for (A)
assuming 0.25 log10 reduction on the HIV plasma viral load, and (B) male circumcision.
While the point estimate for the RR in Scenario 1 (acyclovir) was 0.80, the confidence
interval around this estimate varied from 0.70-0.93 at 200 un-protected coital exposures
to 0.32-1.99 at five un-protected coital exposures. Similarly, for Scenario 3
(circumcision), while the point estimate for the RR was 0.4, the confidence interval
around this estimate varied from 0.37-0.50 at 200 un-protected coital exposures to 0.140.99 at five un-protected coital exposures.
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Chapter 7 - Conclusions

This work aimed to explore the limitations of the notion that the existent heterogeneity of
the HIV epidemic could be explained merely by variations on sexual behavior. Instead,
the inclusion of temporal and individual variation on the HIV infectiveness generated by
co-infection might affect the pattern of the spread of the epidemic at population level, and
could potentially explain the differences on the HIV epidemic among populations.
Co-infection has been consistently proposed as one of the main factors fueling the
spread of HIV in sub-Saharan Africa. Here, I investigated the role of co-infection on the
spread of HIV in this part of the world. Using different methodological approaches, I
conducted statistical and mathematical analyses to assess the relationship between
different infections and HIV in sub-Saharan Africa. This study was based on the
hypothesis that the natural history of HIV in sub-Saharan Africa cannot be fully
understood if individual and temporal variation in infectiousness is neglected. A single
value for HIV infectivity would fail to describe the dynamics of the epidemic, and
regardless of the low probability of heterosexual transmission per sexual contact, the
inclusion of temporal and individual variation generated by transient increases in HIV
viral loads associated with co-infections might provide a biological basis for the
accelerated spread of HIV in sub-Saharan Africa.
The results here suggest that the HIV epidemic in sub-Saharan Africa can be
explained by heterosexual transmission, and that the amplification effect caused by
biological cofactors such as co-infection may have triggered the vast HIV epidemic
observed in sub-Sahara Africa. The high prevalence of infectious diseases such as
malaria and HSV-2 in sub-Saharan Africa probably provided suitable conditions for the
spread of the infection. The remarkably high HIV prevalence observed in sub-Saharan
Africa probably reflects the particularly suitable environment for the epidemic that is
unique to this part of the world. These results highlight the possibility that co-infection
might be a necessary rather than merely a contributing factor in the successful spread and
survival of HIV in populations where heterosexual vaginal-penile contact is the main
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mechanism of transmission, such as in sub-Saharan Africa. Because most studies
attempting to identify the infectivity of HIV have not explicitly accounted for important
cofactors, population average estimations cannot capture the variation in infectivity
associated with these cofactors.
This study emphasize the need for additional research focused on the infectivity
of HIV and underscore the importance of including cofactor effects in HIV infectivity
studies and epidemic models. Here, the results evidence the necessity for more and better
quality data to assess the role of co-infection in the spread of HIV. The results discussed
in chapter 3 and 4 indicate the possible relationship between malaria and HIV in areas
where both infections geographically overlap. This result, however, was derived using
indirect measures of the effect of malaria on the risk of HIV infection, and several
potential confounders such as the impact of HIV on the prevalence of malaria were not
taken into account. Therefore, it would be imperative to compare these results with field
studies designed to estimate the impact of malaria on the incidence of HIV. Currently,
active and efficient control interventions to reduce malaria infections have been
notoriously successful in countries such as Malawi, Kenya and Zimbabwe. This event is
generating a convenient scenario that would allow the study of the direct impact of
reductions on malaria prevalence in the incidence of HIV.
Likewise, results from chapter 5 evidence the priority to continue investigating
the role of viral genetic factors on the transmission of the virus. Despite the controversy
and skepticism surrounding this topic, the mathematical model developed here suggests
some potential implications resulted from the combination of biological factors. In this
chapter, several experiments were proposed to elucidate the potential interactions that
could be useful for understanding the differences observed among HIV epidemics.
Cofactor-enhanced infectivity of the virus might be a key determinant of the HIV
epidemic in sub-Sahara Africa. This suggests that an HIV epidemic may be mitigated or
halted through individual measures that decrease viral infectivity. On the other hand,
whereas limiting the number of sexual partners may be an effective strategy for reducing
an individual’s risk of HIV transmission; this strategy is unlikely to prevent an epidemic.
The control and treatment of several common infectious diseases would decrease the
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incidence of HIV over the long-term. The public health implications of our results are
clear: broad population-based control strategies to decrease infectivity such as condom
distribution, antiretroviral therapies, circumcision and especially control strategies for the
reduction of other sexual and parasitic infectious diseases, may therefore be effective in
reducing the spread of HIV and could be an effective strategy against the progression of
the epidemic in sub-Saharan Africa.
Several studies have been conducted to evaluate the efficacy of these kinds of
interventions on the reduction of HIV incidence. Unexpectedly, and in contrast with the
epidemiological evidence discussed in this study, the majority of the studies have shown
no significant effect of co-infection treatment on the incidence of HIV. Chapter 6 was
devoted to explore the possible causes for the failure of such operational intensive and
costly studies. The results from this chapter evidenced the methodological failures from
these studies that prevented the detection of significant effects of control interventions
focused on co-infection. The treatment of co-infections might indeed be an effective
control intervention; the implementation of studies aimed to evaluate the efficacy of these
interventions, however, need more thorough design, in which computer simulations
might be a powerful tool assessing the role of several unexpected behavioral an
biological factors on the final outcome of the study.
In summary, the general findings from this study have direct implications on the
design of mathematical models attempting to replicate the epidemic curve observed in
sub-Saharan Africa, as well as control interventions focusing on decreasing the incidence
of HIV. If highly infectious individuals can be identified, then the efficiency of control
measures could be greatly increased. The realization of these kinds of targeted
interventions, however, requires a better understanding of factors determining individual
infectiousness such as co-infections.

Copyright © Diego Fernando Cuadros 2011
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Appendix A - Supplementary methods and results Chapter 2

Supplementary methods
Sexual partnerships were assumed to be exclusively heterosexual, and two types of
partnerships, distinguished by duration, were considered. The population was assumed
closed and stable, with only maturation and mortality into and out of the sexual network.
The population size remained constant, with individuals maturing into the network to
offset those who die or mature out of the network. In accord with the highest resolution
of relevant data, a monthly time step was used. With this model, the effects of network
structure on disease transmission, relationship type, and co-infection with other infectious
diseases were evaluated.

Behavioral module
Building individuals

In the model, equal numbers of individuals of each sex were created and assigned an age
and node degree (maximum number of partners per year). The initial age was assigned
with a gamma probability distribution, with a range between 15 to 60 years old (Table
A.1, parameters 5-8).
Consequently, individual age was used to determine when individuals should be
removed from the sexual network, and was the basis for other age-specific traits.
We adopted a likelihood framework to estimate model parameters of the annual
degree node distribution by using the number of sexual partners reported in the Malawi
study for both males and females. For both males and females, the reported number of
sexual partners follows a gamma distribution:
f (n) = n k −1

e − n /θ
Γ(k )θ k

,

(1)

where the annual degree distribution is defined as the frequency of node degrees n
in the network, with shape parameter k and scale parameter θ .
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Because the time step of the simulation is one month, and with the aim of
preserving the degree distribution of the network, we estimated the monthly probability
of generating a partnership according to the degree node for each individual, and we
calculated the maximum number of connections that should be generated in the network
each month. We assumed that casual partnerships were temporally independent, began at
uniformly distributed random times throughout the year, and lasted for a set duration, d.
Further, as marriages generally last more than one year, we assumed that if an individual
was married, the relationship did not end during any observation year.
Thus, the expected number of casual partnerships within a year, cy, is the expected
number of marital partnerships, my, subtracted from the expected number of total
partnerships, ny or
c y = ny − my . (2)
Pm, the probability that a casual partnership recorded within the year, would also be
recorded within one particular month of the year given by
1+ d
.
pm =
12 + d (3)
Here a partnership is recorded within the observation month if its center point
falls within an interval of length 1+d centered on the middle of the month, and a
partnership is recorded within the observation year if its center point falls within an
interval of length 12+d. Because yearly casual partnerships are assumed to be temporally
independent, the expected number of monthly partnerships, nm, for an individual with ny
yearly partnerships is the expected number of yearly casual partnerships, plus the
expected number of yearly marital partnerships, my.

nm = c y pm + my =

(ny − m y )(1 + d )
12 + d

+ m y . (4)

The vector nm was used for estimating the probability of generating a connection
according to the node degree of each individual.
For calculating the maximum number of connections that should be generated
each month, we assumed that the expected numbers of yearly casual partnerships are
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Poisson distributed; therefore, for each nm, the probabilities that the expected cy
partnerships generate nm casual partnerships during the month, are found according to
p (c y , nm ) =

c y nm e

−cy

nm !

,

(5)

evaluated from nm = 0 to nmax. These probabilities are then weighted by the yearly degree
frequencies, correcting for the fraction of individuals that are married, and summing over
partnership numbers. The probabilities for casual partnerships, weighted by the node
degree distribution fy (n) are
pc (c y , nm ) = p(c y , nm ) *(1 − m) * f y (nm ) . (6)

The probabilities for marital partnerships, weighted by fy (n) are
pm (c y , nm ) = p(c y , nm ) * m * f y (nm ) . (7)
The probabilities for all partnerships, weighted by fy (n) are
pt (c y , nm ) = pc (c y , nm ) + pm (c y , nm ) . (8)
The total monthly partnership frequencies are then
ft (nm ) = ∑ cmax=1 pt (c y , nm ) . (9)
y
c

Each frequency includes both males and females; therefore we divided it by two
to obtain the maximum number of connections that should be generated in one month.
Forming initial partnerships

We allowed for two types of relationships; casual relationships, which lasted on average
6 months (Table A.1 parameter 14), and marriage (long-term relationship), which lasted
more than 1 year. Partnership formation occurs in two steps. First, the age mixing pattern
of marriage is generated by estimating the probability of generating a marriage using a
gamma probability distribution (eq 1) according to age and gender (Table A.1, parameter
9-12). This step generates the age mixing pattern of marriage. Then marriages are
generated until the fraction of the married population estimated for Malawi is reached
(Table A.1, parameter 13). Casual partnerships are then formed with the remaining
available individuals (married or single) according to their node degree, and then these
available individuals are randomly connected until the monthly number of connections
fy (eq 9) is reached.
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Dynamic of the network

Partnerships are broken and reformed with data-determined probabilities each month;
thus, with the aim of keeping the yearly degree distribution, individuals may sometimes
have zero partnerships in a particular month. For Malawi, the probability of ending a
marital relationship follows an exponential distribution as a function of the duration of
the marriage X, with an average duration of marriage of 6.92 years. Hence, each marriage
has a probability of ending in each time step according to an exponential cumulative
probability function with a scale parameter λ (eq 10). Casual partnerships break up
following the same function but at a higher rate λ (Table A.1, parameter 14):
f ( x) = 1 − e − λ x . (10)
As the sexual network represents only individuals engaging in sexual activity,
population dynamics consist of maturation into and out of the sexual network by
“mortality” related to age or HIV. At a maximum age of 60, individuals are assumed to
no longer be sexually active and are removed from the sexual network and replaced with
a new individual of age 15. This new individual has the same sex and node degree as the
removed individual, so that the sex ratio and network structure is maintained. Individuals
who have broken a relationship and new individuals who have replaced deceased
individuals or those who have matured out of the sexual network are reconnected by the
same process used to make the initial connections.

Epidemiological model
The epidemiological module was subdivided into two steps, the spread of the infections,
and the progression and recovery of each infection. We assumed that HIV transmission is
caused by penile-vaginal heterosexual contact exclusively. We selected gonorrhea,
syphilis and herpes simplex virus type-2 (HSV-2) as the infections to be simulated in the
sexual network, based on the amplification effect on HIV transmission and their
relevance in terms of prevalence in the Malawi population. The dynamics of these STI's
are well known, and the effect of each infection on the transmission of HIV has been
determined.
A key assumption for the epidemiological module is that the interaction caused by
co-infection has only one direction. In other words, we assumed that HIV infection has
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no effect on the natural history of the other infectious diseases included in the model.
This assumption may be seen as an oversimplification due to the fact that studies have
shown that HIV infection affects the transmission and progression of other infectious
diseases such as HSV-2 and malaria. Yet, studies have mainly focused on the impact of
co-infection on HIV. As a result, uncertainty about the effect of co-infection in the
direction of the other diseases is still high.
Spread of the infections

For the spread of the STI's, the probability of disease transmission per partnership per
month depends on the number of sexual contacts per partnership per month and the
transmission probability per sexual contact for each STI. The number of sexual contacts
per partnership per month is assumed to be a function of the number of partnerships of
the infected sex only. This function is defined as:
cn = c1 N −0.75 , (11)
where C1 is the number of sexual contacts per month for individuals having one
partnership according to age (Table A.2 parameter 7-10) , and N is the number of
partnerships the individual has in the specific month. This function is consistent with
individuals with more partnerships having more sex but keeps the number of sexual
contacts per month realistic.
For each infection, we obtained the estimated amplification factor on the
probability of HIV transmission per sexual contact. For our simulation, the algorithm
assessed whether the individual infected with HIV has another infectious disease, and if
co-infection was present, the HIV transmission probability was increased depending on
the amplification cofactor (Table A.2 parameter 49-53). Then, the new HIV transmission
probability including the amplificatory effect was calculated by
Tc = T * cofactor . (12)
where T is the stage or sex-specific transmission probability per sexual contact (Table
A.2 parameter 1-6). When multiple co-infections are present, we assumed a saturation
effect on the enhancement on the transmission probability. Thus, when more than one coinfection is present, the transmission probability is amplified only by the highest cofactor.
For the special case of HSV-2, the amplification factor is only effective if the HSV-2
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infection is reactivated (shedding) (Celum et al., 2004). Therefore the algorithm not only
verifies the presence of HSV-2 co-infection but also its reactivation. On the other hand,
HSV-2 not only enhances the transmissibility of HIV but also affects the susceptibility to
being infected with HIV (Celum et al., 2004). For this reason, the algorithm verifies if the
susceptible receptor is infected with HSV-2 and its reactivated stage. In this case, the
transmission probability is also increased by the respective amplification factor (Table
A.1 parameter 53).
The transmission probability per partnership per month is then calculated using
the binomial (Bernoulli) model as
Tp = 1 − (1 − Tc )cn , (13)

where Tp is the stage or sex-specific transmission probability per sexual contact (Table
A.2 parameter 1-6) and Cn is the number of sexual contacts the individual has with the
partner (eq 11). The probability of condom use is represented by a gamma probability
function (eq 1), depending on age (Table A.2 parameter 31, 32). If a condom is used, then
the probability of transmission of the STI is reduced 94% (Table A.2, parameter 33):
Tcondom = Tp *0.06

.

(14)

For the spread of Malaria infection, we used the daily Entomological Inoculation
Rate (EIR), defined as the number of infected bites that a person receives per day, for
both rainy and dry seasons estimated for Malawi, as well as the malaria transmission
efficiency for an infected bite. Each individual was exposed to a malaria infection by a
probability of transmission:
Tmalaria = EIR * malaria transmission efficiency . (15)
Because Tmalaria is calculated based on daily EIR, while the time step of the
simulation is the month, we calculated the monthly probability of malaria infection,
TMmalaria, using the Bernoulli model:
TM malaria = 1 − (1 − Tmalaria )30
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.

(16)

In order to include the effect of partial immunity generated by multiple malaria
infections, each new infection is recorded and then used for calculating the susceptibility
of a new infection using the model proposed by Gu and coworkers (Gu et al., 2003):
1
,
S malaria =
(17)
N inf θ
1+
c1
where Ninf is the number of malaria infections an individual has had in his/her life; θ and
C1 are constants. After calculating the susceptibility coefficient, the new probability of
malaria infection TM'malaria becomes
TM'malaria = TMmalaria * Smalaria . (18)
The core of our model is the spread of HIV infection. Before the introduction of
HIV infected individuals, the model simulates for several years the dynamic of the other
infectious diseases previously mentioned. When an endemic steady state for all infectious
diseases is reached (after about 500 time steps), the model introduces HIV infected
individuals until the HIV prevalence reaches 1%, which is the prevalence observed in
Malawi in 1981 (Crampin et al., 2002).
The HIV transmission probability per month was calculated in the same way as it
was calculated for the other STI's using the Bernoulli model (eq 12), as was the
probability of condom use and its effect on the probability of transmission. However, in
the spread of HIV the amplification effect caused by co-infection was taken into account.
Circumcision is known to affect the dynamics of HIV and has been proposed as
one of the explanatory variables for contrasting differences in prevalence among
countries of sub- Sahara Africa. The probability of HIV transmission from infected
female to uninfected male is approximately halved by circumcision.
Tcircum = Tt / 2 . (19)
Circumcision is included in our model at the beginning of the simulation, where a
percentage of males estimated for Malawi (Table A.2 parameter 62) are randomly
selected from the male population and identified as circumcised males.
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HIV transmission caused by commercial sex

The data available show that males do not report sexual contacts with prostitutes as
sexual partners; as a result, the degree node distribution estimated for males does not take
into account sexual contacts with prostitutes.(Ferry et al., 2001; Helleringer et al., 2007a;
Morison et al., 2001) However, because commercial sex has been considered an
important risk factor for acquiring HIV infection, we include this mechanism of HIV
transmission in the model.
Data from another study in Cameroon, Kenya and Zambia, called the four cities
study, was used to parameterize the spread of HIV infections caused by sexual contacts
with prostitutes (Ferry et al., 2001; Morison et al., 2001). In our model, commercial sex is
a simple generalized linear equation for calculating the probability that a male gets any of
the STI's included in our simulation, including HIV. We assumed that in average 8% of
the male population have six sexual contacts with a prostitute per year.
In our model, commercial sex is a simple generalized linear equation for
calculating the probability that a male gets any of the STI's included in our simulation,
including HIV. The model is a mass action Bernoulli model, where the probability of
transmission depends on the actual prevalence of the STI into the population. For HIV,
because prostitutes are cataloged as a core group, and the prevalence is usually higher
compared to the total population, we assumed that the HIV prevalence in prostitutes is
five times the actual HIV prevalence in the population. Thus, the probability of
transmission caused by sexual contact with a female sexual worker (FSW) is calculated
as:
I fsw (t ) = 1 − {(1 − p fsw (t )) + [ p fsw *(1 − Td ) n ]} , (20)

where pfsw(t) is five times the HIV prevalence of the total population at time t, Td is the
probability of female to male transmission in chronic stage of HIV infection (Table A.2
parameter 21) and n is the number of sexual contacts that a male individual has with the
prostitute in a month (Table A.2 parameter 60). Every month, a number of male
individuals (Table A.2 parameter 54) are chosen randomly and become infected via
commercial sex with a probability IFSW. Because our goal was to measure the impact of
co-infection on the spread of HIV infection, we allowed to prostitutes to have infections
with other STIs according to the prevalence of the STI reported for prostitutes. Hence, the
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baseline HIV transmission probability was amplified according to the presence of coinfection.
Progression of the infections

The model simulates the progression of each infection. Gonorrhea is the simplest one,
where each month infected individuals have a constant probability of recovery from the
infection, with an average duration of the infection of ten weeks (Table A.2 parameter
30). An individual that recovers from gonorrhea infection becomes susceptible again.
Syphilis infection has a more complex progression divided in two main stages.
The primary stage of the infection is the first six months, characterized by a high
probability of transmission for both sexes and the highest amplificatory effect on HIV
transmission (Table A.2 parameter 34, 36). After this initial six-month stage, the infection
remains latent for eight years. The latent stage is characterized by a low probability of
transmission and no amplification effect on HIV transmission (Table A.2 parameter 3537). We assume that individuals infected with syphilis receive treatment; therefore, after
the latent stage, individuals recover from the infection and become susceptible again.
HSV-2 infection has the most complex dynamics. A newly infected individual
enters a chronic stage of the infection lasting 10 years. During this interval, there are
about four reactivations of the infection (shedding) per year for non HIV co-infected
individuals, and six episodes per year for co-infected individuals (Table A.2 parameter
25,26). These reactivation periods last 15 days and produce the amplificatory effect of
HSV co-infection on both the transmission and acquisition of HIV (Table A.2 parameter
27). Hence, for our simulation, only co-infected individuals with HSV-2 in shedding
episodes have amplified the transmission and acquisition of HIV.
In contrast to the other STI's included in the simulation, individuals infected with
HSV-2 do not recover from the infections; but after the 10-year chronic stage, individuals
do not transmit the HSV-2 infection, and there is no cofactor effect on HIV transmission
or acquisition (Table A.2 parameter 23, 24).
For malaria, infected individuals recover at a constant rate, with an average
duration of the infection of two months (Rmalaria). However, with the aim of including the
effect of partial immunity generated by multiple infections, we used the equation
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proposed by Gu and coworkers (2003), to calculate a recovery coefficient rmalaria, which
decreases the duration of the infection:
rmalaria =

1
N ρ
1 + inf
c2

.

(23)

Here Ninf is the cumulative lifetime number of the individual's malaria infections;
ρ and C2 are constants. After calculating the susceptibility coefficient, the new

probability of recovery from malaria infections R'malaria becomes
R'malaria = Rmalaria * rmalaria . (24)
In order to maintain the concept of partial immunity, the recovery coefficient was
truncated at 20 malaria infections with a minimum value of 0.5.
Individuals infected with HIV have a probability of developing AIDS calculated
by a Weibull cumulative probability function depending of the duration of the infection x,
with scale parameter λ, and shape parameter k (Table A.2, parameters 11,12):
f ( x) = 1 − e− ( x / λ )

k

.

(25)

We assumed that individuals who develop AIDS are no longer spreaders of the
infection; they leave the sexual network and are replaced by new individuals in the same
way that was explained previously for “mortality”.

Supplementary results
Parameters included in our model are estimated from available published biological and
behavioral data. Due to the variability generated by the different data collections and
analyses, all estimations are associated with some degree of uncertainty. Analyses were
conducted using Latin Hypercube Sampling and Partial Rank Correlation Coefficient
(LHS/PRCC) through Monte Carlo sampling (Blower and Dowlatabadi, 1994; Marino et
al., 2008) from specific ranges using the uniform probability distribution function (pdf)
for 100 runs of the model.
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In the absence of published studies about the distribution and the range of most of
the parameters, ranges were chosen to be as large as possible and represent plausible
values for these parameters given the empirical evidence. These choices represent the
most influential parameters in our formalism as seen in multiple analyses of the model
and there are not precise estimates for them.
We conducted three different analyses where we explored the uncertainty and
sensitivity of each module, behavioral and epidemiological, separately, and then we
explored the uncertainty and sensitivity of the entire model.

Uncertainty and sensitivity analyses of the behavioral module
For the uncertainty and sensitivity analyses of the key parameters of the behavioral
module, we set the default probability of HIV transmission T = 0.003, but we did not
include the cofactor effect caused by co-infection. We sampled seven parameters: the
minimum and maximum age of individuals included in the sexual network, the mean
number of sexual contacts per month (assuming the same for all ages), the mean
durations of casual relationships, the proportion of the married population, the proportion
of the male population that has sex with prostitutes per month, and the number of sexual
contacts that a male has with a prostitute in a month. The specific range for the sampling
of each parameter is specified in Table A.3.
Descriptive statistics for the uncertainty analysis indicated that the variation
generated by the uncertainty of the parameters sampled is fairly low (Table A.3). On
average, all possible combinations of the parameters sampled did not produce an
epidemic. The 95th percentile, however, indicated that with some combination of the
behavioral parameters and without the inclusion of co-infection, 5% of the simulations
generated a HIV close to 5%.
The sensitivity analysis revealed that the average number of sexual contacts per
month and the mean duration of casual relationships were the only statistical significant
parameters; in other words, these parameters may explain most of the variation observed
among simulations (Table A.5). The number of sexual contacts and the duration of the
relationships are parameters related to the HIV transmission risk per partnership.
According to the binomial model for the calculation of the per-partner probability of HIV
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transmission, increasing the duration of the relationship or the number of sexual contacts
will increase the risk of HIV transmission. We observed that simulations with mean
duration of casual relationship longer than 8 months and with 12 sexual contacts per
month were able to produce an HIV epidemic higher than 6%.

Uncertainty and sensitivity analyses of the epidemiological module
For the uncertainty and sensitivity analyses of the key parameters in the epidemiological
module we included the cofactor effect caused by co-infection. We sampled from the
range of the cofactor values of the four infectious diseases included in the model,
gonorrhea, syphilis, HSV-2 and malaria (Table A.6).
The results from this analysis indicated that the variation generated by the
uncertainty of the cofactors is higher than the variation generated by the uncertainty on
the behavioral parameters (Table A.7). The first empirical quartile indicated that at least
in 75% of the simulations the HIV prevalence was higher than 10%. The sensitivity
analysis indicated that infections with a short infectivity period but with high cofactor
such as gonorrhea and syphilis, and the cofactor for infections present in the general
population such as malaria, are the parameters contributing to the variation observed in
the model (Table A.8).

Uncertainty and sensitivity analyses of the complete model
To explore the uncertainty and sensitivity of the complete model to the key behavioral
and biological parameters, we performed an analysis that combined the ranges previously
mentioned for both modules and also the proportion of male population with
circumcision [lower bound = 0.2; upper bound =0.5].
The combination of the uncertainty of the parameters of both modules increased
the imprecision of the model. One important result from this analysis was that, in contrast
with the uncertainty analysis for the epidemiologic module, the combination of both
modules produced some combinations of behavioral parameters that did not allow the
generation of an HIV epidemic. Thus, even with the inclusion of the cofactor effect, the
results indicated that in 25% of the simulations an epidemic could not be produced (Table
A.9).
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The results from the sensitivity analysis of the complete model were similar to the
result of each module separately. The PRCCs showed that as in the behavioral module,
the model was highly sensitive to the average duration of a casual relationship and the
mean number of sexual contacts per month (Table A.10). We observed that in
simulations with an average duration of casual relationships of 2 months the HIV
prevalence was less than 1%, whereas in simulations with an average duration of casual
relationship longer than 4 months, the HIV prevalence was higher than 2%.
These results indicated the relevance of parameters that measure the risk of HIV
transmission per partnership. Clearly, an increment in the duration of a relationship as
well as the number of sexual contacts significantly increased the probability of HIV
transmission and therefore, the HIV prevalence. Due to the methodological difficulties
for measuring these parameters (especially the mean duration of a casual relationship),
they are highly imprecise. Our model indicated however, the relevance of these
parameters on epidemiological models.
Efforts focused on increasing the precision of their estimation will improve the
accuracy of predictions from mathematical and computational models. On the other hand,
the cofactors for infectious diseases present in the general population such as malaria and
the enhanced HIV transmission caused by HSV-2 infection were the most influent
epidemiological parameters.

Limitations of the model
Although the sexual network simulated allows for link dynamics, the degree distribution
of the nodes and the node degree of each individual is maintained constant throughout the
entire simulation. This assumption may be unrealistic, since the degree distribution of
sexual networks on human populations might change over time. The node degree
distribution of the network was estimated from data collected in 2003, and thus this
degree distribution might not correspond to the node degree distribution of the sexual
network in 1980. Intervention programs focused on preventing promiscuity and changes
in behavior resulting from the HIV epidemic itself could decrease the number of sexual
partners that a person has in a year. Consequently, the behavioral data for 2003 could
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underestimate the node degree distribution of the network at the beginning of the
epidemic.
The static degree distribution also has an effect at an individual level. For
simplification, and given the lack of data, we assume that each individual has the same
node degree (number of sexual partners per year) during his/her entire sexual life.
Although the degree distribution of the network may be relatively stable for a long period
of time, nodes (individuals) may change their degree over time. For example, an
individual may start having many sexual partners; but marriage, possible infections with
other STIs, and the HIV epidemic itself may generate a behavioral change in the
individual, resulting in a lower number of sexual partners or even monogamy. This
decision-making may be an important process in the network, where the inclusion of
simulation tools, such as artificial intelligence, may be an interesting approach to
simulating such behavioral changes.
We also assumed no control interventions for the other STIs and malaria, and
therefore the prevalence of these infections remained constant over the simulation. This
assumption may appear unrealistic since important efforts to control malaria and STIs in
sub-Saharan Africa have been effective in reducing their prevalence; consequently, the
effects of these diseases on HIV may have been decreasing in recent years.
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Table A.1 Parameters used in the behavioral module of the model
Parameter
Value
Number of sexual partners per year
Gamma distribution (males)

Reference

Derived from (University of
Pennsylvania, 2003)

1. scale
2. shape
Gamma distribution (females)

1.1
1.9

3. scale
4. shape
Initial condition age distribution
Gamma distribution (males)

3.8
0.4

Derived from (University of
Pennsylvania, 2003)

Derived from (National Statistical
Office)

5. scale
6. shape
Gamma distribution (females)

2.24
17.32
Derived from (National Statistical
Office)

7. scale
8. shape
Marriage age distribution
Gamma distribution (males)

2.46
13.5
Derived from (University of
Pennsylvania, 2003)

9. scale
10. shape
Gamma distribution (females)

2.25
17.23

11. scale
12. shape
13. Percentage of married
population
14. Duration of casual
relationship
Separation probability
(exponential distribution)
15. scale

2.38
13.85
63%

Derived from (University of
Pennsylvania, 2003)

6 months

0.15
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Derived from (University of
Pennsylvania, 2003)
Derived from (University of
Pennsylvania, 2003)
Derived from (University of
Pennsylvania, 2003)

Table A.2 Parameters used in the epidemiological module of the model
Parameter
HIV probability of transmission per sexual contact
(low income countries)
1. Acute male-female
2. Chronic male-female
3. Advanced male-female
4. Acute female-male
5. Chronic female-male
6. Advanced female-male
Number of sexual contacts per month (by age)
7. 15-20
8. 21-30
9. 31-40
10. 41-60
Initial HIV infection age distribution (gamma)

Value

Reference
(Boily et al., 2009)

0.0276
0.003
0.0219
0.03496
0.0038
0.02774
(Gray et al., 2001)
11
9
9
7
Derived from
(National Statistical
Office)

11. Scale
12. Shape
HIV progression (Weibull cumulative probability
function)

8
5

13. Scale
14. Shape
HSV-2 probability of transmission per sexual
contact

5
4

Primary infection
15. Male to female
16. Female to male
Early stage
17. Male to female
18. Female to male
Chronic stage
19. Male to female
20. Female to male
HSV-2 stage duration

(Marion and
Schecter, 1992;
Salomon and
Murray, 2001)

(Abu-Raddad et al.,
2008; Freeman et
al., 2007)
0.3
0.15
0.01
0.005
0.005
0.003
(Abu-Raddad et al.,
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2008; Freeman et
al., 2007)
21. Primary infection
22. Early stage
23. Chronic stage
24. Latent stage
HSV shedding frequency per year

3 weeks
3 months
10 years
lifetime
(Abu-Raddad et al.,
2008)

25. In HIV positive individual
26. In HIV negative individual
27. Shedding during reactivation
Gonorrhea probability of transmission

6 per year
4 per year
15 days
(Buvé et al., 2001;
Orroth et al., 2007)

28. Male to female
29. Female to male
30. Gonorrhea duration of infection

0.23
0.13
3 months

Condom use by age (Gamma distribution)

31. Scale
32. Shape
33. Condom reduction of transmission

14.1
1.78
94%

Syphilis probability of transmission

34. Early stage male to female
35. Latent stage male to female
36. Early stage female to male
37. Latent stage female to male
Syphilis stage duration

(Buvé et al., 2001;
Ghani et al., 1998;
Orroth et al., 2007)
Derived from
(National Statistical
Office)

(Holmes et al.,
2004; Pinkerton
and Abramson,
1997)
(Buvé et al., 2001;
Orroth et al., 2007;
Oxman et al., 1996;
Pourbohloul et al.,
2003)

0.175
0.018
0.088
0.009
(Buvé et al., 2001;
Orroth et al., 2007;
Oxman et al., 1996;
Pourbohlou et al.,
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2003)
38. Duration early stage
39. Duration latent stage
Malaria Entomological Inoculation Rate (EIR)

40. Rainy season
41. Dry season
42. Duration of rainy season

6 months
8 years
Derived from
(Doherty et al.,
2005)
1.2
0.6
6 months

43. Malaria transmission efficiency
Malaria susceptibility coefficients
44. Alpha
45. N1
Malaria recovery coefficients
46. Beta
47. N2
48. Time of malaria parasite clearance

2
400
2 months

Amplificatory factor in HIV transmission
49. Gonorrhea

3

(Aron and May,
1982; Smith et al.,
2006)

0.026
2
200

(Gu et al., 2003)
(Gu et al., 2003)

(Anderson et al.,
1991; Kublin et al.,
2005)

(Celentano et al.,
1996; Galvin and
Cohen, 2004;
Kapiga and
Lugalla, 1998;
Kassler et al., 1994;
Laga et al., 1993;
Sexton et al., 2005)
2.5
(Deschamps et al.,
1996; Otten et al.,
1994; Rakwar et al.,
1999; Sexton et al.,
2005)
1.25 Derived from (AbuRaddad et al., 2006;
Kublin et al., 2005;
Quinn et al., 2000)
3 (Abu-Raddad et al.,

50. Syphilis

51. Malaria

52. HSV-2
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53. Enhanced susceptibility to HIV in HSV-2
infected individual

Commercial sex parameters
54. Proportion of male population having sex
with prostitutes per month

2008; Blower and
Ma, 2004; Celum et
al., 2004; Corey et
al., 2004; Freeman
et al., 2007; Sexton
et al., 2005; Weiss
et al., 2001)
3 (Abu-Raddad et al.,
2008; Blower and
Ma., 2004; Celum
et al., 2004; Corey
et al., 2004;
Freeman et al.,
2007a; Sexton et
al., 2005; Weiss et
al., 2001)
0.0066 (8%
in a year)

55. Gonorrhea prevalence in prostitutes

23%

56. Syphilis prevalence in prostitutes

16%

57. HSV prevalence in prostitutes

90%

58. Percentage of circumcised males

31%

59. HIV reduction in probability of transmission
in circumcised males
60. Number of sexual contacts a male individual
has with a prostitute in a month
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2 times
6

(Ferry et al., 2001;
Morison et al.,
2001; Nzila et al.,
1991)
(Morison et al.,
2001; Nzila et al.,
1991)
(Morison et al.,
2001; Nzila et al.,
1991)
(Ferry et al., 2001;
Morison et al.,
2001; Nzila et al.,
1991)
Derived from
(National Statistical
Office)
(Auvert et al., 2001;
Baeten et al., 2005)
Derived from
(Morison et al.,
2001)

Table A.3 Parameters sampled and their range for the uncertainty analysis for
behavioral module
Parameter

Range of uniform pdf

Minimum age

[14-18]

Maximum age
Number of sexual contacts per
month
Duration of casual relationship
(months)

[55-62]
[6-14]
[3-9]

Proportion of married population
Proportion of male population
having sex with prostitutes per
month
Number of sexual contacts a male
individual has with a prostitute in
a month

[0.5-0.7]

Reference
Derived from (National
Statistical Office)
Derived from (National
Statistical Office)
Representative
assumption
Representative
assumption
Derived from (National
Statistical Office)
Representative
assumption

[0.005-0.01]
Representative
assumption
[1-20]
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Table A.4 Descriptive statistics from the uncertainty analysis for the behavioral
module in the absence of co-infections
Descriptive Statistics
Mean
Median
Standard Deviation
25th percentile
95th percentile
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HIV prevalence
0.87
0
2.07
0
4.95

Table A.5 Partial rank correlation coefficients of the parameters sampled from the
behavioral module
Parameter
Minimum age
Maximum age
Number of sexual contacts per month
Duration of casual relationship
Proportion of married population
Proportion of male population having sex with prostitutes per month
Number of sexual contacts a male individual has with a prostitute in a month
The results are significant at the 0.05 level (*), the 0.01 level (**) or the 0.001 level (***).
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PRCC
0.02
0.07
0.49***
0.53***
0.04
0.01
0.04

Table A.6 Parameters sampled and their range for the uncertainty analysis for the
epidemiological module
Parameter

Range of
uniform pdf

Amplificatory factor in HIV transmission
Gonorrhea

[1.1-9]

Syphilis

[1.4-10]

Malaria

[1.1-1.6]

Enhanced transmission to HIV in HSV-2
co-infected individual

[2-5]

Enhanced susceptibility to HIV in HSV2 infected individual

[2-10]
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Reference

(Celentano et al., 1996;
Galvin and Cohen, 2004;
Kapiga and Lugalla, 1998;
Kassler et al., 1994; Laga et
al., 1993)
(Deschamps et al., 1996;
Otten et al., 1994; Rakwar et
al., 1999)
Derived from (Kublin et al.,
2005; Quinn et al., 2000)
(Abu-Raddad et al., 2008;
Blower and Ma., 2004;
Celum et al., 2004; Corey et
al., 2004; Freeman et al.,
2007a; Weiss et al., 2001)
(Abu-Raddad et al., 2008;
Blower et al., 2004; Celum et
al., 2004; Corey et al., 2004;
Freeman et al., 2007a; Weiss
et al., 2001)

Table A.7 Descriptive statistics from the uncertainty analysis for the epidemiological
module
Descriptive Statistics
Mean
Median
Standard Deviation
25th percentile
95th percentile

HIV prevalence
23.44
22.83
7.35
17.02
32.80
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Table A.8 First Table in Chapter 1
Parameter
Amplificatory factor in HIV transmission
Gonorrhea
Syphilis
Malaria
Enhanced transmission to HIV in HSV-2 co-infected individual
Enhanced susceptibility to HIV in HSV-2 infected individual
The results are significant at the 0.05 level (*), the 0.01 level (**) or the 0.001 level (***).
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PRCC

0.42**
0.46**
0.75***
0.04
0.29

Table A.9 Descriptive statistics from the uncertainty analysis for the complete
module
Descriptive Statistics
Mean
Median
Standard Deviation
25th percentile
95th percentile

HIV prevalence
14.03
7.12
16.02
0.23
45.06
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Table A.10 Partial rank correlation coefficients of the parameters sampled from the
complete module
Parameter
Minimum age
Maximum age
Number of sexual contacts per month
Duration of casual relationship
Proportion of married population
Proportion of male population having sex with prostitutes per month
Circumcision
Amplificatory factor in HIV transmission
Gonorrhea
Syphilis
Malaria
Enhanced transmission to HIV in HSV-2 co-infected individual
Enhanced susceptibility to HIV in HSV-2 infected individual
The results are significant at the 0.05 level (*), the 0.01 level (**) or the 0.001 level (***).
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PRCC
-0.04
0.09
0.45***
0.79***
-0.10
0.068
-0.17

-0.03
-0.31
0.23**
0.31**
0.10

Figure A.1 Annual degree distribution of the number of sexual partners per year

Males: (A) Estimated for Malawi (University of Pennsylvania, 2003) (B) resulting from
the simulations; and for females: (C) Estimated for Malawi (University of Pennsylvania,
2003) (D) resulted from the simulations. Red lines represent the fitted gamma
distribution. The histograms represent the distribution of the data.
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Figure A.2 Age distribution of males and females combined

(A) Age distribution of sexual active population estimated for Malawi in 2003 (National
Statistical Office) and (B) Age distribution of sexual active population resulting from the
simulation for 2003. Red lines represent the fitted gamma distribution. The histograms
represent the distribution of the data.
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A

Age

Age

138

Figure A.3 Marriage distribution according to age

(A) Female age distribution estimated from Malawi in 2003 (National Statistical Office)
and (B) the age distribution from the simulation estimated for 2003. (C) Male age
distribution estimated from Malawi in 2003 (National Statistical Office) and (D) the age
distribution from the simulation estimated for 2003. Red lines represent the fitted gamma
distribution. The histograms represent the distribution of the data.
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Figure A.4 Number of long-term relationship (marriages) during the entire sexual
life an individual male or female

(A) Derived from Malawi in 2003 (National Statistical Office) and (B) derivate from the
simulations.
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Number of marriages
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Figure A.5 Age-distribution of the HIV prevalence

(A) the observed data from Malawi in 2004 (Glynn, 2008), (B) the resulting HIV
prevalence distribution from Simulation 2 for the same year. (C) The observed agedistribution data from Malawi for HSV-2 in 2004 (Glynn, 2008), and (D) the HSV-2 agedistribution prevalence from Simulation 2 for the same year.
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Appendix B - Supplementary methods Chapter 5

Mathematical Approach of the Spread of HIV at Population Level
To evaluate the effect of co-infection at population level, I used a standard deterministic
population model constructed by Abu-Raddad and coworkers (Abu-Raddad et al., 2008;
Abu-Raddad et al., 2006). The model is a deterministic compartment model, which
stratifies the population into compartments according to HIV sero-status and stage of
HIV infection, and sexual-risk activity group,
dS (i )
= μ p N 0 (i ) − μ p S (i ) − Λ i S (i )
dt
dI1 (i )
= Λ i S (i ) − μ p I1 (i ) − ω1 I1 (i )
dt
.
dI 2 (i )
= ω1 I1 (i ) − μ p I 2 (i ) − ω2 I 2 (i )
dt
dI 3 (i )
= ω2 I 2 (i ) − μ p I 3 (i ) − ω3 I 3 (i )
dt

The index i stands for an i -sexual risk population where i = 1, 2, 3, 4 represent
the low, low to intermediate, intermediate to high, and high risk groups, respectively.

S (i ) is the susceptible population, and Iα (i) is the HIV infected populations. The index

α indicates the stage of HIV pathogenesis, where α = 1, 2, 3 stand for acute, chronic, and
late stages respectively. N 0 (i) is the initial population size, of each i -risk group.
The progression of HIV is described by ω1 , the rate of progression from acute to
chronic stage, ω 2 , the rate from chronic to late stage, and ω 3 , the rate of HIV/AIDS
disease mortality. μ p is the death rate. The rates Λ i are the HIV forces of infection
(hazard rates of infection) experienced by the susceptible populations given by:
⎛
⎞
ρ Iα ′ ( j ) I α ′ ( j )
⎜
⎟
Ψ (i, j )
∑ t
Λ i = ρ S ( i ) × ∑ ⎜⎜ α ′=1,2 ,3 I α ′ ( j ) → S ( i )
ρ S ( j ) S ( j ) + ∑ ρ I α ′′ ( j ) I α ′′ ( j ) ⎟⎟
j = 1, 2 ,3 , 4 ⎝
α ′′ = 1, 2 ,3
⎠
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.

Here, ρ X ( i ) describes the new sexual partner acquisition rate for each
population X ( i ) . The expression Ψ (i , j ) represents the mixing among the four risk
groups. It estimates the probability that an individual in risk group i would choose a
partner in risk group j (Garnett and Anderson, 1993) and is described by:
Ψ ( i , j ) = eδ i , j + (1 − e )

ρ s( j)S ( j)

∑

α ′= 1, 2 ,3

ρ Iα

′

I ( j)

( j) α ′

⎛
⎞
⎜ ρ s ( k ) S ( k ) + ∑ ρ Iα ′ ( k ) I α ′ ( k ) ⎟
k = 1, 2 ,3 , 4 ⎝
α ′ = 1, 2 ,3
⎠

∑

.

Here, δ i , j is the identity matrix and the parameter e ∈ [ 0,1] measures the degree of
assortativeness in the mixing. For example, at the extreme e = 0 , the mixing in the
population is fully proportional, while at the other extreme e = 1 , individuals mix in
assortative fashion exclusively.
The parameter t Iα represents the HIV transmission probability per partnership in a
partnership between a member of the susceptible population S ( j ) and a member of the
HIV infected population Iα (i) . This value is calculated using the binomial model
t I α = 1 − (1 − p IHα I(Vi ) → S ( j ) )

n Iα

( i ) ↔ S ( j )τ I α ( i ) ↔ S ( j )

,

which includes the HIV transmission probability per sexual contact per HIV stage
), the frequency of sexual contacts per HIV stage in this partnership
( pIHIV
α ( i )→ S ( j )
( n Iα ( i ) ↔ S ( j ) ), and the duration of the partnership ( τ Iα ( i ) ↔ S ( j ) ). Assumptions for parameter
values are summarized on Table B.1.
I focused on the study of the endemic equilibrium solutions of the system, which
yields the following expressions for the population variables in terms of the force of
infection and other parameters:
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Si =

μ N 0,i
μ + Λi

I i ,1 =

μ N 0,i ⎡ Λ i ⎤
⎢
⎥
μ + ω1 ⎣ μ + Λ i ⎦

I i ,2 =

μω1 N 0,i
⎡ Λi ⎤
⎢
⎥
( μ + ω1 )( μ + ω2 ) ⎣ μ + Λi ⎦

I i ,3 =

μω1ω2 N 0,i
⎡ Λi ⎤
⎢
⎥
( μ + ω1 )( μ + ω2 )( μ + ω3 ) ⎣ μ + Λ i ⎦
.

The equilibrium solution was found through convergent successive
approximations. Once the force of infection per risk group was determined, I calculated
the total prevalence and incidence using the different values for the p IHIV
( i ) → S ( j ) with and
without co-infection.
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Table B.1 Co-infection between-host parameter values
Parameter

Value

Reference

HIV transmission probability per coital act per
stage of infection ( piHIV )
Acute stage

0.036

(Hollingsworth et al.,
2008; Pinkerton, 2008;
Wawer et al., 2005)

Chronic stage

0.0008

(Wawer et al., 2005)

Late stage

0.0042

(Wawer et al., 2005)

49 days

(Pinkerton, 2008;
Wawer et al., 2005)

Chronic stage

9.0 years

(Morgan and
Whitworth, 2001;
UNAIDS, 2007;
UNAIDS/WHO)

Late stage

2.0 years

(Wawer et al., 2005)

Acute stage

10.6/month

(Wawer et al., 2005)

Chronic stage

11.0/month

(Wawer et al., 2005)

7.1/month

(Wawer et al., 2005)

Low risk

65%

(Ferry et al., 2001)

Low to intermediate risk

23%

(Ferry et al., 2001)

Low to high risk

9.5%

(Ferry et al., 2001)

High risk

2.5%

(Morison et al., 2001a)

0.095
partners/year

(Abu-Raddad et al.,
2008)

Duration of each HIV stage (1/ ωi )
Acute stage

Frequency of coital acts per HIV stage ( nIα (i )→S ( j ) )

Late stage
Fraction of the initial population size in each risk
group

Net sexual partner acquisition rate ( ρ X ( i ) )
Low risk
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Low to intermediate risk

1.30
partners/year

(Abu-Raddad et al.,
2008)

Low to high risk

5.46
partners/year

(Abu-Raddad et al.,
2008)

High risk

35.78
partners/year

(Abu-Raddad et al.,
2008)

Low risk with low risk

48 months

(Abu-Raddad et al.,
2008)

Low risk with low to intermediate risk

36 months

(Abu-Raddad et al.,
2008)

Low risk with intermediate to high risk

24 months

(Abu-Raddad et al.,
2008)

Low risk with high risk

12 months

(Abu-Raddad et al.,
2008)

24 months

(Abu-Raddad et al.,
2008)

Low to intermediate risk with intermediate
to high risk

12 months

(Abu-Raddad et al.,
2008)

Low to intermediate risk with high risk

6 months

(Abu-Raddad et al.,
2008)

Intermediate to high risk with intermediate
to high risk

6 months

(Abu-Raddad et al.,
2008)

Intermediate to high risk with high risk

1 months

(Abu-Raddad et al.,
2008)

1 week

(Abu-Raddad et al.,
2008)

Duration of sexual partnership ( τ Yα ( i ) ↔ S ( j ) )

Low to intermediate risk with low to
intermediate risk

High risk with high risk
Duration of sexual lifespan ( 1 μ )
Degree of assortativenes ( e )

146

35 years

(Abu-Raddad et al.,
2008)

0.224

(Abu-Raddad et al.,
2006; Buve, 2001a)
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